Loading organization details...
Loading organization details...
Source: IRS Form 990 via ProPublica Nonprofit Explorerⓘ Leadership data below reflects a more recent filing (Tax Year 2024) from the IRS e-file system.
Total Revenue
▼$241K
Total Contributions
$48.6K
Total Expenses
▼$262.9K
Total Assets
$282.9K
Total Liabilities
▼$556
Net Assets
$282.3K
Officer Compensation
→$0
Other Salaries
$163.3K
Investment Income
▼$6,250
Fundraising
▼$0
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$15.8M
VA/DoD Award Count
10
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding (partial)
$513.3M
Awards Found
200+
Additional awards may exist. View all on USAspending.gov →
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Education | LOYOLA_CARES_INSTITUTIONAL | $29.3M | FY2020 | May 2020 – May 2022 |
| Department of Education | LOYOLA CARES | $23.9M | FY2020 | Apr 2020 – May 2022 |
| Department of Health and Human Services | TCR GENE MODIFIED T CELLS FOR ADOPTIVE IMMUNOTHERAPY | $14.8M | FY2011 | Sep 2011 – Aug 2018 |
| Department of Education | LOYOLA MARYMOUNT UNIVERSITY CARES INSTITUTIONAL FUND | $13.7M | FY2020 | Jun 2020 – May 2022 |
| Department of Education | LMU STUDENT EMERGENCY RELIEF | $11.2M | FY2020 | Jun 2020 – Jun 2023 |
| Department of Education | INSTITUTIONAL PORTION OF HIGHER EDUCATION EMERGENCY RELIEF FUND FORMULA GRANTS | $8.5M | FY2020 | May 2020 – May 2022 |
| Department of Health and Human Services | STRUCTURAL DETERMINANTS OF CALCIUM PUMP REGULATION | $8.1M | FY2008 | Jul 2008 – Jun 2026 |
| Department of Health and Human Services | COLLABORATIVE INTEGRATION OF HCV MOLECULAR VIROLOGY AND MATHEMATICAL MODELING | $7.5M | FY2011 | Jun 2011 – May 2025 |
| Department of Education | LOYOLA UNIVERSITY MARYLAND CARES CERTIFICATION AGREEMENT 2 | $7.2M | FY2020 | May 2020 – May 2022 |
| Department of Education | EMERGENCY FINANCIAL AID GRANTS TO STUDENTS UNDER THE CORONAVIRUS AID, RELIEF, AND ECONOMIC SECURITY (CARES) ACT | $6.9M | FY2020 | Apr 2020 – May 2022 |
| Department of Health and Human Services | MECHANISMS OF VIRAL PROTEASES IN CORONAVIRUS REPLICATION AND PATHOGENESIS | $6.8M | FY2010 | Jul 2010 – Jun 2022 |
| Department of Education | LOYOLA UNIVERSITY MARYLAND CARES CERTIFICATION AGREEMENT | $6M | FY2020 | Apr 2020 – May 2022 |
| Department of Health and Human Services | PARADOXICAL EFFECTS OF NF-KB IN ISCHEMIA; NOVEL POLYMERIC GENE SILENCING IN VIVO | $5.7M | FY2008 | Jul 2008 – May 2018 |
| Department of Health and Human Services | IDO1 AND IMMUNOTOLERANCE IN GLIOBLASTOMA | $4.6M | FY2016 | Aug 2016 – Jun 2027 |
| Department of Health and Human Services | GSK-3? LOCALIZES TO THE MYOFILAMENT AND MODIFIES ITS FUNCTION IN ISCHEMIC CARDIOMYOPATHY | $4.5M | FY2017 | Apr 2017 – Mar 2027 |
| Department of Health and Human Services | PLUS LOYOLA CLINICAL CENTER | $4.4M | FY2015 | Aug 2015 – Jun 2025 |
| Department of Health and Human Services | INVESTIGATING INTERFERON ANTAGONISTS IN DELAYING INNATE IMMUNE RESPONSES TO SARS-COV-2 - TITLE: INVESTIGATING INTERFERON ANTAGONISTS IN DELAYING INNATE IMMUNE RESPONSES TO SARS-COV-2 PI: SUSAN C. BAKER, PHD, LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE THE GOAL OF THIS PROPOSAL IS TO DETERMINE HOW VIRAL INTERFERON ANTAGONISTS FUNCTION IN THE REPLICATION AND PATHOGENESIS OF CORONAVIRUSES, PARTICULARLY DURING REPLICATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2). CORONAVIRUSES (COVS) ARE A DIVERSE FAMILY OF POSITIVE-SENSE RNA VIRUSES THAT INCLUDE PATHOGENIC STRAINS INFECTING HUMAN AND ANIMAL HOSTS. COVS HAVE REPEATEDLY JUMPED FROM ANIMAL RESERVOIRS INTO HUMAN CIRCULATION, CAUSING SEVERE DISEASE AND PANDEMICS, AS WE ARE CURRENTLY EXPERIENCING WITH SARS-COV-2. DEVELOPING APPROPRIATE PROTECTIVE MEASURES AGAINST EMERGING COVS, INCLUDING SARS-COV- 2, WILL DEPEND UPON GAINING AN UNDERSTANDING OF CORONAVIRUS-HOST INTERACTIONS. WE DISCOVERED THAT THE ENDORIBONUCLEASE (ENDOU), A HIGHLY CONSERVED COMPONENT OF THE COV REPLICASE COMPLEX, REDUCES DSRNA SPECIES RECOGNIZED BY HOST PATTERN RECOGNITION RECEPTOR MDA5, DELAYING THE INDUCTION OF INTERFERON. WE REPORTED THAT VIRUSES EXPRESSING AN INACTIVE FORM OF ENDOU REPLICATE AS EFFICIENTLY AS WILD TYPE VIRUS IN IFN NON- RESPONSIVE CELLS. IMPORTANTLY, REPLICATION OF ENDOU MUTANT COVS IN INTERFERON-RESPONSIVE CELLS ACTIVATE ROBUST IMMUNE RESPONSES, WHICH EXTINGUISHES VIRUS REPLICATION AND REDUCES PATHOGENESIS IN ANIMALS. RECENTLY, WE IDENTIFIED THE TARGET OF ENDOU ACTIVITY TO BE POLY-URIDINE CONTAINING NEGATIVE SENSE RNA, WHICH WE TERM PUN RNA. THIS REMOVAL OF THE PUN RNA DELAYS THE GENERATION OF DSRNA SPECIES THAT ARE RECOGNIZED BY HOST PATTERN RECOGNITION RECEPTOR MDA5. WE HYPOTHESIZE THAT ENDOU ACTIVITY CONTRIBUTES TO THE DELAY IN THE INNATE IMMUNE RESPONSE TO SARS-COV-2 REPLICATION. HERE, WE PROPOSE TO INVESTIGATE THE MECHANISM OF HOW ENDOU ACTS IN SARS-COV-2, HOW ENDOU ASSOCIATES WITH THE REPLICASE COMPLEX, AND HOW PUN RNA CONTRIBUTES TO ACTIVATING MDA5. IN AIM 1, WE WILL EVALUATE ENDOU AND OTHER IFN ANTAGONISTS FOR THEIR ROLE AS MODULATORS OF TYPE I AND TYPE III IFN RESPONSES TO SARS-COV-2 INFECTION IN PRIMARY HUMAN AIRWAY CELLS AND IN ENTEROCYTES. WE WILL USE REVERSE GENETICS TO GENERATE VIRUSES WITH INACTIVE IFN ANTAGONISTS AND EVALUATE THE EFFECTS OF COMBINING INACTIVATION OF ENDOU WITH INACTIVATING MUTATIONS OF OTHER VIRAL PROTEIN IFN ANTAGONISTS. IN AIM 2 WE WILL DELINEATE AND DISRUPT ENDOU INTERACTIONS WITHIN THE CORONAVIRUS REPLICASE COMPLEX. THE RESULTS OF THESE STUDIES WILL GUIDE STRATEGIES FOR DISRUPTION OF ENDOU FROM THE COV REPLICASE COMPLEX, WHICH WOULD ACTIVATE PROTECTIVE IMMUNE RESPONSES TO COV INFECTIONS. IN AIM 3, WE WILL IDENTIFY REGIONS OF POLY-URIDINE NEGATIVE-SENSE RNA, TERMED PUN RNA, REQUIRED FOR RECOGNITION BY ENDOU AND MDA5. THESE STUDIES WILL PROVIDE NEW INFORMATION ON HOW PUN RNAS ARE RECOGNIZED BY ENDOU AND MDA5. OVERALL, THESE STUDIES WILL DEFINE A NEW MECHANISM FOR HOW AN ENDORIBONUCLEASE ACTS AS A VIRULENCE FACTOR. THIS NEW INFORMATION CAN BE USED TO DEVELOP ANTIVIRAL THERAPIES AND VACCINES AGAINST EXISTING AND EMERGING CORONAVIRUSES. | $3.8M | FY2021 | Jul 2021 – Jun 2026 |
| Department of Health and Human Services | GENETICS OF HYPERTENSION IN BLACKS | $3.7M | FY1995 | Sep 1995 – Apr 2015 |
| Department of Health and Human Services | LIGAND-INDEPENDENT SIGNALING OF ESTROGEN RECEPTOR BETA AND THE AGING BRAIN | $3.7M | FY2009 | Aug 2009 – May 2023 |
| Department of Health and Human Services | MOLECULAR MECHANISMS OF FOCAL ADHESION KINASE IN PROMOTING HEPATOCARCINOGENESIS | $3.6M | FY2015 | Jul 2015 – Dec 2026 |
| Department of Health and Human Services | METS-SLEEP: SLEEP TIMING, GUT MICROBIOTA AND CARDIOMETABOLIC RISK ACROSS THE EPIDEMIOLOGIC TRANSITION | $3.5M | FY2019 | Sep 2019 – May 2026 |
| Department of Health and Human Services | DATA-DRIVEN MATHEMATICAL AND COMPUTATIONAL MODELING OF HEPATITIS D INFECTION AND TREATMENT RESPONSE | $3.5M | FY2020 | Feb 2020 – Jan 2025 |
| Department of Health and Human Services | COMPUTATIONAL MODELING FOR HCV VACCINE TRIAL DESIGN AND OPTIMAL VACCINE-BASED COMBINATION INTERVENTIONS - PROJECT SUMMARY/ABSTRACT DESPITE REMARKABLE PROGRESS WITH DIRECT-ACTING ANTIVIRALS (DAAS), HEPATITIS C VIRUS (HCV) INFECTION REMAINS A SERIOUS GLOBAL PUBLIC HEALTH PROBLEM WITH OVER 1% OF THE WORLD’S POPULATION AND ABOUT 3 MILLION IN THE UNITED STATES (U.S.) INFECTED. THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES RECENTLY RENEWED THE ACTION PLAN TO PREVENT, CARE AND TREAT VIRAL HEPATITIS TO ELIMINATE VIRAL HEPATITIS INFECTION AS A PUBLIC HEALTH THREAT AND THE WHO INTRODUCED GLOBAL TARGETS FOR THE CARE AND MANAGEMENT OF HCV. WHILE THE HIGHEST UPTAKE OF HCV TREATMENT OCCURRED IN 2017 AND 1.5 MILLION PEOPLE WERE CURED, 1.6 MILLION NEW INFECTIONS OCCURRED. DUE TO MANY TREATMENT BARRIERS, ONLY AN ESTIMATED 21% OF INFECTED PATIENTS ARE DIAGNOSED AND ONLY 2% OF TOTAL INFECTED PATIENTS ARE BEING TREATED FOR THE DISEASE ANNUALLY. DAAS ALONE ARE UNLIKELY TO ACHIEVE HCV ELIMINATION; AS SUCH, THE DEVELOPMENT OF A VACCINE TO PREVENT HCV INFECTION IS AN IMPORTANT FOCUS OF ONGOING RESEARCH. VACCINE CLINICAL TRIALS FOR HCV INFECTION WILL NEED TO RECRUIT FROM HIGH-RISK POPULATIONS, SUCH AS PERSONS WHO INJECT DRUGS (PWID), WHO CONTRIBUTE AN ESTIMATED 60% OF ALL NEW HCV INFECTIONS IN THE U.S. AND HAVE AN INCREASING INCIDENCE OF HCV, ESPECIALLY AMONG YOUNG PWID. ADDITIONALLY, LIMITED ACCESS TO DAA TREATMENT, SYRINGE SERVICE PROGRAMS (SSP), AND CONTINUED INJECTION DRUG USE POSES CHALLENGES AMONG PWID EVEN AS TREATMENT WITH MEDICATION FOR OPIOID USE DISORDER (MOUD) IS EXPANDING. FACTORS CONTRIBUTING TO TRANSMISSION AND SUCCESSFUL INTERVENTION (DAAS, MOUD, SSP) AMONG PWID ARE DYNAMIC AND COMPLEX AND OCCUR AT THE INDIVIDUAL (E.G., PATHOGEN-HOST INTERPLAY, RISK BEHAVIORS), SOCIAL (E.G., INJECTION NETWORK, SOCIAL NORMS), STRUCTURAL (E.G., ACCESS TO SSP AND MOUD), AND GEOGRAPHIC (E.G., INTERACTION LOCATIONS) LEVELS. AS SUCH, PERFORMING HCV VACCINE RANDOMIZED CLINICAL TRIALS (RCT) IN THE PWID POPULATION PRESENTS MAJOR CHALLENGES. WE PROPOSE TO DEVELOP AN INTEGRATED COMPREHENSIVE COMPUTATIONAL MODELING APPROACH TO EXAMINE THESE CHALLENGES SYSTEMATICALLY AND ASSESS THE IMPACT OF SPECIFIC RCT MODIFICATIONS ON CLINICAL TRIAL SUCCESS. TO EXPLORE VACCINE TRIAL DESIGN AND OUTCOMES, OUR INTERDISCIPLINARY TEAM WILL: (1) DESIGN AND EVALUATE CLINICAL TRIALS IN LOW INCIDENCE PWID SITES, USING METROPOLITAN CHICAGO AS THE MODEL, WHICH REDUCES THE CHANCE OF SOMEONE BECOMING EXPOSED BEFORE BEING FULLY PROTECTED; (2) DESIGN AND EVALUATE CLINICAL TRIALS IN HIGH INCIDENCE PWID SITES, USING SAN FRANCISCO AS THE MODEL, WHICH INCREASES THE CHANCE OF SOMEONE BECOMING EXPOSED BEFORE BEING FULLY PROTECTED; AND (3) DISCOVER EFFECTIVE HCV VACCINE-BASED INTERVENTION STRATEGIES TO ACHIEVE WHO ELIMINATION GOALS IN THE CONTEXT OF A LICENSED VACCINE. THE LITERATURE SUPPORTS THAT NON-STERILIZING VACCINES ARE EXPECTED TO BE THE FOCUS OF FUTURE TRIALS, REMINISCENT OF RECENT COVID-19 VACCINES, THEREFORE WE WILL SIMULATE THEIR EFFECT ON TRANSMISSION TO REACH ELIMINATION. WE WILL ACCOUNT FOR SSP AND MOUD AND THEIR EFFECT ON OUTCOMES IN TWO CITIES WITH DISPARATE HCV EPIDEMIC PROFILE AMONG PWID—CHICAGO AND SAN FRANCISCO. | $3.5M | FY2022 | Nov 2021 – Oct 2026 |
| Department of Health and Human Services | ALCOHOL INTOXICATION AND POSTBURN INTESTINAL IMMUNITY | $3.5M | FY2007 | Apr 2007 – Jun 2020 |
| Department of Health and Human Services | HOST-ASSOCIATED BIOFILM FORMATION AND DISPERSAL MECHANISMS | $3.5M | FY2019 | May 2019 – Apr 2029 |
| Department of Health and Human Services | NOVEL PARACRINE MECHANISMS FOR CELL-BASED THERAPY OF INJURED LUNGS | $3.4M | FY2017 | Sep 2017 – Apr 2027 |
| Department of Health and Human Services | A NOVEL ANTI-SPORE NASAL VACCINE FOR PROTECTION FROM ANTHRAX | $3.3M | FY2011 | Aug 2011 – Jul 2018 |
| Department of Health and Human Services | TRAINING IN NEUROIMMUNOENDOCRINE EFFECTS OF ALCOHOL | $3.3M | FY2002 | Jul 2002 – Jun 2024 |
| Department of Health and Human Services | NEUROMOLECULAR CONSEQUENCES OF ADOLESCENT BINGE DRINKING | $3.3M | FY2013 | Sep 2013 – Jun 2027 |
| Department of Health and Human Services | THE FEMALE URINARY MICROBIOME AND URINARY INCONTINENCE | $3.1M | FY2016 | Apr 2016 – Mar 2022 |
| Department of Health and Human Services | MAINTAINING B CELL IMMUNITY WITH AGED B LYMPHOCYTES | $3M | FY2007 | Mar 2007 – Jul 2017 |
| Department of Health and Human Services | DETERMINANTS AND CONSEQUENCES OF LOW VITAMIN D IN POPULATIONS OF AFRICAN DESCENT | $3M | FY2011 | Sep 2011 – Jun 2018 |
| Department of Health and Human Services | GUT MICROBIOTA, SHORT CHAIN FATTY ACIDS, AND ADIPOSITY ACROSS THE EPIDEMIOLOGIC TRANSITION | $3M | FY2017 | Apr 2017 – Mar 2024 |
| Department of Health and Human Services | SOMATIC DIVERSIFICATION OF IMMUNOGLOBULIN GENES IN GALT | $3M | FY2001 | Aug 2001 – Jul 2017 |
| Department of Education | PURPOSEFUL ENGAGEMENT IN ACADEMIC RIGOR AND LANGUAGE LEARNING (PEARLL): EFFECTS OF THE SOBRATO EARLY ACADEMY LANGUAGE (SEAL) MODEL TO PREVENT LONG TERM ENGLISH LEARNER STATUS | $3M | FY2021 | Sep 2021 – Aug 2026 |
| Department of Health and Human Services | NEW MECHANISMS OF SERCA REGULATION: DIMERIZATION AND MICROPEPTIDES | $3M | FY2019 | Jan 2019 – May 2029 |
| Department of Health and Human Services | DEFINING THE NUCLEAR IMPORT PATHWAYS OF HIV-1 - ABSTRACT HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), LIKE ALL PRIMATE LENTIVIRUSES POSSESSES THE ABILITY TO INFECT NON-DIVIDING CELLS BY ENGAGING WITH COMPONENTS OF THE NUCLEAR PORE COMPLEX AND MEDIATING THE NUCLEAR TRANSLOCATION OF THE VIRAL RIBONUCLEOPROTEIN COMPLEX (RNP) FOR SUBSEQUENTLY INTEGRATION INTO THE HOST CELL GENOME. THE VIRAL CAPSID PROTEIN (CA) INTERACTS WITH NUMEROUS HOST FACTORS INVOLVING CONSTITUENTS OF THE NUCLEAR PORE COMPLEX (NPC) TO ACCOMPLISH THE PROCESS OF NUCLEAR IMPORT. UNFORTUNATELY, THE EXACT MECHANISM BY WHICH HIV-1 TRANSLOCATES THROUGH THE NUCLEAR PORE COMPLEX REMAINS ONE OF THE LEAST UNDERSTOOD STEPS OF THE VIRAL LIFE CYCLE. IN ADDITION, RECENT EVIDENCES SUPPORTING THE NOTION OF NPCS BEING MORE HETEROGENEOUS THAN PREVIOUSLY THOUGHT FURTHER CONFOUNDS THIS SITUATION. WE HAVE DEVELOPED AN INDUCIBLE NUCLEAR PORE BLOCKADE THAT ALLOWS THE RATE OF NUCLEAR IMPORT OF FUNCTIONAL, INFECTIOUS VIRAL GENOMES TO BE MONITORED IN ANY RELEVANT CELLS TYPES. USING THIS TECHNIQUE, WE OBSERVE THAT CERTAIN CA MUTANTS ARE INSENSITIVE TO A NUP62 MEDIATED NUCLEAR PORE BLOCKADE IN CELLS WHICH POTENTLY BLOCK INFECTION BY WILD TYPE CA, DEMONSTRATING THAT HIV-1 CAN UTILIZE DISTINCT NUCLEAR IMPORT PATHWAYS DURING INFECTION. IN THIS APPLICATION, WE WILL DETERMINE THE DEGREE TO WHICH NPC ARE HETEROGENEOUS AND MAP THE SPECIFIC NUCLEAR PORE CONSTITUENTS THAT MAKEUP THE NPCS UTILIZED BY HIV-1 DURING NUCLEAR ENTRY. WITH OUR NUCLEAR PORE BLOCKADE, WE NOW HAVE THE CAPABILITY TO BLOCK NPCS USING DIFFERENT NUCLEAR PORE CONSTITUENTS. AS SUCH, THIS APPLICATION AIMS TO DEFINE AND VISUALIZE THE SPECIFIC NUCLEAR PORE CONSTITUENTS THAT INTERACT AND MEDIATE THE NUCLEAR IMPORT OF HIV-1 AND HOW SPECIFIC NPC USAGE AFFECTS VIRAL INTEGRATION IN TARGET CELLS. COLLECTIVELY THIS APPLICATION WOULD CLOSE CRITICAL GAPS TO OUR UNDERSTANDING IN TO THE NUCLEAR IMPORT OF HIV-1. | $2.9M | FY2021 | Jul 2021 – Jun 2025 |
| National Science Foundation | COLLABORATIVE RESEARCH: TRI-ALLIANCE FOR POST-AWARD INNOVATION -THE TRI-ALLIANCE CONSORTIUM AIMS TO TRANSFORM POST-AWARD ACTIVITIES AT EMERGING RESEARCH INSTITUTIONS (ERIS) TO REDUCE ADMINISTRATIVE BURDEN, BETTER SUPPORT FACULTY IN THEIR RESEARCH, AND INCREASE GRANT ACTIVITY. WITHOUT ADEQUATE RESEARCH INFRASTRUCTURE, FACULTY AND STAFF AT ERIS FACE DISTINCT CHALLENGES, INCLUDING LACK OF SUPPORT SYSTEMS FOR MANAGING THE POST-AWARD RESPONSIBILITIES, ACCESS TO ACCURATE INFORMATION, AND POST-AWARD COMPLIANCE. ADDRESSING THESE ISSUES CAN HELP INCREASE THE RESEARCH CONTRIBUTIONS FROM DIVERSE INSTITUTIONS, THEREBY SUPPORTING U.S. ECONOMIC GROWTH. THE TRI-ALLIANCE CONSORTIUM, WHICH INCLUDES LOYOLA MARYMOUNT UNIVERSITY, SANTA CLARA UNIVERSITY, AND UNIVERSITY OF SAN FRANCISCO, IS DEDICATED TO ADVANCING RESEARCH EXCELLENCE THROUGH COLLABORATION AND RESOURCE SHARING. THESE CALIFORNIA-BASED INSTITUTIONS, PART OF THE ASSOCIATION OF JESUIT COLLEGES AND UNIVERSITY (AJCU), AND RECOGNIZED AS ERIS, WILL FOCUS ON THREE CORE COMPONENTS: 1) BUILDING CAPACITY FOR POST-AWARD SERVICE STRUCTURES, FUNCTIONS, AND DATA COLLECTION; 2) DEVELOPING SHARED EDUCATION AND TRAINING OPPORTUNITIES AND RESOURCE MATERIALS TO INCREASE EFFICIENCY AND REDUCE ADMINISTRATIVE BURDENS; AND 3) PILOTING INNOVATIVE CROSS-DIVISION SUPPORT ROLES THAT SPAN PRE- AND POST-AWARD ADMINISTRATION. BY SHARING RESOURCES, PILOTING INNOVATIVE POSITIONS, AND DOCUMENTING BEST PRACTICES, THE TRI-ALLIANCE WILL CREATE A TOOLKIT AVAILABLE TO ERIS, THUS FOSTERING A STRONGER, MORE EFFICIENT RESEARCH ENVIRONMENT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD. | $2.9M | FY2024 | Sep 2024 – Aug 2029 |
| Department of Education | COMPREHENSIVE PREPARATION OF SCHOOL PSYCHOLOGISTS TO SUPPORT THE MENTAL HEALTH OF STUDENTS THAT ARE CULTURALLY AND LINGUISTICALLY DIVERSE IN THE CICERO COMMUNITY | $2.9M | FY2023 | Jan 2023 – Dec 2026 |
| Department of Health and Human Services | MOLECULAR GENETICS OF MLL-ASSOCIATED LEUKEMIA | $2.9M | FY2005 | Sep 2005 – Jul 2011 |
| Department of Health and Human Services | ADVANCED NURSING EDUCATION WORKFORCE | $2.8M | FY2017 | Jul 2017 – Jun 2024 |
| Department of Health and Human Services | WEIGHTING LONGITUDINAL DATA TO ACCESS OPIOID ANALGESIA TAPERING OUTCOMES AMONG PATIENTS WITH CO-OCCURRING CHRONIC PAIN AND SUBSTANCE USE DISORDER - PROJECT SUMMARY/ABSTRACT IN 2016, THE CENTERS FOR DISEASE CONTROL (CDC) RELEASED GUIDELINES RECOMMENDING NON-PHARMACOLOGIC TREATMENT FOR CHRONIC PAIN OVER USE OF OPIOID ANALGESIA IN RESPONSE TO RISING OVERDOSE DEATHS AND BASED ON STUDIES SHOWING NONOPIOID AND MULTIDISCIPLINARY APPROACHES TO PAIN CONTRIBUTE TO FUNCTIONAL AND PAIN SEVERITY IMPROVEMENTS. CDC GUIDELINES ALSO RECOMMENDED OPIOID TAPERING FOR CHRONIC PAIN PATIENTS WITH SUBSTANCE USE DISORDER (SUD) AND TRANSITION TO MEDICATIONS FOR OPIOID USE DISORDER (MOUD) FOR PATIENTS WITH CO-OCCURRING OPIOID USE DISORDER (OUD). WHILE OPIOID TAPERING HAS BEEN WIDELY IMPLEMENTED, FEW STUDIES ASSESS TRANSITIONS TO MOUD OR MULTIDISCIPLINARY MEDICINE USE SPECIFICALLY AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD. A PRIMARY REASON FOR THIS LIMITED KNOWLEDGE IS THE POPULATION WITH CHRONIC PAIN AND CO-OCCURRING SUD IS OFTEN RELATIVELY SMALL IN ANY GIVEN HEALTHCARE FACILITY OR SYSTEM, AND OUTCOMES OF INTEREST MAY OCCUR IN LOW TOTAL NUMBERS. THUS, A LARGE DATABASE IS REQUIRED TO CONDUCT MULTIFACTORIAL RESEARCH ON OUTCOMES ASSOCIATED WITH DIFFERENT APPROACHES TO OPIOID TAPERING, ESPECIALLY WHEN EVALUATING WHETHER TRENDS HOLD AMONG SMALLER DEMOGRAPHIC GROUPS. TO ADDRESS THIS CRITICAL GAP, OUR GOAL IS TO CREATE WEIGHTS FOR THE CERNER REAL-WORLD© DATABASE, WHICH INCLUDES ELECTRONIC HEALTH RECORDS (EHR) DATA FROM OVER 100 MILLION UNIQUE U.S. PATIENTS AT 600 PARTICIPATING HOSPITALS AND CLINICS. OUR HYPOTHESIS IS THAT WEIGHTING THE DATABASE WILL SIGNIFICANTLY ENHANCE ITS REPRESENTATIVENESS IN ORDER TO LONGITUDINALLY ASSESS THE RELATIONSHIP BETWEEN OPIOID TAPERING, MULTIDISCIPLINARY MEDICINE, MOUD, AND OUTCOMES FOR CHRONIC PAIN PATIENTS WITH CO-OCCURRING SUD. OUR AIMS ARE TO USE AMERICAN HOSPITAL ASSOCIATION AND U.S. CENSUS DATA TO CREATE WEIGHTS, STRATIFIED BY HOSPITAL CHARACTERISTICS AND ADJUSTED BY DEMOGRAPHIC VARIABLES, FOR ANALYZING THE CERNER DATABASE (AIM 1); VALIDATE THE WEIGHTING SCHEME IN AIM 1 BY COMPARING WEIGHTED ESTIMATES FROM THE CERNER DATABASE TO ESTIMATES FROM A WELL-ESTABLISHED POPULATION (THE NATIONWIDE INPATIENT SAMPLE) FOR CHRONIC PAIN, SUD, AND OVERDOSE DIAGNOSES AND RELEVANT MULTIDISCIPLINARY PAIN INTERVENTIONS FOR THE YEARS 2000-2025 (AIM 2); AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING OUD, EXAMINE HOW TAPERING OPIOID ANALGESICS AND TRANSITIONING TO MOUD AFFECTS RISK FOR OVERDOSE, SUICIDE, AND OTHER HOSPITALIZATIONS, AND ASSESS HOW SEX AND RACE/ETHNICITY OPERATE AS EFFECT MODIFIERS IN THESE RELATIONSHIPS (AIM 3); AND AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD, EXAMINE HOW TAPERING OPIOID ANALGESICS WHILE USING MULTIDISCIPLINARY PAIN TREATMENT AFFECTS RISK FOR OVERDOSE, SUICIDE, AND OTHER HOSPITALIZATIONS, AND ASSESS HOW SEX AND RACE/ETHNICITY OPERATE AS EFFECT MODIFIERS IN THESE RELATIONSHIPS (AIM 4). THIS PROJECT WILL CREATE A NATIONAL DATABASE WITH VALIDATED WEIGHTING THAT WILL ENABLE RIGOROUS EXAMINATION OF OPIOID TAPERING APPROACHES AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD, WHICH WILL SUBSEQUENTLY IMPROVE KNOWLEDGE OF HOW MULTIDISCIPLINARY PAIN TREATMENT AND MOUD AFFECT RISKS, WHILE CONSIDERING TAPERING-RELATED INEQUITIES AMONG DEMOGRAPHIC SUBPOPULATIONS. | $2.8M | FY2022 | Sep 2022 – Sep 2025 |
| Department of Education | ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM | $2.7M | FY2016 | Sep 2016 – Aug 2021 |
| Department of Health and Human Services | THE NKA INTERACTOME IN HEALTH AND DISEASE - PROJECT SUMMARY/ABSTRACT: THE NA/K-ATPASE (NKA), OR “SODIUM PUMP”, IS AN ENZYME THAT TRANSPORTS IONS ACROSS CELL MEMBRANES. BETWEEN 30-70% OF THE CELL’S ATP BUDGET IS SPENT BY THE NKA TO CREATE STRONG CHEMICAL GRADIENTS FOR SODIUM AND POTASSIUM. THESE GRADIENTS CONTROL CELL VOLUME, SUPPORT ELECTRICAL SIGNALING (ACTION POTENTIALS) AND ENERGIZE MANY OTHER TRANSPORT PROCESSES. DISRUPTION OF SODIUM HANDLING IS ASSOCIATED WITH DISEASES INCLUDING CARDIAC HYPERTROPHY/FAILURE, PARKINSON’S DISEASE, SCHIZOPHRENIA, AND ALZHEIMER’S DISEASE. VARIOUS CELL TYPES IN DIVERSE TISSUES OF THE BODY HAVE VERY DIFFERENT REQUIREMENTS FOR NA/K TRANSPORT, AND TRANSPORT RATES MUST RESPOND TO PHYSIOLOGICAL CHALLENGES (E.G. EXERCISE). TO ADAPT NKA TO THESE DIFFERENT CONDITIONS, THE PUMP IS REGULATED BY TISSUE-SPECIFIC TRANSMEMBRANE PEPTIDES THAT INCREASE OR DECREASE THE PUMP’S ENZYMATIC ACTIVITY. IN AIM 1 OF THE PROJECT WE WILL FOCUS ON THE NORMAL PHYSIOLOGICAL REGULATION OF NKA BY FXYDS, TESTING HOW FXYD PROTEINS BIND AND STABILIZE SPECIFIC NKA CONFORMATIONS TO ALTER NKA TRANSPORT KINETICS. WE WILL USE NOVEL SPECTROSCOPIC ASSAYS TO INVESTIGATE THE STRUCTURE AND STABILITY OF DIFFERENT NKA-FXYD REGULATORY COMPLEXES. WE WILL INVESTIGATE HOW PHYSICAL COUPLING OF TWO PUMPS INTO A SINGLE FUNCTIONAL UNIT CAN ALLOW FASTER OVERALL CYCLING. AIM 2 IS THE TRANSLATIONAL ARM OF THE RESEARCH PROJECT. THE RESEARCH TEAM WILL INVESTIGATE HOW NKA REGULATION BY FXYDS BECOMES DISORDERED IN DISEASE, USING PROTEOMIC ANALYSIS TO COMPARE THE NKA-FXYD INTERACTOME IN HEALTHY AND FAILING HUMAN HEART TISSUE. WE WILL DETERMINE WHETHER FRAGMENTS OF DIGESTED MEMBRANE PROTEINS MAY DISRUPT NKA FUNCTION IN DISEASE. WE WILL ALSO TEST THE FEASIBILITY OF USING GENE DELIVERY OF AN INHIBITORY SPECIES (FXYD1) AS A THERAPY TO IMPROVE THE CONTRACTION STRENGTH OF A FAILING HEART. FINALLY, WE WILL COMPARE FXYDS THAT ACTIVATE NKA AND FXYDS THAT INHIBIT NKA. THE PROJECT BRINGS TOGETHER 6 DIFFERENT INVESTIGATORS THAT SPECIALIZE IN DIFFERENT COMPLEMENTARY APPROACHES. THE LABORATORY OF THE PROJECT PI, PROF. SETH ROBIA, USES FLUORESCENCE SPECTROSCOPY AND CELL PHYSIOLOGY TO INVESTIGATE THE STRUCTURE, AFFINITY, AND FUNCTION OF NKA-FXYD COMPLEXES IN CARDIAC MYOCYTES AND HETEROLOGOUS CELLS. HE WORKS CLOSELY WITH TWO LOYOLA UNIVERSITY CHICAGO COLLEAGUES: JONATHAN KIRK (CO-I) AND PETE KEKENES-HUSKEY (CO-I). PROF. KIRK WILL USE PROTEOMICS APPROACHES SUCH AS MASS SPECTROMETRY TO DISCOVER POST- TRANSLATIONAL MODIFICATIONS AND NOVEL NKA REGULATORS. PROF. KEKENES-HUSKEY WILL ASSIST WITH COMPUTATIONAL MODELING OF THE PROTEIN COMPLEXES. PROF. JULIE BOSSUYT (MPI) WILL INVESTIGATE A-A COUPLING, CONDUCTING MICROSCOPY AND BIOCHEMISTRY EXPERIMENTS TO IDENTIFY THE INTERACTION INTERFACE. PROF. ARTIGAS (CO-I) AT TEXAS TECH WILL PERFORM DETAILED ELECTROPHYSIOLOGICAL ANALYSES OF FXYD PROTEINS AND MEMBRANE PROTEIN FRAGMENTS. PROF. RAZVAN CORNEA (CONSULTANT) IS AN EXPERT IN MEMBRANE PROTEIN BIOPHYSICS. HE WILL ADVISE THE TEAM ON ALL ASPECTS OF THE PROJECT. TOGETHER, THE COLLABORATORS WILL UNCOVER IMPORTANT NEW INFORMATION ABOUT NKA-FXYD STRUCTURE/FUNCTION RELATIONSHIPS, AND LEARN HOW THESE MECHANISMS BECOME DISORDERED IN DISEASE. | $2.7M | FY2022 | Apr 2022 – Mar 2027 |
| Department of Health and Human Services | LOYOLA RESEARCH COMPUTING CORE | $2.7M | FY2010 | Mar 2010 – Mar 2012 |
| Department of Health and Human Services | PATHOLOGICAL RESPONSES TO MITOCHONDRIAL ROS IN SEPSIS-INDUCED CARDIAC DYSFUNCTION | $2.7M | FY2014 | Sep 2014 – Aug 2025 |
| Department of Health and Human Services | BINGE ALCOHOL-INDUCED NEURODEGENERATION AND OMEGA-3 DHA PROTECTION | $2.7M | FY2009 | Sep 2009 – Feb 2020 |
| Department of Health and Human Services | EXPERIMENTAL IMMUNOLOGY TRAINING GRANT | $2.7M | FY1997 | Aug 1997 – Aug 2025 |
| Department of Health and Human Services | MINDFULNESS BASED STRESS REDUCTION FOR PSYCHO-IMMUNE DYSREGULATION IN CANCER | $2.7M | FY2008 | Aug 2008 – May 2013 |
| Department of Health and Human Services | IMMUNE DYSREGULATION BY PSYCHOSOCIAL DISTRESS | $2.7M | FY2010 | Mar 2010 – Jan 2015 |
| Department of Education | SUPPORT OF THE UPWARD BOUND PROGRAM AT LOYOLA UNIVERSITY NEW ORLEANS | $2.7M | FY2022 | Jun 2022 – Aug 2026 |
| Department of Health and Human Services | SEX-SPECIFIC REGULATION OF MICRORNAS IN ALZHEIMER DISEASE - PROJECT SUMMARY ALZHEIMER’S DISEASE IS MORE PREVALENT IN WOMEN THAN MEN, YET A BIOLOGICAL BASIS FOR THIS SEX DIFFERENCE IS NOT UNDERSTOOD. THE PRIMARY OBJECTIVE OF THIS PROPOSAL IS TO UNDERSTAND HOW 17SS-ESTRADIOL (E2) REGULATES MICRORNA (MIR) BIOGENESIS AND STABILITY ACROSS THE LIFESPAN AND IN ALZHEIMER’S DISEASE (AD). WE HYPOTHESIZE THAT DYSREGULATION OF E2-MEDIATED MIR EXPRESSION IN THE AGED BRAIN LEADS TO GREATER ALZHEIMER DISEASE RISK IN WOMEN. THE STUDIES PROPOSED ARE FOCUSED ON UNDERSTANDING HOW ESTROGENS REGULATE THESE MIRS TO GET A BETTER UNDERSTANDING OF THEIR DYSREGULATION IN AD - SPECIFICALLY IN WOMEN. THIS WILL ADDRESS A MAJOR GAP IN OUR UNDERSTANDING BECAUSE HOW E2 INFLUENCES THE COMPONENTS OF THE MIR BIOGENESIS PATHWAY TO REGULATE MATURE MIR EXPRESSION LEVELS IN A CELL- AND/OR AGE-SPECIFIC MANNER IS UNKNOWN, DESPITE SEVERAL STUDIES DEMONSTRATING TEMPORAL AND CELL-SPECIFIC EFFECTS OF E2 ON MIR EXPRESSION IN A VARIETY OF ORGAN SYSTEMS. OUR PRIOR STUDIES DEMONSTRATED THAT E2 TREATMENT ALTERED THE EXPRESSION LEVELS OF A SUBSET OF MIRS IN THE FEMALE BRAIN, AND THE ABILITY TO REGULATE THESE MIRS DEPENDED ON AGE, BRAIN REGION, AND LENGTH OF E2 DEPRIVATION (I.E., TIME POST- MENOPAUSE). COLLECTIVELY THE EXPERIMENTS IN AIM 1 WILL TEST THE HYPOTHESIS THAT E2 DIFFERENTIALLY MEDIATES MATURE MIR STABILITY DEPENDING ON AGE AND IN ALZHEIMER’S DISEASE. WE WILL USE MIR DEGRADATION ASSAYS TO DETERMINE WHETHER AGE AND/OR E2 AFFECT THE RATE OF MIR DEGRADATION AND, USING A PROTEOMICS APPROACH, IDENTIFY THE CIS- AND TRANS-ACTING FACTORS THAT REGULATE MIR STABILITY. AIM 2 WILL ADDRESSES MECHANISTICALLY HOW A SELECT SUBSET OF MIRS COULD BE SPECIFICALLY REGULATED BY E2 POST-TRANSCRIPTION. WE WILL TEST THE HYPOTHESIS THAT HNRNP H BINDING TO ERSS REDUCES ITS ASSOCIATION WITH PRI-MIR TRANSCRIPTS, ERSS INTERACTS WITH BRCA1 TO DIFFERENTIALLY FACILITATE DROSHA COMPLEX ASSEMBLY, AND THAT THESE INTERACTIONS ARE DEPENDENT ON AGE AND E2 TREATMENT. AIM 3 WILL DETERMINE THE EFFECTS OF AGE AND E2 ON MIR SUBCELLULAR LOCALIZATION AND ASSESS DISRUPTION OF E2- MEDIATED MIR SUBCELLULAR LOCALIZATION IN ALZHEIMER’S DISEASE. THIS AIM WILL TEST THE HYPOTHESIS THAT E2 FACILITATES SUBCELLULAR TRAFFICKING OF MIRS, THEREBY IMPACTING MIR FUNCTION. MOREOVER, WE WILL TEST THE HYPOTHESIS THAT MIR SUBCELLULAR LOCALIZATION CHANGES ACROSS THE LIFESPAN AND THAT NORMAL AGE-RELATED SUBCELLULAR LOCALIZATION IS DISRUPTED IN ALZHEIMER’S DISEASE. IMPACT: UNDERSTANDING THE BASIC MOLECULAR SIGNALING PATHWAYS OF E2 IN THE AGING BRAIN WILL HELP DRIVE THERAPEUTIC ADVANCES AND INFORM TREATMENT STRATEGIES FOR WOMEN WITH ALZHEIMER’S DISEASE. | $2.6M | FY2023 | Apr 2023 – Dec 2027 |
| Department of Health and Human Services | INTESTINAL BACTERIA AND EPITHELIAL BARRIER DISRUPTION AFTER ALCOHOL AND BURN INJURY | $2.5M | FY2018 | Jul 2018 – Aug 2027 |
| Department of Health and Human Services | NATIONAL INSTITUTE FOR MENTORING EARLY MINORITY FACULTY IN NEUROSCIENCE | $2.4M | FY2014 | Jan 2014 – Aug 2026 |
| Department of Health and Human Services | USING THE FITBIT FOR EARLY DETECTION OF INFECTION AND REDUCTION OF HEALTHCARE UTILIZATION AFTER DISCHARGE IN PEDIATRIC SURGICAL PATIENTS - PROJECT SUMMARY PEDIATRIC APPENDECTOMY, THE MOST PREVALENT INPATIENT PROCEDURE IN CHILDREN, IS ASSOCIATED WITH SIGNIFICANT BURDEN TO THE PATIENT, THEIR PARENTS, HEALTHCARE SYSTEMS AND THIRD PARTY PAYORS. AFTER DISCHARGE, MONITORING BY PARENTS CONSISTS ONLY OF SUCH “PROXY” SUBJECTIVE ASSESSMENTS, WHICH HAVE BEEN REPORTED AS INACCURATE, AND RESULTED IN BOTH INCREASED COMPLICATIONS (E.G., READMISSIONS), AND WASTED HEALTHCARE RESOURCES (E.G., POTENTIALLY AVOIDABLE EMERGENCY DEPARTMENT (ED) VISITS AFTER SURGERY). ADVANCES IN CONSUMER WEARABLE DEVICES (“CWDS”) THAT PASSIVELY AND NON-INVASIVELY MONITOR PHYSICAL ACTIVITY (PA), HEART RATE (HR), AND SLEEP ARE USHERING IN A NEW ERA OF SYMPTOMS SCIENCE, PARTICULARLY AFTER SURGERY. THEIR EXPANDING CAPABILITY TO GENERATE CONTINUOUS, VALID, OBJECTIVE, AND ACTIONABLE MEASURES IN NEAR-REAL TIME IN CHILDREN, PROVIDE OPPORTUNITIES TO DETECT ALTERED POST-OPERATIVE RECOVERY PATTERNS EARLY, AND THEREFORE IMPROVE THE PRECISION AND TIMELINESS OF ANY NECESSARY CLINICAL INTERVENTIONS. THE PROPOSED STUDY WILL USE A CWD, THE FITBIT INSPIRE 2, AND WILL APPLY MACHINE LEARNING METHODS TO THE FITBIT DATA (PHYSICAL ACTIVITY, HR, AND SLEEP) TO CREATE CLINICALLY MEANINGFUL ALERTS FOR EARLY DETECTION OF POSTOPERATIVE INFECTION. DURING HOSPITALIZATION AND CONTINUING AFTER DISCHARGE, A FITBIT INSPIRE 2, A WIDELY-USED, COMMERCIALLY WEARABLE DEVICE WELL-TOLERATED BY YOUNG CHILDREN (3- 18 YEARS OLD) WILL BE USED TO MEASURE STEP COUNTS, SLEEP, AND HR. THE PROPOSAL HAS 2 AIMS. AIM 1 DEVELOPS AND VALIDATES MACHINE LEARNING ALGORITHM FOR INFECTION USING THE FITBIT. AIM 2 PROSPECTIVELY FEEDS NEAR-REAL TIME FITBIT DATA ON POSTOPERATIVE APPENDECTOMY PATIENTS TO CLINICIANS, AND EXAMINES THEIR EFFECT ON CLINICAL DECISION MAKING, TIME TO FIRST CONTACT WITH THE HEALTHCARE SYSTEM, AND ON OVERALL HEALTHCARE USE PATTERNS. THE PROPOSAL IS ALIGNED WITH NINR’S RESEARCH PRIORITIES. METHODS DEVELOPED FROM THIS WORK WILL PAVE THE WAY TO DEVELOP SIMILAR ALGORITHMS FOR OTHER PATIENT POPULATIONS NEEDING A PROXY, AS WELL AS TO CHARACTERIZE OTHER SURGERIES AND, SHOULD IMPROVE OVERALL POSTOPERATIVE MANAGEMENT FOR ALL SURGICAL PATIENTS. | $2.4M | FY2023 | Sep 2023 – Jun 2027 |
| Department of Health and Human Services | MODELING THE EPIDEMIOLOGIC TRANSITION: ENERGY EXPENDITURE, OBESITY AND DIABETES | $2.4M | FY2009 | Apr 2009 – Feb 2013 |
| Department of Health and Human Services | MECHANISMS OF CONTRACTILE NETWORK ASSEMBLY | $2.4M | FY2020 | Sep 2020 – Aug 2025 |
| National Science Foundation | CYBERCORPS SCHOLARSHIP FOR SERVICE: CYBERRAMBLERS BOLSTER NATIONAL SECURITY -CYBERSECURITY IS CRITICAL TO ALL ASPECTS OF MODERN LIFE, FROM ENERGY, COMMERCE, FINANCE, EDUCATION, AND HEALTHCARE TO MANUFACTURING AND AGRICULTURE. WELL-TRAINED CYBERSECURITY PROFESSIONALS SERVING IN THE GOVERNMENT WORKFORCE ARE CRITICAL TO NATIONAL SECURITY. THIS PROJECT WILL ESTABLISH THE CYBERRAMBLERS ? LOYOLA UNIVERSITY CHICAGO CYBERCORPS? SCHOLARSHIP FOR SERVICE PROGRAM TO IMPROVE THE UNITED STATES' NATIONAL SECURITY. SCHOLARS WILL BE TRAINED IN TECHNICAL KNOWLEDGE FROM COMPUTER SCIENCE AND CYBERSECURITY, AND SOCIAL AND BEHAVIORAL KNOWLEDGE OF CYBERCRIME FROM PSYCHOLOGY, AND CRIMINAL JUSTICE AND CRIMINOLOGY. THIS LEADS TO SCHOLARS RECEIVING A WELL-ROUNDED CYBERSECURITY EDUCATION AND TRAINING. FOUR COHORTS OF UNDERGRADUATE STUDENTS MAJORING IN THE B.S. FOR CYBERSECURITY PROGRAM WILL BE RECRUITED FOR A TOTAL OF 20 STUDENTS OVER FIVE YEARS. THE STUDENT RECRUITMENT PROCESS EMPHASIZES RECRUITING AND RETAINING MEMBERS OF UNDERREPRESENTED AND UNDERSERVED GROUPS. THE OUTCOME OF THIS PROJECT WILL BE A WELL-PREPARED COHORT OF CYBERSECURITY PROFESSIONALS AND LEADERS READY TO MEET THE NATION?S CYBERSECURITY WORKFORCE NEEDS. THE PROJECT WILL BUILD ON THE EXISTING INTERDISCIPLINARY CYBERSECURITY PROGRAM TO RECRUIT STUDENTS FROM COMPUTER SCIENCE, CYBERSECURITY, PSYCHOLOGY, AND CRIMINAL JUSTICE AND CRIMINOLOGY. EACH CYBERRAMBLER SCHOLAR WILL RECEIVE TWO YEARS OF SCHOLARSHIP SUPPORT AND ADVISING AND MENTORING SUPPORT TO ENSURE ADEQUATE PROGRESS TOWARD GRADUATION AND SUCCESSFUL JOB PLACEMENT. SCHOLARS WILL BE INVOLVED IN INTERDISCIPLINARY RESEARCH AND EDUCATION AND RECEIVE TRAINING TO DEVELOP THE CRITICAL THINKING, INDEPENDENCE, TEAMWORK, AND TECHNICAL KNOWLEDGE REQUIRED IN A CYBERSECURITY CAREER. THESE SCHOLARSHIPS FOR SERVICE WILL PROVIDE THE NECESSARY HANDS-ON TRAINING AND EDUCATION FOR SCHOLARS TO START A SUCCESSFUL CYBERSECURITY CAREER AS PART OF THE GOVERNMENT WORKFORCE. TO ENSURE THE EFFECTIVENESS AND SUSTAINABILITY OF THE PROGRAM, COMPREHENSIVE FORMATIVE AND SUMMATIVE EVALUATION MECHANISMS WILL BE USED TO ASSESS THE PROGRESS AND ACHIEVEMENTS OF THE STUDENT SCHOLARS. THESE WILL SPECIFICALLY FOCUS ON SCHOLARS? SKILL DEVELOPMENT, KNOWLEDGE ACQUISITION, AND READINESS TO MEET THE NATION'S CYBERSECURITY WORKFORCE NEEDS. THIS PROJECT AIMS TO CREATE CYBERSECURITY PROFESSIONALS WHO WILL POSITIVELY IMPACT NATIONAL SECURITY AND MEET THE EVOLVING CHALLENGES OF THE CYBER LANDSCAPE THROUGH STRATEGIC RECRUITMENT, INTERDISCIPLINARY CYBERSECURITY-FOCUSED CURRICULUM, RIGOROUS EVALUATION, AND GOVERNMENT PARTNERSHIPS. THIS PROJECT IS SUPPORTED BY THE CYBERCORPS? SCHOLARSHIP FOR SERVICE (SFS) PROGRAM, WHICH FUNDS PROPOSALS ESTABLISHING OR CONTINUING SCHOLARSHIP PROGRAMS IN CYBERSECURITY AND ALIGNS WITH THE U.S. NATIONAL CYBER STRATEGY TO DEVELOP A SUPERIOR CYBERSECURITY WORKFORCE. FOLLOWING GRADUATION, SCHOLARSHIP RECIPIENTS ARE REQUIRED TO WORK IN CYBERSECURITY FOR A FEDERAL, STATE, LOCAL, OR TRIBAL GOVERNMENT ORGANIZATION FOR THE SAME DURATION AS THEIR SCHOLARSHIP SUPPORT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD. | $2.3M | FY2024 | Jan 2024 – Dec 2028 |
| Department of Education | CENTER ON ENGLISH LEARNERS AND MULTILINGUALISM | $2.3M | FY2025 | Oct 2024 – Sep 2026 |
| Department of Health and Human Services | MICROBE-DRIVEN DEVELOPMENT OF GALT | $2.3M | FY2018 | May 2018 – Apr 2025 |
| Department of Education | LOYOLA UNIVERSITY NEW ORLEANS UPWARD BOUND PROJECT | $2.3M | FY2017 | Jun 2017 – Sep 2022 |
| Department of Education | LOYOLA UNIVERSITY MARYLAND SCHOOL COUNSELING SCHOLARSHIP PROGRAM: CULTURALLY RESPONSIVE AND INCLUSIVE SCHOOL-COUNSELOR PREPARATION (CRISP) | $2.3M | FY2023 | Apr 2023 – Dec 2026 |
| Department of Health and Human Services | UNCOVERING AND HARNESSING CONNECTED METABOLIC PATHWAYS ESSENTIAL TO VIRUS INFECTION. | $2.3M | FY2020 | Sep 2020 – Aug 2025 |
| Department of Health and Human Services | SELENOF IS A NOVEL TUMOR SUPPRESSOR AND A NEW TARGET TO OVERCOME RACIAL DISPARITY IN BREAST CANCER. - PROJECT SUMMARY / ABSTRACT THIS PROPOSAL ADDRESSES THE CHALLENGE OF CLOSING THE RACIAL DISPARITY GAP IN BREAST CANCER MORTALITY BY IDENTIFYING A CONTRIBUTING BIOLOGICAL FACTOR AND DEVELOPING THERAPEUTIC STRATEGIES TO OVERCOME ITS IMPACT. THE SELENOPROTEIN, SELENOF, WAS RECENTLY IDENTIFIED AS A NEW TUMOR SUPPRESSOR IN BREAST CANCER. THE BROAD HYPOTHESIS IS THAT LOWER SELENOF LEVELS IN AFRICAN AMERICAN PATIENTS CONTRIBUTE TO THE RACIAL DISPARITY IN BREAST CANCER MORTALITY BY DRIVING TUMOR PROGRESSION AND POOR PATIENT OUTCOME. THEREFORE, THERAPEUTIC STRATEGIES TO MITIGATE ITS LOSS ARE NEEDED TO HELP CLOSE THE DISPARITY GAP. THE SCIENTIFIC PREMISE FOR THE HYPOTHESIS IS BASED ON THE FOLLOWING: 1) THE GENOMES OF BREAST TUMORS FROM AFRICAN AMERICANS HAVE A 5-10 FOLD HIGHER FREQUENCY OF SELENOF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS), WHICH ACCOUNT FOR LOWER SELENOF PROTEIN LEVELS, 2) SELENOF MRNA EXPRESSION IS SIGNIFICANTLY LOWER IN BREAST TUMORS FROM AFRICAN AMERICAN PATIENTS COMPARED TO CAUCASIANS, AND LOWER SELENOF LEVELS PREDICT SHORTER SURVIVAL IN THESE PATIENTS, 3) LOSS OF SELENOF IN NORMAL BREAST EPITHELIAL CELLS RESULTED IN INCREASED PROLIFERATION AND ABROGATED CELL DEATH, FEATURES OF CELLULAR TRANSFORMATION, AND 4) OVEREXPRESSION OF SELENOF IN BREAST CANCER CELLS INDUCED CELL DEATH, BLOCKED PROLIFERATION AND SURVIVAL, ENHANCED RESPONSE TO THERAPIES, AND INHIBITED TUMOR GROWTH IN VIVO. THE EUKARYOTIC INITIATION FACTOR 4A3 (EIF4A3) WAS IDENTIFIED AS A TRANSLATIONAL REPRESSOR OF SELENOF. THE SELENOF LOCUS SNPS ARE PREDICTED TO ENHANCE EIF4A3’S BINDING AFFINITY RESULTING IN STRONGER REPRESSION OF SELENOF TRANSLATION. PRELIMINARY DATA SHOWED THAT PHARMACOLOGIC INHIBITION OF EIF4A3 RESULTS IN INCREASED SELENOF PROTEIN LEVELS AND REDUCED BREAST CANCER CELL VIABILITY IN A SELENOF-DEPENDENT MANNER. LOSS OF SELENOF ALSO RESULTED IN HYPERACTIVATION OF THE KINASE/RNASE INOSITOL-REQUIRING ENZYME 1 (IRE1), A MASTER REGULATOR OF THE UNFOLDED PROTEIN RESPONSE. THIS RENDERED CELLS HIGHLY SUSCEPTIBLE TO IRE1 INHIBITION, THUS IDENTIFYING A NEW VULNERABILITY IN THESE CELLS. FOUR AIMS ARE PROPOSED: 1) DETERMINE THE MECHANISMS UNDERLYING SELENOF-INDUCED CELL FATE IN BREAST CANCER, 2) DETERMINE WHETHER LOSS OF SELENOF DRIVES TUMORIGENESIS BY USING AFRICAN AMERICAN DERIVED XENOGRAFTS AND A MURINE MODEL OF BREAST CANCER, 3) DETERMINE THE IMPACT OF SNPS ON THE REGULATION OF SELENOF TRANSLATION BY EIF4A3, AND 4) DETERMINE WHETHER EIF4A3 OVEREXPRESSION AND THE SNPS CONTRIBUTE TO REDUCED SELENOF TUMOR LEVELS AND POOR OUTCOME IN AFRICAN AMERICAN BREAST CANCER PATIENTS. OUR WORK WILL ESTABLISH SELENOF AS A NEW TARGET TO REDUCE RACIAL DISPARITY IN BREAST CANCER, AND THUS SUPPORT THE DEVELOPMENT OF SELENOF-BASED THERAPIES. IN THE CLINIC, SELENOF’S SNPS AND LEVELS CAN ALSO SERVE AS CANDIDATE BIOMARKERS TO IDENTIFY AFRICAN AMERICAN PATIENTS AT RISK OF AGGRESSIVE DISEASE. THE DISTINCT THERAPEUTIC STRATEGIES INVESTIGATED HERE ARE LIKELY TO RESULT IN NOVEL AND MORE EFFECTIVE PERSONALIZED MEDICINE AND MAY HELP CLOSE THE DISPARITY GAP. | $2.3M | FY2023 | Sep 2023 – Aug 2025 |
| Department of Health and Human Services | A REGULATORY CASCADE THAT CONTROLS PNEUMOCOCCAL CAPSULE BIOSYNTHESIS | $2.3M | FY2019 | Aug 2019 – Jul 2024 |
| Department of Health and Human Services | MONOCYTE REGULATION OF INFANT IMMUNE RESPONSES | $2.2M | FY2012 | Aug 2012 – Jul 2018 |
| Department of Health and Human Services | NURSING WORKFORCE DIVERSITY | $2.2M | FY2021 | Jul 2021 – Jun 2025 |
| Department of Health and Human Services | SOUTHWEST ONCOLOGY GROUP | $2.2M | FY1988 | Jan 1988 – Dec 2013 |
| Department of Health and Human Services | REVOLUTIONIZING NORMATIVE RE-EDUCATION: DELIVERING ENHANCED PNF WITHIN A SOCIAL MEDIA INSPIRED GAME ABOUT COLLEGE LIFE | $2.2M | FY2019 | Jun 2019 – May 2025 |
| Department of Health and Human Services | ETHANOL EFFECTS ON RECOVERY AFTER INJURY | $2.2M | FY1999 | Aug 1999 – Jun 2013 |
| Department of Health and Human Services | MARKERLESS MOTION TRACKING OF LUNG TUMORS USING DUAL ENERGY IMAGING | $2.2M | FY2017 | Mar 2017 – Feb 2026 |
| Department of Health and Human Services | COLLABORATIVE INTEGRATION OF HEPATITIS B MOLECULAR VIROLOGY AND MATHEMATICAL/COMPUTATIONAL MODELING | $2.2M | FY2019 | Jan 2019 – Jun 2025 |
| Department of Education | UPWARD BOUND | $2.1M | FY2012 | Jun 2012 – May 2017 |
| Department of Health and Human Services | NURSE, EDUCATION, PRACTICE, QUALITY AND RETENTION - REGISTERED NURSES IN PRIMARY CARE | $2.1M | FY2018 | Jul 2018 – Jun 2023 |
| VA/DoDDepartment of Defense | A NOVEL ANTI-INFLAMMATORY PROTEIN THERAPEUTIC THAT IMPROVES RESUSCITATION AND REDUCES TRAUMA, SHOCK AND ISCHEMIA INDUCES TISSUE DAMAGE | $2.1M | FY2011 | Oct 2010 – Oct 2014 |
| Department of Health and Human Services | TRAINING IN TRAUMA AND BURN RESEARCH | $2M | FY2000 | Jul 2000 – Jun 2025 |
| Department of Health and Human Services | CHROMATIN ORGANIZATION AS A PREDICTOR OF STRESS INDUCED IMMUNE DYSREGULATION | $2M | FY2016 | Apr 2016 – Mar 2021 |
| Department of Education | UPWARD BOUND PROGRAM | $2M | FY2010 | Jun 2010 – May 2012 |
| Department of Health and Human Services | COMPUTATIONAL DISCOVERY OF EFFECTIVE HEPATITIS C INTERVENTION STRATEGIES | $2M | FY2017 | Aug 2017 – Jul 2024 |
| National Science Foundation | EMPOWERING STEM SCHOLARS FOR SUCCESS -THIS PROJECT WILL CONTRIBUTE TO THE NATIONAL NEED FOR WELL-EDUCATED SCIENTISTS, MATHEMATICIANS, ENGINEERS, AND TECHNICIANS BY SUPPORTING THE RETENTION AND GRADUATION OF HIGH-ACHIEVING, LOW-INCOME STUDENTS WITH DEMONSTRATED FINANCIAL NEED AT LOYOLA UNIVERSITY MARYLAND. A TOTAL OF 24 SCHOLARS PURSUING BACHELOR'S DEGREES IN BIOLOGY, CHEMISTRY, BIOCHEMISTRY, ENGINEERING (WITH CONCENTRATIONS IN COMPUTER, MECHANICAL, MATERIALS, OR ELECTRICAL ENGINEERING), AND FORENSIC SCIENCE WILL RECEIVE SCHOLARSHIPS AVERAGING $15,000 PER YEAR FOR UP TO FOUR YEARS. SCHOLARS WILL RECEIVE FACULTY, PEER, AND INDUSTRY MENTORING, AND THE PROJECT WILL BUILD STRONG SCHOLAR COHORTS THROUGH PRE-COLLEGE ORIENTATION; MESSINA, A COMMON FIRST-YEAR STUDENT EXPERIENCE FOR ALL LOYOLA STUDENTS THAT WILL BE SPECIALIZED FOR STEM PROJECT STUDENTS; SMALL-GROUP TUTORING; AND REGULAR COHORT EVENTS. ADDITIONAL ACTIVITIES FOR SCHOLARS WILL INCLUDE SEMINARS AND NETWORKING WITH INDUSTRY PARTNERS, ON-SITE VISITS TO REGIONAL STEM ORGANIZATIONS AND BUSINESSES, AND ASSESSMENT AND WORKSHOPS FOR THE DEVELOPMENT OF EMOTIONAL INTELLIGENCE AND PROFESSIONAL SKILLS. THE OVERALL GOAL OF THIS TRACK 2 SCHOLARSHIPS IN STEM PROJECT IS TO INCREASE STEM DEGREE COMPLETION OF ACADEMICALLY TALENTED, LOW-INCOME UNDERGRADUATE STUDENTS WITH DEMONSTRATED FINANCIAL NEED. THERE IS A SIGNIFICANT NATIONAL NEED TO GROW THE STEM WORKFORCE AND NURTURE KEY TALENT THAT WILL ENSURE ECONOMIC COMPETITIVENESS AND PROVIDE DOMESTIC LEADERSHIP ACROSS CRITICAL SECTORS. THIS PROJECT DIRECTLY SPEAKS TO THIS NEED BY SUPPORTING STEM STUDENT SUCCESS, WHICH WILL STRENGTHEN THE WORKFORCE IN ENGINEERING, BIOLOGY, CHEMISTRY AND BIOCHEMISTRY, AND FORENSIC SCIENCE FIELDS AND OTHER KEY AREAS OF NEED. THE PROJECT WILL BE ASSESSED BY AN EXPERIENCED EVALUATOR THAT WILL PROVIDE FORMATIVE AND SUMMATIVE EVALUATIONS THROUGH A WIDE-RANGE OF DATA COLLECTION METHODS (E.G., SURVEYS, FOCUS GROUPS, INSTITUTIONAL RESEARCH DATA, PROFESSIONAL DEVELOPMENT SCALES, PARTICIPATION COUNTS, ETC.) TO DETERMINE THE STEM PROJECT'S SUCCESS IN ACHIEVING ITS OBJECTIVES IN RECRUITMENT, RETENTION AND GRADUATION, CAREER AND PROFESSIONAL DEVELOPMENT, COHORT BUILDING, AND EMPLOYMENT OUTCOMES. THE DATA GENERATED WILL CONTRIBUTE TO THE KNOWLEDGE BASE REGARDING EFFECTIVE STRATEGIES TO SUPPORT TALENTED, LOW-INCOME STUDENTS IN STEM. THIS PROJECT IS FUNDED BY NSF'S SCHOLARSHIPS IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS PROGRAM, WHICH SEEKS TO INCREASE THE NUMBER OF ACADEMICALLY TALENTED, LOW-INCOME STUDENTS WITH DEMONSTRATED FINANCIAL NEED WHO EARN DEGREES IN STEM FIELDS. IT ALSO AIMS TO IMPROVE THE EDUCATION OF FUTURE STEM WORKERS, AND TO GENERATE KNOWLEDGE ABOUT ACADEMIC SUCCESS, RETENTION, TRANSFER, GRADUATION, AND ACADEMIC/CAREER PATHWAYS OF LOW-INCOME STUDENTS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD. | $2M | FY2026 | Feb 2026 – Jan 2032 |
| Agency for International Development | CUBA CIVIL SOCIETY PROGRAM - CNECT | $2M | FY2010 | Sep 2010 – Jan 2013 |
| Department of Health and Human Services | LINKING NICOTINIC ACTIVATION WITH SKIN INNATE IMMUNITY AND ATOPIC DERMATITIS | $2M | FY2012 | May 2012 – Apr 2019 |
| Department of Health and Human Services | INCREASING ACCESS FOR EARLY CHILDHOOD MENTAL HEALTH CARE SERVICES - THE LOYOLA CENTER FOR COUNSELING & EDUCATION (LCCE) IS APPLYING FOR FUNDING TO SUPPORT THE PROPOSED PROJECT INCREASING ACCESS FOR EARLY CHILDHOOD MENTAL HEALTH CARE SERVICES. THE LCCE IS HOUSED WITHIN THE COLLEGE OF NURSING & HEALTH AT LOYOLA UNIVERSITY NEW ORLEANS. SINCE ITS INCEPTION IN 2019, LCCE HAS BEEN COMMITTED TO PROVIDING EFFECTIVE MENTAL HEALTH COUNSELING SERVICES ON A SLIDING SCALE TO UNDERSERVED FAMILIES, COUPLES, GROUPS, AND INDIVIDUALS AT EVERY STAGE OF LIFE. IN TANDEM WITH CLINICAL SERVICES, LCCE SUPERVISES EXEMPLARY TRAINING FOR GRADUATE STUDENTS IN LOYOLA UNIVERSITY’S DEPARTMENT OF COUNSELING. WITH SUPPORT FROM THE INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROGRAM, THE LCCE AIMS TO IMPROVE OUTCOMES FOR CHILDREN FROM BIRTH UP TO 12 YEARS OF AGE BY DEVELOPING, MAINTAINING, OR ENHANCING INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROMOTION, INTERVENTION, AND TREATMENT SERVICES. PROVIDING ACCESS TO THESE SERVICES TO THIS TARGET POPULATION WILL BE ADDRESSING A SIGNIFICANT NEED IN OUR COMMUNITY. THE TARGET POPULATION FOR THIS PROJECT INCLUDES CHILDREN UP TO AGE 12 IN NEED OF ACCESS TO MENTAL HEALTH CARE WHO ARE UNABLE TO ACCESS THESE SERVICES WITH A PROVIDER THAT BILLS MEDICAID OR PRIVATE INSURANCE. THERE IS A SIGNIFICANT LACK OF AVAILABLE PROVIDERS IN THE EIGHT PARISHES OF THE GREATER NEW ORLEANS AREA AND THE MAJORITY ARE EITHER NOT TAKING NEW PATIENTS OR DO NOT ACCEPT MEDICAID CLIENTS. THE TARGET POPULATION WILL BE LOW-INCOME AND MIRROR THE DEMOGRAPHICS OF THE GREATER NEW ORLEANS AREA: WHITE ALONE NOT HISPANICE: 43%; AFRICAN AMERICAN: 33%; HISPANIC: 11%; ASIAN, PACIFIC ISLANDER NOT HISPANIC: 3%; AND TWO OR MORE RACES: 4%. WITH GRANT FUNDING, THE LCCE WILL ACCOMPLISH THE FOLLOWING GOALS AND MEASURABLE OBJECTIVES: PROGRAM GOALS: 1. PROVIDE AN ADDITIONAL ACCESS POINT FOR CHILDREN OF THE GREATER NEW ORLEANS AREA IN NEED OF MENTAL HEALTH CARE SERVICES WHO ARE UNABLE TO SECURE TREATMENT FROM OTHER SOURCES MEASURABLE OBJECTIVE: SERVE 220 CHILDREN UP TO AGE 12 OVER 5 YEARS 2.PROVIDE CHILDREN WITH ACCESS TO COMPREHENSIVE SCREENING AND EVIDENCE-BASED THERAPIES MEASURABLE OBJECTIVE:100% OF CLIENTS WILL RECEIVE A RISK & NEEDS ASSESSMENT AT IN-TAKE AND ACCESS TO EVIDENCE-BASED TRAUMA-INFORMED CARE AND CHILD CENTERED PLAY THERAPY 3.CREATE A COMMUNITY OF EARLY CHILDHOOD EDUCATORS AND CARE PROVIDERS EQUIPPED TO RECOGNIZE CHILDREN IN NEED OF MENTAL HEALTHCARE SERVICES MEASURABLE OBJECTIVE:ESTABLISH 20 PARTNERSHIPS WITH EARLY CARE AND EDUCATION PROGRAMS, CHILD AND FAMILY-SERVING PROFESSIONALS OVER FIVE YEARS TO PROVIDE EDUCATIONAL AND TRAINING OUTREACH SERVICES AND PROVIDE 2 WORKSHOPS PER YEAR 4. PROVIDE SPECIALIZED TRAINING FOR MENTAL HEALTH CLINICIANS IN INFANT AND EARLY CHILDHOOD MENTAL HEALTH, INCLUDING SPECIFIC TRAINING IN PROMISING AND EVIDENCE-BASED PRACTICES AND MODELS FOR PREVENTION, EARLY INTERVENTION, AND TREATMENT MEASURABLE OBJECTIVE: 52 GRADUATE STUDENTS WILL BE TRAINED AND CERTIFIED TO USE EVIDENCE-BASED TRAUMA-INFORMED CARE AND CHILD CENTERED PLAY THERAPY OVER FIVE YEARS THE PROPOSED PROJECT WILL ALSO COLLECT ALL SAMHSA REQUIRED DATA AND PROGRAM SPECIFIC DATA, CREATE A QI PLAN, AND WORK WITH A LEAD EVALUATOR WHO WILL MONITOR THE EFFECTIVENESS AND QUALITY OF THE SERVICES PROVIDED AND THE PROGRESS TOWARDS MEETING THE PROJECT GOALS AND DELIVERABLES. | $2M | FY2023 | Sep 2023 – Sep 2028 |
| Department of Health and Human Services | THE IMPACT OF A RACE-BASED STRESS REDUCTION INTERVENTION ON WELL-BEING, INFLAMMATION, AND DNA METHYLATION IN OLDER AFRICAN AMERICAN WOMEN AT RISK FOR CARDIOMETABOLIC DISEASE - PROJECT SUMMARY THIS RANDOMIZED CONTROLLED TRIAL WILL EVALUATE THE IMPACT OF A NOVEL RACE-BASED STRESS REDUCTION PROGRAM ON WELL-BEING, INFLAMMATORY BURDEN, AND DNA METHYLATION (DNAM) IN OLDER AFRICAN AMERICAN (AA) WOMEN AT RISK FOR CARDIOMETABOLIC DISEASE (CMD). ALTHOUGH THE NUMBER OF DEATHS RELATED TO CMD CONTINUES TO DECLINE, THAT DECLINE HAS SLOWED RECENTLY WITH AAS BEARING A DISPROPORTIONATE BURDEN. FURTHERMORE, WOMEN FACE MORE SEX- SPECIFIC RISK FACTORS FOR INCREASED ADIPOSITY AND AA WOMEN HAVE THE HIGHEST PREVALENCE OF OBESITY, HYPERTENSION, AND PREDIABETES COMPARED TO ALL OTHER RACIAL AND ETHNIC GROUPS. CHRONIC STRESS IS ASSOCIATED WITH LOW-GRADE INFLAMMATION AND INCREASED CMD RISK. GROWING EVIDENCE DEMONSTRATES THAT STRESSORS SUCH AS RACISM AND DISCRIMINATION ARE SIGNIFICANT CONTRIBUTING FACTORS TO PSYCHOLOGICAL DISTRESS, LOW-GRADE CHRONIC INFLAMMATION, AND CMD HEALTH DISPARITIES AMONG MINORITIES, PARTICULARLY AMONG OLDER AA WOMEN WHO ENDURE THE INTERSECTION OF BOTH RACISM AND SEXISM ACROSS THEIR LIFESPAN. RESILIENCE, STRESS, AND ETHNICITY (RISE) IS A GROUP-BASED, 8-WEEK INTERVENTION THAT INTEGRATES COGNITIVE-BEHAVIORAL STRATEGIES FOCUSED ON THE BIOPSYCHOSOCIAL IMPACT OF RACISM, RACIAL IDENTITY DEVELOPMENT, AND EMPOWERMENT. BASED ON OUR PRELIMINARY WORK, WE ANTICIPATE THAT PARTICIPATION IN RISE WILL REDUCE PSYCHOLOGICAL DISTRESS AND INFLAMMATION. FURTHER, OUR PREVIOUS WORK DEMONSTRATED THAT WOMEN WITH HIGH LEVELS OF PERCEIVED DISCRIMINATION HAVE A GREATER PROINFLAMMATORY CYTOKINE RESPONSE TO ACUTE STRESS AND DECREASED DNAM OF GENES RELATED TO INFLAMMATION AND HYPERTENSION. DNAM IS ONE TYPE OF EPIGENETIC PROCESS THAT MODULATES GENE EXPRESSION BY ADDING OR REMOVING METHYL GROUPS TO DNA IN RESPONSE TO THE ENVIRONMENT. STUDIES DEMONSTRATE THAT HYPER OR HYPO METHYLATION OF GENES DUE CHRONIC STRESSORS, INCLUDING RACISM AND DISCRIMINATION ARE SIGNIFICANTLY ASSOCIATED WITH CMD RISK. EMERGING EVIDENCE DEMONSTRATES THAT PSYCHOBEHAVIORAL INTERVENTIONS MAY MODIFY METHYLATION OF STRESS RESPONSE-RELATED GENES POTENTIALLY BUFFERING THE IMPACT OF PSYCHOLOGICAL STRESS AT THE MOLECULAR LEVEL. HOWEVER, FEW STUDIES HAVE EXAMINED THE IMPACT OF A PSYCHOBEHAVIORAL INTERVENTION ON CHANGES IN DNAM AND NONE HAVE ADDRESSED CHRONIC STRESS IN OLDER AA WOMEN.THEREFORE, THE SPECIFIC AIMS ARE: (1) DETERMINE THE EXTENT TO WHICH PARTICIPATION IN RISE DECREASES STRESS-RELATED SYMPTOMS AND INFLAMMATORY BURDEN IN OLDER AA WOMEN AT RISK FOR CMD; (2) EVALUATE THE EXTENT TO WHICH RISE INCREASES THE USE OF ADAPTIVE COPING VERSUS MALADAPTIVE COPING STRATEGIES IN OLDER AA WOMEN AT RISK FOR CMD; AND (3) DETERMINE THE EXTENT TO WHICH PARTICIPATION IN RISE MODIFIES DNAM OF STRESS RESPONSE- RELATED CANDIDATE GENES IN OLDER AA WOMEN AT RISK FOR CMD FROM BASELINE TO POST RISE INTERVENTION. AA WOMEN 50 TO 70 YEARS OF AGE WHO ARE AT RISK FOR CMD WILL BE RANDOMIZED INTO EITHER AN 8-WEEK RISE PROGRAM OR A HEALTH EDUCATION PROGRAM. RISE IS AN INNOVATIVE INTERVENTION THAT ADDRESSES PERCEIVED RACISM AND DISCRIMINATION AT THE INDIVIDUAL LEVEL. FURTHER, RISE HAS THE POTENTIAL TO IMPROVE THE HEALTH OF MINORITY WOMEN IMPACTED BY RACISM AND DISCRIMINATION. | $2M | FY2023 | Apr 2023 – Jan 2028 |
| VA/DoDDepartment of Defense | ANALYZING THE SPREAD OF ANTHRAX IN FARMS IN PAKISTAN AND JORDAN | $2M | FY2017 | Aug 2017 – Jun 2022 |
| Department of Health and Human Services | FRANK-STARLING'S LAW OF THE HEART: CELLULAR MECHANISMS | $2M | FY2005 | Jul 2005 – Jul 2013 |
| Department of Health and Human Services | PS09-007, EVALUATING LOCALLY DEVELOPED HOMEGROWN HIV PREVENTION INTERVENTIONS | $2M | FY2010 | May 2010 – Apr 2015 |
| Department of Education | ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM | $2M | FY2012 | May 2012 – Aug 2017 |
| Department of Education | ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM | $2M | FY2012 | May 2012 – Apr 2018 |
| Department of Health and Human Services | SCHOLARSHIPS FOR DISADVANTAGED STUDENTS | $1.9M | FY2016 | Jul 2016 – Jun 2020 |
| Department of Health and Human Services | BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING PROGRAM | $1.9M | FY2021 | Jul 2021 – Jun 2026 |
| Department of Health and Human Services | COMMENSAL EXOPOLYSACCHARIDE PROTECTION FROM INFLAMMATION | $1.9M | FY2015 | Sep 2015 – Feb 2021 |
| Department of Health and Human Services | INFLAMMASOME-MEDIATED CORNEAL EPITHELIAL CELL DEFENSES INHIBITED BY PATHOGENIC BACTERIA - PROJECT SUMMARY/ABSTRACT THE HEALTHY CORNEAL EPITHELIUM IS AN EFFECTIVE BARRIER TO PATHOGENIC AND ENVIRONMENTAL BACTERIA. BECAUSE OF THIS, CORNEAL INFECTION OR KERATITIS MODELS OFTEN RELY ON BYPASSING THE EPITHELIUM ALTOGETHER BY INTRODUCING MICROBES DIRECTLY INTO THE CORNEAL STROMA, WHERE THEY INITIATE IMMUNE CELL RESPONSES THAT CAN DAMAGE TISSUE AND CAUSE VISION-THREATENING SCARRING. A LIMITATION OF THIS EXPERIMENTAL APPROACH IS THAT EPITHELIAL DEFENSE MECHANISMS ARE UNABLE TO BE IDENTIFIED OR INVESTIGATED. THE BACTERIAL PATHOGEN PSEUDOMONAS AERUGINOSA IS THE MOST COMMON INFECTION ASSOCIATED WITH SOFT CONTACT LENS WEAR, SUGGESTING IT IS UNIQUELY CAPABLE OF CAUSING INFECTION IN THE STROMA EVEN WHEN THE EPITHELIUM REMAINS INTACT. ONE WAY IN WHICH P. AERUGINOSA COLONIZES THE EPITHELIUM IS BY INVADING AND REPLICATING INSIDE EPITHELIAL CELLS, WHICH HAS BEEN INVESTIGATED IN CULTURED CELLS, AND OBSERVED IN MOUSE CORNEAL INFECTION MODELS. PRELIMINARY DATA SHOW THAT THE TOXIN EXOS PRODUCED BY P. AERUGINOSA SUPPRESSES CASPASE-4 MEDIATED PYROPTOSIS OF INVADED CORNEAL EPITHELIAL CELLS, BUYING TIME FOR BACTERIA TO REPLICATE IN A PROTECTED NICHE. ADDITIONAL DATA INDICATE THAT A DIFFERENT INFLAMMASOME PATHWAY IS ALSO ACTIVE IN CORNEAL EPITHELIAL CELLS, AND LEADS TO PRODUCTION OF THE CYTOKINE IL-1SS, WHICH EXOS ALSO SUPPRESSES. THEREFORE, A NOVEL ROLE FOR EXOS IN CORNEAL INFECTION COULD BE TO PROLONG A NICHE FOR BACTERIA TO REPLICATE WITHIN CORNEAL EPITHELIAL CELLS, WHILE LIMITING SECRETION OF CYTOKINES THAT RECRUIT IMMUNE CELLS. USING IMAGING METHODS TO SELECTIVELY MONITOR INVADED CELLS, AND CRISPR-CAS9 TO MANIPULATE CORNEAL EPITHELIAL CELLS GENETICALLY, WE WILL ANSWER THREE OUTSTANDING QUESTIONS REGARDING BOTH CORNEAL EPITHELIAL DEFENSE, AND BACTERIAL SUBVERSION OF IT: 1. HOW DOES EXOS BLOCK CASPASE-4-MEDIATED PYROPTOSIS? 2. HOW DO CORNEAL EPITHELIAL CELLS DETECT AND RESPOND TO P. AERUGINOSA? 3. WHAT IS THE SIGNIFICANCE OF EPITHELIAL CELL INFLAMMASOME ACTIVATION AND PYROPTOSIS IN PROTECTING THE EYE FROM DEVELOPING KERATITIS IN THE STROMA? SUCCESSFUL COMPLETION OF THESE AIMS WILL IDENTIFY A NEW MECHANISM OF HOST DEFENSE AT THE OCULAR SURFACE, FURTHER OUR UNDERSTANDING OF INFLAMMASOMES IN EPITHELIAL CELLS, AND ELUCIDATE HOW A UNIQUELY DEVASTATING CORNEAL PATHOGEN IS ABLE TO OVERCOME HOST DEFENSES. | $1.9M | FY2022 | Sep 2022 – Apr 2027 |
| Department of Health and Human Services | KCNQ CHANNELS AND VASOCONSTRICTOR SIGNAL TRANSDUCTION | $1.9M | FY2009 | Jan 2009 – Dec 2014 |
| Department of Health and Human Services | MECHANISMS UNDERLYING SEXUALLY DIFFERENTIATED BRAIN REMODELING DURING ADOLESCENCE | $1.9M | FY2010 | Jun 2010 – Feb 2015 |
| Department of Health and Human Services | ACETYL PHOSPHATE AS A GLOBAL STRESS SIGNAL | $1.9M | FY2004 | May 2004 – Feb 2013 |
| Department of Health and Human Services | PHOSPHODIESTERASE 1 (PDE1) REGULATION OF MYOCARDIAL CALCIUM AND FUNCTION - PROJECT SUMMARY THE CYCLIC NUCLEOTIDE CAMP SERVES AS A SECOND MESSENGER CRITICAL IN MULTIPLE CELLULAR PROCESSES. TWO PROTEINS HELP TO REGULATE THE LEVEL OF CAMP. G-PROTEIN COUPLED RECEPTORS (GPCRS) ARE TRANSMEMBRANE PROTEINS INVOLVED IN CAMP PRODUCTION. G PROTEINS ARE HETEROTRIMERIC, AND A SUBSET OF GPCRS CONSISTS OF A STIMULATORY, CATALYTIC G⍺ SUBUNIT (G⍺S) THAT UPON RECEPTOR LIGAND BINDING, INCREASE ADENYLYL CYCLASE (AC) PRODUCTION OF CAMP. PHOSPHODIESTERASES (PDES), ON THE OTHER HAND, HYDROLYZE CAMP INTO AMP. IN HEART FAILURE ANIMAL MODELS AND HUMAN PATIENTS, PDE1 INHIBITION HELPS TO IMPROVE CARDIAC FUNCTION BY INCREASING MYOCARDIAL CONTRACTILITY, IMPROVING RELAXATION, AND VASODILATING TO LOWER HEMODYNAMIC STRESS ON THE HEART. THESE EFFECTS ARE SIMILAR TO THOSE UPON PDE3 INHIBITION, BUT WHEREAS THE LATTER IS ASSOCIATED WITH FATAL ARRHYTHMIAS, NO ARRHYTHMIC EVENTS HAVE BEEN ASSOCIATED WITH PDE1 INHIBITOR USE. COMPARTMENTALIZED CAMP SIGNALING THAT IS UNIQUE TO PDE1 VS PDE3 MAY HELP TO EXPLAIN THIS IMPORTANT DIFFERENCE. IT IS KNOWN THAT SPECIFIC PDE-GPCR PAIRINGS WORK TOGETHER TO REGULATE DISTINCT POOLS OF CAMP. THE HEART EXPRESSES MORE THAN 200 GPCRS AND 3 CAMP-HYDROLYZING PDES (1, 3, AND 4). UNIQUE PAIRINGS HELP TO ESTABLISH COMPARTMENTALIZED GRADIENTS OF CAMP SIGNALING THAT ENABLE THE MODULATION OF SPECIFIC CELLULAR PROCESSES IN RESPONSE TO DIFFERENT STIMULI. WHILE MULTIPLE GPCR PAIRINGS WITH PDE3 OR PDE4 HAVE BEEN KNOWN, WHICH GPCR(S) PAIR WITH PDE1 REMAINS UNKNOWN. IN THIS DIVERSITY SUPPLEMENTAL PROJECT, WE WILL IDENTIFY THE GPCR(S) THAT FUNCTIONALLY ENHANCE(S) THE POSITIVE INOTROPIC EFFECTS OF PDE1 INHIBITION. WE WILL DO SO BY EMPLOYING CARDIOMYOCYTE CONTRACTILITY AND CALCIUM, AND FORSTER RESONANCE ENERGY TRANSFER (FRET) IMAGING EXPERIMENTS, AND CARDIAC SLICE PHYSIOLOGIC STUDIES. GUINEA PIG HEARTS, WHICH ARE MUCH MORE LIKE THE HUMAN HEART IN PDE BIOLOGY VERSUS THE COMMONLY USED RAT AND MOUSE MODELS WILL BE USED. OUR HYPOTHESIS IS THAT PDE1 WILL ESTABLISH A G⍺S- ASSOCIATED CAMP GRADIENT THAT IS DISTINCT FROM THAT REGULATED BY PDE3. THIS IS AN IMPORTANT QUESTION BECAUSE OF CLINICAL POTENTIALS OF PDE1 INHIBITION IN PATIENTS WITH PARKINSON’S DISEASE OR HEART FAILURE. THE COMPLETION OF OUR AIM WILL THUS CONTRIBUTE ORIGINAL FINDINGS WITH DIRECT CLINICAL RELEVANCE THAT CAN POTENTIALLY HELP IMPROVE THE HEALTH AND LIFE QUALITY OF PATIENTS. | $1.9M | FY2024 | Jan 2024 – Dec 2028 |
| Department of Health and Human Services | CONTRIBUTION OF CDIA TO PSEUDOMONAS AERUGINOSA PATHOBIOLOGY - PROJECT SUMMARY/ABSTRACT PSEUDOMONAS AERUGINOSA IS A LEADING CAUSE OF HEALTHCARE-ACQUIRED INFECTIONS WORLDWIDE. MANY GLOBALLY- DISTRIBUTED HIGH-RISK STRAINS ARE EMERGING DUE TO AN INCREASE IN ANTIBIOTIC RESISTANCE AND ACQUISITION OF NOVEL VIRULENCE TRAITS. WITH DIMINISHING TREATMENT OPTIONS FOR MANY OF THESE SEVERE P. AERUGINOSA INFECTIONS, STUDIES AIMED AT UNCOVERING THE VIRULENCE STRATEGIES USED BY THESE AGGRESSIVE CLINICAL STRAINS SHOULD HELP TO IDENTIFY NEW TARGETS FOR THERAPEUTIC INTERVENTION. OUR RESEARCH PROGRAM AIMS TO ELUCIDATE VIRULENCE STRATEGIES THAT ENHANCE THE PATHOGENICITY OF P. AERUGINOSA. WE RECENTLY EMPLOYED A COMPARATIVE GENOMICS APPROACH TO INTERROGATE THE ACCESSORY GENOMES OF 100 CLINICAL ISOLATES FOR POTENTIAL FACTORS THAT AUGMENT THE VIRULENCE OF P. AERUGINOSA. BY COMPARING VIRULENCE IN A MOUSE INFECTION MODEL WITH THE PRESENCE OR ABSENCE OF GENES IN THE ACCESSORY GENOME, WE IDENTIFIED SEVERAL VIRULENCE DETERMINANTS ENRICHED AMONG HIGHLY VIRULENT P. AERUGINOSA STRAINS THAT WERE ABSENT FROM LESS VIRULENT STRAINS. FROM THIS WORK WE IDENTIFIED AN ACCESSORY VIRULENCE FACTOR THAT SPANNED A PORTION OF TWO GENES ENCODING PRODUCTS INVOLVED IN CONTACT-DEPENDENT GROWTH INHIBITION (CDI). CDI IS ONE TYPE OF COMPETITIVE MECHANISM MICROORGANISMS USE TO ANTAGONIZE THEIR IMMEDIATE NEIGHBORS BY DELIVERING PROTEIN TOXINS DIRECTLY INTO TARGETED CELLS. THIS ANTAGONISM IS EXECUTED BY CDIA, A LARGE MULTIDOMAIN EXOPROTEIN THAT SITS AT THE SURFACE OF AN ATTACKING CELL AND DELIVERS A SELF-CONTAINED TOXIN DOMAIN INTO THE TARGETED CELL. THE IMPORTANCE OF THIS PROPOSAL STEMS FROM OUR DISCOVERY THAT: (I) CDIA CONTAINS A TOXIN DOMAIN THAT HAS TRNASE ACTIVITY AGAINST PROKARYOTIC AND EUKARYOTIC SUBSTRATES, (II) MUTATIONS THAT ABROGATE THE IN VITRO TRNASE ACTIVITY ATTENUATE BOTH CDI AND VIRULENCE IN MICE, (III) THE CDIA-TOXIN DOMAIN HAS CYTOPATHIC EFFECTS ON EUKARYOTIC CELLS DEPENDENT UPON ITS TRNASE ACTIVITY. TO OUR KNOWLEDGE THIS DULE ROLE FOR CDIA IN BOTH INTERBACTERIAL COMPLETION AND VIRULENCE WITHIN A MAMMALIAN HOST HAS NOT YET BEEN INVESTIGATED FOR P. AERUGINOSA. FROM THIS PRELIMINARY WORK WE HYPOTHESIZE THAT P. AERUGINOSA CAN UTILIZE CDIA TO INTOXICATE HOST CELLS FOR OVERCOMING BARRIERS TO INFECTION. OUR PROPOSAL SEEKS TO ANSWER A NUMBER OF OUTSTANDING QUESTIONS AT THE MOLECULAR (AIM 1), CELLULAR (AIM 2), AND ORGANISMAL (AIM 3) LEVEL. SUCCESSFUL COMPLETION OF THESE AIMS WILL PROVIDE DETAILED INSIGHT INTO HOW CDIA CONTRIBUTES TO P. AERUGINOSA PATHOBIOLOGY. | $1.8M | FY2021 | Jun 2021 – May 2027 |
| Department of Health and Human Services | THE ROLE OF PTEN PHOSPHORYLATION REMODELING IN HEMATOPOIETIC STEM CELL REGULATION | $1.8M | FY2010 | Mar 2010 – Nov 2014 |
| Department of Health and Human Services | PROBING CELLULAR INTRACELLULAR CALCIUM SIGNALING AND SENSING THROUGH COMPUTATION | $1.8M | FY2017 | Aug 2017 – Apr 2023 |
| Department of Health and Human Services | NUCLEAR LIPID-SENSOR IN TYPE II DIABETIC NEUROPATHY | $1.8M | FY2018 | Mar 2018 – May 2023 |
| Department of Health and Human Services | REQUIREMENTS FOR BACTERIAL COLONIZATION OF ANIMAL TISSUE | $1.8M | FY2000 | Apr 2000 – Mar 2015 |
| Department of Health and Human Services | DEVELOPMENT OF B CELL MEMORY IN ALLERGIC ASTHMA - PROJECT SUMMARY/ABSTRACT ALLERGIC ASTHMA IS A CHRONIC INFLAMMATORY DISEASE OF THE LUNGS WITHOUT CURE. REPETITIVE ALLERGEN EXPOSURE IN THE AIRWAY LEADS TO THE GENERATION OF PATHOGENIC IMMUNE MEMORY AND THE EXCESSIVE PRODUCTION OF ALLERGEN SPECIFIC IGE ANTIBODIES THAT MEDIATE INFLAMMATION, AIRWAY CONSTRICTION AND RESPIRATORY DISTRESS IN PATIENTS WITH ALLERGIC ASTHMA. MEMORY B CELLS ARE A KEY COMPONENT OF IMMUNE MEMORY. THE PHENOTYPIC AND FUNCTIONAL HETEROGENEITY OF MBCS AFFORDS THEIR DIFFERENTIAL ANTIBODY RESPONSES AS WELL AS IMPACT THEIR TRAFFICKING, TISSUE RETENTION AND ABILITY TO DISSEMINATE SYSTEMICALLY. IN A MOUSE MODEL OF ALLERGIC LUNG INFLAMMATION, WE HAVE OBSERVED STABLE LUNG- LOCALIZED MBCS AND EVIDENCE FOR THE GENERATION OF PATHOGENIC ANTIBODY RESPONSES IN SENSITIZED LUNGS. WE HYPOTHESIZE THAT AFTER LOCAL ANTIGEN SENSITIZATION, THE LUNG ACQUIRES IMMUNE FUNCTIONS REMINISCENT OF THOSE IN SECONDARY LYMPHOID TISSUES, CAPABLE OF MAINTAINING LONG-LIVED MEMORY B CELLS AS WELL AS GENERATING NEW MBCS THAT CAN RECIRCULATE AND DISSEMINATE IN OTHER TISSUES TO MEDIATE SYSTEMIC ALLERGIC INFLAMMATION. IN THIS STUDY, WE WILL 1) PROBE THE DEVELOPMENT OF MEMORY B CELLS (MBCS) IN ALLERGIC LUNGS INCLUDING IN-DEPTH CHARACTERIZATION OF THE CRITICAL MBC SUBSET THAT CONTRIBUTES TO ALLERGEN SPECIFIC IGE RESPONSE, AND 2) HOW THESE MBCS DISSEMINATE SYSTEMICALLY. WE WILL ALSO 3) EXPLORE STRATEGIES TO INTERCEPT THE SYSTEMIC DISSEMINATION OF PATHOGENIC MBCS TO HALT THE PROGRESSION OF ALLERGIC INFLAMMATION. THESE STUDIES WILL ADVANCE OUR FUNDAMENTAL UNDERSTANDING OF MEMORY B CELLS AS WELL AS HELP DEVISE NEW THERAPEUTIC STRATEGIES FOR ALLERGIC ASTHMA. | $1.8M | FY2022 | Jun 2022 – Apr 2027 |
| Department of Health and Human Services | THE CELL BIOLOGY OF TRIM5ALPHA | $1.8M | FY2011 | Feb 2011 – Sep 2016 |
| Department of Health and Human Services | SELF-MANAGEMENT IN ADOLESCENTS AND YOUNG ADULTS WITH SPINA BIFIDA | $1.8M | FY2016 | Sep 2016 – Jul 2022 |
| VA/DoDDepartment of Defense | EFFECTS OF INFECTION ON HOST RESPONSE TO TRAUMA | $1.8M | FY2010 | Sep 2010 – Oct 2012 |
| VA/DoDDepartment of Defense | TAS::57 3600::TAS "CONGRESSIONAL ADD FOR THE NANOTECHNOLOGY AND RAPID PROTOTYPING PROJECT AT LOYOLA MARYMOUNT UNIVERSITY" | $1.8M | FY2010 | Sep 2010 – Sep 2011 |
| Department of Health and Human Services | A PRECISION MEDICINE APPROACH TO RETT SYNDROME | $1.7M | FY2020 | May 2020 – Apr 2025 |
| Department of Health and Human Services | DEVELOP AN ORAL HIV VACCINE USING PAPILLOMA VIRUS-LIKE PARTICLES AS A VECTOR | $1.7M | FY2008 | Mar 2008 – Feb 2013 |
| Department of Health and Human Services | NEW MECHANISMS OF SERCA2A REGULATION: ROLE OF LUMINAL CALCIUM - PROJECT SUMMARY/ABSTRACT SERCA2A CA PUMP PLAYS A CENTRAL ROLE IN HEART FUNCTION. THE SPEED AT WHICH SERCA2A REMOVES CA FROM THE CYTOSOL IS THE MAIN DETERMINANT OF THE RATE OF CARDIAC MUSCLE RELAXATION. SERCA2A ALSO SETS THE TOTAL AMOUNT OF CA IN THE SARCOPLASMIC RETICULUM (SR), WHICH DETERMINES THE STRENGTH OF CARDIAC CONTRACTION. IT IS NOT SURPRISING, THAT IMPAIRED SERCA2A FUNCTION HAS BEEN REPORTED IN A NUMBER OF PATHOLOGICAL CONDITIONS, INCLUDING HEART FAILURE (HF). THUS, UNDERSTANDING MECHANISMS OF SERCA REGULATION IS OF GREAT CLINICAL IMPORTANCE. BESIDES ACTIVATION OF MUSCLE CONTRACTION, SR LUMINAL CA ([CA]SR) PLAYS AN IMPORTANT ROLE IN REGULATION OF SR PROTEIN FUNCTION. WHILE SERCA2A ACTIVITY CONTROLS [CA]SR, LESS IS KNOWN ABOUT HOW CHANGES IN [CA]SR AFFECT SERCA2A CA TRANSPORT. OUR PRELIMINARY RESULTS SUGGEST THAT SR LUMINAL CA PLAYS AN IMPORTANT ROLE IN REGULATION OF SERCA2A. IN THIS PROJECT WE WILL USE ADVANCED STRUCTURAL ANALYSES, INNOVATIVE MOLECULAR BIOLOGICAL TECHNIQUES, NEW ORGANELLE-SPECIFIC SENSORS, STATE-OF-THE-ART OPTICAL METHODS AND IN VIVO GENE DELIVERY TO EXPLORE THIS NEW MECHANISM OF SERCA2A REGULATION. IN AIM 1, WE WILL TEST THE HYPOTHESIS THAT LUMINAL CA REGULATES SERCA2A BY INCREASING THE PUMP’S CATALYTIC EFFICACY AND BY RELIEVING THE PHOSPHOLAMBAN (PLB) INHIBITORY EFFECT. MOLECULAR DYNAMIC SIMULATIONS WILL BE USED TO SELECT SPECIFIC DOMAINS ON THE SERCA2A LUMINAL SIDE THAT ARE INVOLVED IN CA REGULATION. SITE-DIRECTED MUTAGENESIS WILL BE USED TO IDENTIFY THE SPECIFIC AMINO ACIDS THAT FORM THE LUMINAL CA-BINDING SITES AND TO DEVELOP THE LUMINAL CA-INSENSITIVE SERCA2A MUTANT. WE WILL ASSESS EFFECTS OF THE LUMINAL CA REGULATION ON CA TRANSPORT, THE ATPASE ACTIVITY AND THE PLB INTERACTION. THEN, MYOCYTES EXPRESSING THE LUMINAL CA-INSENSITIVE SERCA2A MUTANT WILL BE STUDIED TO DEFINE THE ROLE OF THIS NOVEL MECHANISM IN CARDIAC CA CYCLING. WE EXPECT THAT THE OUTCOME OF THIS WORK WILL GREATLY ADVANCE OUR UNDERSTANDING OF SERCA2A FUNCTION. WE EXPECT THAT THE OUTCOME OF THESE STUDIES WILL PROVIDE A DETAILED VIEW OF THIS NEW MECHANISM OF SERCA2A REGULATION, ADVANCING OUR UNDERSTANDING OF THE CA PUMP’S FUNCTION. IN AIM 2, WE WILL TEST THE HYPOTHESIS THAT LUMINAL REDOX POTENTIAL REGULATES SERCA2A BY STABILIZING ITS LUMINAL CA BINDING SITES, THUS, IMPROVING THE PUMP’S REGULATION BY [CA]SR. MOLECULAR DYNAMIC SIMULATIONS WILL BE USED TO FORECAST THE ROLE OF THE SERCA2A LUMINAL DISULFIDE BOND IN THE PUMP CATALYTIC CYCLE. WE WILL ASSESS WHETHER MUTATION OF LUMINAL CYSTEINES LEADS TO A LOSS-OF-FUNCTION PHENOTYPE BY ABOLISHING SERCA2A REGULATION BY LUMINAL CA. NEWLY DEVELOPED APPROACHES TO MEASURE LUMINAL REDOX POTENTIAL AND [CA]SR WILL BE USED TO DEFINE THE CROSS-TALK BETWEEN LUMINAL REDOX POTENTIAL AND SERCA2A ACTIVITY. WE WILL INVESTIGATE THE CONTRIBUTION OF THIS NEW MECHANISM TO SERCA2A DYSFUNCTION AND CA MISHANDLING IN HF. THE LIKELY OUTCOME OF THESE STUDIES IS A NEW CONCEPT THAT CAN EXPLAIN HOW ALTERATIONS IN SERCA2A STRUCTURE/FUNCTION CAUSE DEFECTS IN CA REGULATION IN HF. | $1.7M | FY2021 | Feb 2021 – Jan 2025 |
| Department of Health and Human Services | CAN THE SUNSHINE VITAMIN IMPROVE MOOD AND SELF-MANAGEMENT IN WOMEN WITH DIABETES | $1.7M | FY2013 | Jun 2013 – Mar 2018 |
| VA/DoDDepartment of Defense | USE OF NOVEL ANGIOPOIETIN-1 MIMETIC PEPTIDE FOR THE TREATMENT OF BURN SHOCK-ASSOCIATED ENDOTHELIAL DYSFUNCTION IN SEVERE BURN INJURY | $1.7M | FY2026 | Sep 2026 – Aug 2029 |
| Department of Health and Human Services | RIP1/RIP3-CALPAIN-STAT3 AND NF-KAPPA B PATHWAYS IN AML PATHOGENESIS AND TREATMENT | $1.7M | FY2018 | May 2018 – Apr 2024 |
| Department of Health and Human Services | BRAVE MINORITY YOUTH VIOLENCE PREVENTION PROGRAM | $1.7M | FY2017 | Jul 2017 – Jun 2022 |
| Department of Health and Human Services | MECHANISMS OF ENTEROPATHOGENIC E. COLI EFFECTS ON POLARITY AND TIGHT JUNCTIONS | $1.6M | FY2012 | Sep 2012 – Jul 2017 |
| Department of Health and Human Services | TARGETING HSP70 IN AUTOIMMUNE VITILIGO | $1.6M | FY2008 | Sep 2008 – Aug 2013 |
| Department of Health and Human Services | FEASIBILITY AND EFFECTIVENESS OF GAMIFIED DIGITAL INTERVENTION TO PREVENT ALCOHOL AND MENTAL HEALTH RISKS - PROJECT ABSTRACT SEXUAL MINORITY WOMEN CONSUME ALCOHOL, EXPERIENCE ALCOHOL-RELATED PROBLEMS, AND SUFFER FROM MENTAL HEALTH PROBLEMS AT HIGHER RATES THAN DO THEIR HETEROSEXUAL PEERS. ALTHOUGH SEVERAL CLINICAL PROGRAMS ARE BEING DEVELOPED FOR SEXUAL MINORITY WOMEN (SMW) SEEKING TREATMENT FOR THESE PROBLEMS, ONLY A SMALL PROPORTION OF SMW NEEDING IT EVER SEEK TREATMENT. MEANWHILE, PREVENTIVE INTERVENTIONS ABLE TO AVOID THESE PROBLEMS BY REDUCING DRINKING AND IMPROVING PSYCHOLOGICAL WELL-BEING AMONG NON-TREATMENT SEEKING SMW HAVE BEEN SLOW TO EMERGE. THE PROPOSED RESEARCH BUILDS ON R21AA025767, WHICH ESTABLISHED THE PRELIMINARY FEASIBILITY AND EFFECTIVENESS OF DELIVERING PERSONALIZED NORMATIVE FEEDBACK ON DRINKING AND COPING BEHAVIORS TO SMW WITHIN A BROADER APP-BASED SOCIAL COMPETITION DESIGNED TO CHALLENGE HARMFUL STEREOTYPES ABOUT THIS POPULATION AND FOSTER A SUPPORTIVE VIRTUAL COMMUNITY. IN OUR PILOT TRIAL, SEXUAL MINORITY WOMEN ENTHUSIASTICALLY ENGAGED WITH THE APP IN THE ABSENCE OF PARTICIPATION INCENTIVES FOR DOING SO. FURTHER, RELATIVE TO A SUB-SAMPLE THAT RECEIVED PNF ON CONTROL TOPICS WITHIN THE COMPETITION, THOSE WHO RECEIVED PNF ON DRINKING AND COPING SUBSTANTIALLY REDUCED THEIR CONSUMPTION AND NEGATIVE CONSEQUENCES OVER A 4-MONTH PERIOD. MOREOVER, QUALITATIVE FEEDBACK SUGGESTED THAT NEGATIVE STEREOTYPE DISCONFIRMING PNF AND SOCIAL MEDIA INSPIRED COMMUNITY FEATURES (PRESENT ACROSS CONDITIONS) MAY HAVE ALSO PROVIDED PSYCHOLOGICAL BENEFITS BEYOND THE ALCOHOL AND COPING PNF EVALUATED. TO BUILD ON THESE PROMISING FINDINGS AND REMEDY LIMITATIONS, THIS RESEARCH PROPOSES TO FIRST OPTIMIZE THE APP BASED ON FEEDBACK FROM PARTICIPANTS IN THE PILOT TRIAL (AIM1) AND THEN CONDUCT A LARGE, SOPHISTICATED, TYPE I IMPLEMENTATION-EFFECTIVENESS TRIAL TO SIMULTANEOUSLY EXAMINE THE EFFECTS OF THE FULLY FEATURED APP ON DRINKING, ALCOHOL-RELATED PROBLEMS, AND PSYCHOLOGICAL WELL-BEING RELATIVE TO A LIMITED FEATURE PSYCHOEDUCATIONAL CONTROL VERSION OF THE APP (AIM2), IDENTIFY EXPLANATORY PSYCHOLOGICAL MECHANISMS ASSOCIATED WITH THE FULLY FEATURED APP’S EFFECTIVENESS (AIM3), ELUCIDATE DEMOGRAPHIC AND SEXUAL MINORITY STIGMA-RELATED MODERATORS (AIM4), AND EXAMINE ENGAGEMENT, ACCEPTABILITY, AND SUSTAINABILITY OF USE UNDER REAL WORLD CONDITIONS AMONG A SUB-SAMPLE OF UNINCENTIVIZED, FULLY FEATURED APP USERS (AIM 5). | $1.6M | FY2023 | Sep 2023 – Aug 2028 |
| VA/DoDDepartment of Defense | A NEW PHARMACOLOGICAL TARGET TO REDUCE THE INCIDENCE OF ACUTE RESPIRATORY DISTRESS SYNDROME AFTER ACUTE LUNG INJURY IN TRAUMA PATIENTS | $1.6M | FY2015 | Sep 2015 – Aug 2019 |
| Department of Health and Human Services | MODULATING TOLERANCE IN A SPONTANEOUS MOUSE MODEL OF AUTOIMMUNE VITILIGO | $1.6M | FY2010 | Sep 2010 – Apr 2015 |
| Department of Health and Human Services | THE ROLE OF SPARTIN IN AUTOPHAGY OF LIPID DROPLETS: IMPLICATIONS FOR SPG20 DISEAS | $1.6M | FY2012 | Feb 2012 – Jul 2019 |
| Department of Health and Human Services | LOYOLA-UKRAINIAN CATHOLIC UNIVERSITY INTERNATIONAL BIOETHICS RESEARCH TRAINING PROGRAM | $1.6M | FY2020 | Mar 2020 – Jun 2030 |
| Department of Health and Human Services | TCR AFFINITY AND THERAPEUTIC EFFICACY OF T CELLS | $1.6M | FY2007 | Jul 2007 – Apr 2013 |
| Department of Health and Human Services | DEFINING THE MICROTUBULE MOTORS WHICH DRIVE THE UNCOATING AND TRAFFICKING OF HIV | $1.6M | FY2015 | Jun 2015 – May 2021 |
| Department of Health and Human Services | RESCUING ANTI-TUMOR RESPONSES OF TCR-TD T CELLS BY NKG2D-STIMULATION | $1.6M | FY2014 | Aug 2014 – Jul 2020 |
| Department of State | STRENGTHENING THE CAPACITY OF THE AFRICAN UNION TO PROMOTE GOVERNANCE AND THE RULE OF LAW IN ITS STATES | $1.6M | FY2014 | Sep 2014 – Sep 2018 |
| Department of Health and Human Services | PROBING MACROPHAGE CELL NUCLEOTIDE SENSING AND CALCIUM SIGNALING THROUGH COMPUTATION - WHILE INAMMATION IS A NATURAL IMMUNE SYSTEM RESPONSE THAT BEGINS THE HEALING PROCESS, CHRONIC INAM- MATION IS TIED TO MANY HUMAN DISEASES INCLUDING CANCER, CARDIAC DYSFUNCTION, AND SEPSIS. A KEY ELEMENT OF INAMMATORY RESPONSES ARE MACROPHAGES, A WHITE BLOOD CELL THAT ELIMINATES PATHOGENS OR DYING TISSUES. AN ENDOGENOUS 'DANGER SIGNAL', ADENOSINE TRIPHOSPHATE (ATP), STIMULATES CA-DEPENDENT INAMMATORY PATHWAYS IN MACROPHAGES. WHILE PREVIOUS RESEARCH HAS MADE GREAT STRIDES IN UNDERSTANDING INAMMATION, MY LAB SEEKS TO UNCOVER ROLES OF ATP IN DRIVING MACROPHAGE INAMMATORY RESPONSES THROUGH MULTI-SCALE COMPUTATIONAL MODELS WE DEVELOP. WITH NEW MODELS OF INAMMATORY RESPONSES IN MACROPHAGES, OUR LAB CAN PREDICT PROTEIN AND CELL BEHAVIOR IN INTEGRATED, PHYSIOLOGICAL SYSTEMS TO BETTER UNDERSTAND THE IMMUNE SYSTEM. THE CURRENT PARADIGM FOR ATP-TRIGGERED INAMMATION IN MACROPHAGES IS THAT UPREGULATION OF NUCLEOTIDE- SENSING P2X CHANNELS SENSITIZES INAMMATORY RESPONSES, INCLUDING CYTOKINE AND REACTIVE OXYGEN SPECIES (ROS) RELEASE. HOWEVER, THIS PARADIGM DOES NOT ACCOUNT FOR SEVERAL OBSERVATIONS. ONE, WHILE P2X EXPRESSION IS INCREASED IN INAMMATORY MACROPHAGES, THESE RECEPTORS ALSO SUPPORT PHAGOCYTOSIS AND MIGRATION IN RESTING MACROPHAGES. HOW THESE PROCESSES ARE SELECTIVELY CONTROLLED BY P2X SUBTYPES LIKE P2X4 AND P2X7 IS UNRESOLVED. TWO, INAMMATORY MACROPHAGES HARBOR POST-TRANSLATIONAL MODICATIONS (PTMS) OF MANY PROTEINS THAT SENSE CA, YET LITTLE IS KNOWN ABOUT HOW PTMS IMPACT IMMUNE PATHWAYS THEY CONTROL. THREE, RELEASE AND DEGRADATION OF ATP BY PANNEXINS AND ECTONUCLEOTIDASES CONTROL ATP THAT ACTIVATES P2X, YET FEW STUDIES HAVE EVALUATED THEIR COUPLING. OUR LAB IS UNIQUELY POSITIONED TO EXTEND THIS PARADIGM BY PROBING MECHANISMS UNDERLYING THESE OBSERVATIONS AND THE LARGELY UNSTUDIED COUPLING OF P2X-, ATP-, AND CA-DRIVEN INAMMATION. OUR LAB AND ASSEMBLED COLLAB- ORATORS WILL INVESTIGATE THE OVERALL HYPOTHESIS VIA COMPUTATIONAL MODELING AND EXPERIMENTAL APPROACHES: P2X CHANNELS IN MACROPHAGES HELP NUCLEATE CHRONIC INAMMATION VIA ATP-INDUCED ATP RELEASE (AUTOCRINIC) MECHANISMS THAT SELECTIVELY PRIME CA-DEPENDENT, PRO-INAMMATORY SIGNALING PATHWAYS. THIS HYPOTHESIS STEMS FROM QUESTIONS THAT EMERGED FROM OUR INVESTIGATIONS DURING THE INITIAL ESI MIRA AWARD: 1. DOES INCREASED P2X4 AND P2X7 EXPRESSION AND THE RESULTING CA SIGNALS THEY INDUCE IN MACROPHAGES PROLONG PRO-INAMMATORY RELEASE OF CYTOKINES AND ROS? 2. DO PTMS LIKE ROS OXIDATION IN THE CA-SENSOR CALMODULIN (CAM) ATTENUATE ITS ACTIVATION OF PRO-INAMMATORY SIGNALING PATHWAYS? 3. DO (AUTOCRINIC) ATP-INDUCED, ATP RELEASE IN MACROPHAGES PROLONG PRO-INAMMATORY INCREASES IN INTRACELLULAR CA? OUR LONG-TERM GOAL TO UNDERSTAND MACROPHAGE PHYSIOLOGY THROUGH COMPUTATION WILL BE ACCELERATED BY THE PROPOSED INVESTIGATIONS. KEY EXPECTED OUTCOMES FROM THIS GRANT PERIOD INCLUDE NEW MECHANISMS AND SIMULATION TOOLS FOR AUTOCRINIC, ATP-DRIVEN INAMMATORY RESPONSES MEDIATED BY P2X RECEPTORS. SINCE ALL EUKARYOTIC CELLS USE CA, INSIGHTS FROM MODELING MACROPHAGES WILL HAVE BROAD IMPACTS BEYOND IMMUNE FUNCTION. | $1.5M | FY2023 | May 2023 – Mar 2028 |
| Department of Health and Human Services | ADVANCED NURSING EDUCATION WORKFORCE | $1.5M | FY2017 | Jul 2017 – Jun 2019 |
| Department of Health and Human Services | NURSE EDUCATION, PRACTICE, QUALITY, AND RETENTION - INTERPROFESSIONAL COLLBORATIVE PRACTICE | $1.5M | FY2016 | Jul 2016 – Jun 2019 |
| Department of Education | OER FOR SOCIAL JUSTICE AT FOUR CALIFORNIA CATHOLIC COLLEGES & UNIVERSITIES | $1.5M | FY2023 | Jan 2023 – Dec 2025 |
| Department of Health and Human Services | EXTRATUMORAL BIOLOGICAL DETERMINANTS THAT DECREASE SURVIVAL IN OLDER ADULTS WITH GLIOBLASTOMA - PROJECT SUMMARY WILD-TYPE ISOCITRATE DEHYDROGENASE 1/2 GLIOBLASTOMA (GBM) IS THE MOST COMMON AND AGGRESSIVE FORM OF MALIGNANT PRIMARY BRAIN TUMOR IN ADULTS WITH A MEDIAN AGE OF ONSET AT 68-70 YEARS OLD. IDHWT GBM PATIENTS REPRESENT >70% OF ALL GBM PATIENT DIAGNOSES, AND AMONG THOSE INDIVIDUALS, OLDER ADULTS =65 YEARS OF AGE HAVE A SIGNIFICANTLY DECREASED MEDIAN OVERALL SURVIVAL (MOS) AS COMPARED TO YOUNGER IDHWT GBM PATIENTS AFTER TREATMENT WITH STANDARD OF CARE RADIATION (RT) AND TEMOZOLOMIDE. WE HAVE ALSO STUDIED OUR ONGOING CLINICAL TRIAL NCT04047706 AND DETERMINED THAT NEWLY-DIAGNOSED OLDER ADULT IDHWT MGMT PROMOTER UNMETHYLATED GBM PATIENTS WHO ARE TREATED WITH RT, NIVOLUMAB (PD-1 MAB), AND BMS-986205 [IDO ENZYME INHIBITOR (IDOI)] HAVE A DECREASED MOS AS COMPARED TO SIMILARLY-TREATED YOUNGER GBM PATIENTS (P<0.0007). STRIKINGLY, >33% OF THE YOUNGEST PATIENTS IN THIS TRIAL ARE STILL ALIVE AT 36 MONTHS POST-TREATMENT INITIATION. THE POOR PROGNOSIS OF OLDER ADULT GBM PATIENTS STARKLY CONTRASTS WITH INDIVIDUALS WHO UNDERGO TREATMENT FOR OTHER FORMS OF AGGRESSIVE CANCER THAT ARISES OUTSIDE OF THE BRAIN. FOR EXAMPLE, FORMER PRESIDENT JIMMY CARTER WAS DIAGNOSED WITH METASTATIC MELANOMA AT 91 YEARS OF AGE AND SUBSEQUENTLY TREATED WITH IMMUNOTHERAPY. STRIKINGLY, PRESIDENT CARTER IS STILL ALIVE TODAY AT 98 YEARS OLD. WE HYPOTHESIZE THAT MAJOR CONTRIBUTING FACTORS TO THE WORSE SURVIVAL OUTCOMES OF OLDER ADULT GBM PATIENTS DEPEND ON: (I) HOW INTRATUMORAL GENE EXPRESSION LEVELS DO NOT CHANGE WITH DIFFERENCES IN GBM PATIENT AGE [SHAH ET AL., 2021, CELL REPORTS. 37(10):110100], BUT RATHER, (II) HOW EXTRATUMORAL LEVELS OF IMMUNOSUPPRESSION INCREASE IN THE OLDER ADULT BRAIN AND POTENTLY SUPPRESS THERAPEUTIC EFFICACY IN OLDER ADULTS WITH GBM [LADOMERSKY…WAINWRIGHT, 2020, CLINICAL CANCER RESEARCH. 26(19):5232-5245], AND (III) HOW EXTRATUMORAL LEVELS OF SENESCENCE INCREASE IN THE OLDER ADULT BRAIN [KIM…WAINWRIGHT, 2021, NEURO-ONCOLOGY ADVANCES. 3(1):VDAB125]. TO UNDERSTAND THE EFFECTS OF ADVANCED AGE-MEDIATED CHANGES IN THE EXTRATUMORAL OLDER ADULT BRAIN, THAT IN-TURN, PROMOTES THE MALADAPTIVE RESPONSE TO GBM AND/OR GBM TREATMENTS, WE WILL: (I) STUDY EXTRATUMORAL IDO-MEDIATED IMMUNOSUPPRESSION OF THERAPEUTIC EFFICACY IN OLDER ADULT MICE WITH GBM; (II) CHARACTERIZE EXTRATUMORAL SENESCENCE LEVELS AND THEIR EFFECTS ON SURVIVAL OUTCOMES OF OLDER ADULT MICE WITH GBM; (III) QUANTIFY AGING PARAMETERS IN THE EXTRATUMORAL HUMAN BRAIN FROM INDIVIDUALS ACROSS THE LIFESPAN THAT DID OR DID NOT HAVE GBM. THIS RESEARCH IS HIGHLY INNOVATIVE AND SIGNIFICANT FOR ITS GOAL TO UNDERSTAND AGING- DEPENDENT MECHANISMS THAT CONTRIBUTE TO WORSE SURVIVAL OUTCOMES IN OLDER ADULTS WITH IDHWT GBM. | $1.5M | FY2023 | Aug 2023 – Apr 2028 |
| Department of Health and Human Services | RATIONAL DESIGN OF A UNIQUE VACCINE FOR EMERGING PANDEMIC CORONAVIRUSES - ABSTRACT SARS-COV-2 HAS CAUSED THE GLOBAL COVID-19 PANDEMIC. VACCINES AGAINST SARS-COV-2, MOSTLY USING SPIKE (S) PROTEIN AS A TARGET ANTIGEN TO INDUCE NEUTRALIZING ANTIBODIES, HAVE BEEN DEVELOPED AT UNPRECEDENTED SPEED AND SEVERAL HAVE BEEN APPROVED FOR USE IN HUMAN. THE CURRENTLY DEVELOPED VACCINES INDUCE NEUTRALIZING ANTIBODIES AND PROVIDE PROTECTION AGAINST SARS-COV-2 ORIGINAL STRAIN OR EARLIER VARIANTS, BUT THEY HAVE REDUCED NEUTRALIZING ACTIVITY OR PROTECTION AGAINST RECENT VARIANTS. BASED ON THE FACT THAT THREE PANDEMIC CORONAVIRUSES (COVS) HAVE EMERGED WITHIN 20 YEARS, SOME UNKNOWN COVS WITH PANDEMIC POTENTIAL ARE EXPECTED TO EMERGE IN THE FORESEEABLE FUTURE. THEREFORE, A VACCINE IS URGENTLY NEEDED TO PREVENT A FUTURE EMERGING COV. THREE COV OUTBREAKS CAUSED BY THE THREE HIGHLY PATHOGENIC COVS (SARS-COV, SARS-COV-2 AND MERS-COV) ARE ALL FROM BETA-COVS, IN PARTICULAR, FROM SARBECOVIRUS AND MERBECOVIRUS LINEAGES, WE THUS REASON THAT FUTURE EMERGING COVS CAUSING PANDEMICS MAY MOST LIKELY COME FROM THESE TWO LINEAGES AND THAT BOTH LINEAGES SHOULD BE TARGETED TO DEVELOP A VACCINE TO PREVENT AGAINST THE FUTURE EMERGING VIRUS. HOWEVER, WE CANNOT PREDICT THE SEQUENCES OF S PROTEIN OF FUTURE EMERGING COV TO MAKE A VACCINE TARGETING S TO INDUCE NEUTRALIZING ANTIBODIES. OUR PRIOR DATA SHOWED THAT A S PROTEIN-BASED VACCINE BY USING UBIQUITINATION AND GENE REARRANGEMENT STRATEGY TO ENHANCE ITS DEGRADATION IN PROTEASOME INDUCED STRONG T CELL RESPONSES, IN PARTICULAR CTLS. THIS VACCINE SIGNIFICANTLY PROTECTED MICE AGAINST SARS-COV-2-INDUCED SURVIVAL AND WEIGHT LOSS, AND THE PROTECTION REQUIRED CD4+ AND CD8+ T CELLS. THUS, WE WILL DESIGN COV VACCINES THAT TARGET THE PROTEINS WITH GREAT HOMOLOGY (I.E., S2, M, AND N) FROM SARBECOVIRUSES AND MERBECOVIRUSES TO INDUCE PROTECTIVE T CELLS. FURTHERMORE, UPPER RESPIRATORY TRACT TISSUE-RESIDENT MEMORY T CELLS (TRM) PLAY ESSENTIAL ROLES IN PROVIDING IMMEDIATE PROTECTION, AND MUCOSAL IMMUNIZATION IS THE ONLY WAY TO INDUCE UPPER RESPIRATORY TRACT TRM. BECAUSE PAPILLOMAVIRUS-LIKE PARTICLES (PV- VLPS) INDUCE MUCOSAL IMMUNE RESPONSES, WHICH SERVE AS A MUCOSAL DELIVERY VECTOR AND ADJUVANT, WE HYPOTHESIZE THAT PV-VLPS CAN DELIVER COV HOMOLOGOUS ANTIGENS TO NASAL-ASSOCIATED LYMPHOID TISSUE, AND INDUCE RESPIRATORY TRACT TRM FOR EFFECTIVE PROTECTION AGAINST SARBECOVIRUS AND MERBECOVIRUS-CAUSED RESPIRATORY SYNDROME AND PNEUMONIA. USING SARBECOVIRUSES AND MERBECOVIRUSES AS MODEL VIRUSES, THIS PROPOSAL WILL 1) DEVELOP A PV-VLP-BASED, T CELL-INDUCING MUCOSAL COV VACCINE TARGETING CONSERVED COV ANTIGENS (S2, M AND N) AND USING GENE REARRANGEMENT AND UBIQUITINATION STRATEGIES, 2) DETERMINE IF THE VACCINE INDUCES MUCOSAL AND SYSTEMIC IMMUNE RESPONSES TO SARBECOVIRUSES AND MERBECOVIRUSES, IN PARTICULAR, LONG-TERM UPPER RESPIRATORY TRACT TRM, AND 3) EVALUATE VACCINE'S CROSS-PROTECTIVE EFFICACY AGAINST INFECTIONS OF SARBECOVIRUSES AND MERBECOVIRUSES IN MOUSE MODELS. WE HAVE SOLID PRELIMINARY DATA, WELL-ESTABLISHED ANIMAL MODELS AND VACCINE PLATFORMS, AND A STRONG RESEARCH TEAM WITH DECADES OF EXTENSIVE EXPERIENCE IN DEVELOPING SAFE AND EFFECTIVE COV VACCINES, PROVIDING FEASIBILITY AND BASIS FOR THE PROPOSED STUDIES. | $1.5M | FY2025 | Dec 2024 – Nov 2029 |
| Department of Education | ACCELERATING TRANSFER AND LOW-INCOME ACCESS AND SUCCESS (ATLAS) PROGRAM | $1.5M | FY2024 | Oct 2023 – Sep 2026 |
| Department of Health and Human Services | CALCIUM RELEASE CHANNEL DYSFUNCTION: MOLECULAR MECHANISMS | $1.5M | FY2016 | Jan 2016 – Dec 2020 |
| Department of Health and Human Services | REGULATION OF NOTCH SIGNALING BY ERBB-2: NOVEL THERAPEUTIC STRATEGY | $1.5M | FY2012 | Sep 2012 – Jun 2018 |
| Department of Health and Human Services | NURSE EDUCATION, PRACTICE, QUALITY, AND RETENTION - INTERPROFESSIONAL COLLBORATIVE PRACTICE | $1.5M | FY2013 | Jul 2013 – Dec 2017 |
| Department of Health and Human Services | NOTCH-1 AND IGF-1 CROSSTALK: NEW THERAPEUTIC STRATEGIES FOR NSCLC | $1.5M | FY2009 | Jun 2009 – Apr 2015 |
| Agency for International Development | AWARDING LOYOLA UNIVERSITY CHICAGO A TWO YEAR COOPERATIVE AGREEMENT FOR $1,500,000 IN SUPPORT OF THEIR PROGRAM ENTITLED, "YES WE CAN!: PARTNERING WIT | $1.5M | FY2009 | Sep 2009 – Aug 2011 |
| Department of Health and Human Services | SYSTEMATIC IDENTIFICATION OF HEMATOPOIETIC STEM CELL EXPANSION FACTORS | $1.5M | FY2017 | Aug 2017 – Jul 2022 |
| Department of Health and Human Services | JNK SUPPRESSION OF CONNEXIN43 ENHANCES ATRIAL FIBRILLATION IN AGED ATRIA | $1.5M | FY2012 | Jul 2012 – Mar 2016 |
| Department of Health and Human Services | STRUCTURE CHANGES OF ION-MOTIVE ATPASES | $1.5M | FY2011 | Aug 2011 – May 2015 |
| Department of Health and Human Services | THE MODERATION EFFECT OF SOCIAL SUPPORT NETWORKS ON THE RELATIONSHIP BETWEEN OPIOID USE AND SUICIDE ATTEMPTS AMONG NATIVE AMERICAN YOUTH IN NEW MEXICO | $1.5M | FY2019 | Sep 2019 – Aug 2024 |
| Department of Education | LMU UPWARD BOUND CLASSIC | $1.5M | FY2017 | Sep 2017 – Apr 2022 |
| Department of Health and Human Services | CHEMOKINE-MEDIATED MODULATON OF OPIOID-INDUCED PAIN | $1.5M | FY2008 | Sep 2008 – May 2013 |
| Department of Health and Human Services | MECHANISMS OF FORK RESTART IN RESPONSE TO GENOTOXIC STRESS | $1.5M | FY2014 | Sep 2014 – Aug 2020 |
| VA/DoDDepartment of Defense | EFFECTS OF INFECTION ON BURN-INDUCES HYPERMETABOLISM AND ORGAN DYSFUNCTION | $1.4M | FY2011 | Sep 2011 – Sep 2015 |
| Department of Health and Human Services | NURSE EDUCATION PRACTICE AND RETENTION | $1.4M | FY2009 | Jul 2009 – Jun 2014 |
| Department of Health and Human Services | BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING FOR PROFESSIONALS AND PARAPROFESSIONALS | $1.4M | FY2014 | Sep 2014 – Jan 2018 |
| Department of Health and Human Services | STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS THAT IMPROVE Y537S ESTROGEN RECEPTOR ANTAGONISM - SUMMARY THIS PROPOSAL STUDIES HOW DRUG-INDUCED STRUCTURAL CHANGES TO Y537S ESTROGEN RECEPTOR ALPHA (ERA) IMPACT ANTI- TUMORAL ACTIVITIES IN HORMONE-RESISTANT BREAST CANCER CELLS. BREAST CANCER IS THE SECOND LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES. ACQUIRED RESISTANCE TO HORMONE THERAPIES IS A LEADING CONTRIBUTOR TO MORTALITY. IN APPROXIMATELY 40% OF PROGRESSIVE ER+ PATIENTS, PROLONGED SELECTIVE PRESSURE BY ANTIESTROGENIC THERAPIES GIVES RAISE TO TUMORS BEARING ACTIVATING SOMATIC ESR1 (THE GENE FOR ERA) MUTATIONS. THESE MUTATIONS RESIST INHIBITION BY CLINICALLY APPROVED HORMONE THERAPIES AND ENGAGE NEW TRANSCRIPTIONAL PROGRAMS THAT BOOST METASTATIC POTENTIAL. Y537S MISSENSE MUTATION IS AMONG THE MOST COMMON AND ENABLES THE GREATEST HORMONE-FREE TRANSCRIPTIONAL ACTIVITIES AND RESISTANCE TO ANTIESTROGEN. NEXT GENERATION SELECTIVE ESTROGEN RECEPTOR DEGRADERS (SERDS) HAVE BEEN CLINICALLY DEPLOYED TO ADDRESS THIS MECHANISM OF DRUG RESISTANCE. HOWEVER, THEY SHOW VARIABLE ACTIVITIES IN Y537S ESR1 BREAST CANCERS AND POSSESS COMMON SIDE-EFFECTS THAT WILL LIMIT THEIR LONG-TERM USE. WE RECENTLY STUDIED HOW A PANEL OF 17 SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS) AND SERDS BIND TO AND AFFECT Y537S ERA ACTIVITIES IN BREAST CANCER CELLS. WE IDENTIFIED STRUCTURALLY DISTINCT SERMS AND SERDS WITH IMPROVED ACTIVITIES IN THIS SETTING. WHILE STRUCTURALLY DISTINCT, OUR X-RAY CO-CRYSTAL STRUCTURES SHOWED THAT THE MOST EFFECTIVE MOLECULES ENGAGED THE SAME S537-E380 HYDROGEN BOND TO REINFORCE THE THERAPEUTIC ANTAGONIST CONFORMATION. THEREFORE, WE HYPOTHESIZE THAT NOVEL LIGAND-DEPENDENT STRUCTURAL INTERACTIONS WILL IMPROVE THERAPEUTIC ANTAGONISTIC ACTIVITIES IN THE Y537S ESR1 SETTING. IN THIS STUDY, WE WILL LEVERAGE OUR LIBRARY OF OVER 100 DIVERSE SERMS AND SERDS TO REVEAL THE STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS THAT UNDERLIE IMPROVED ANTI- CANCER ACTIVITIES Y537S ESR1 BREAST CANCER CELLS. WE WILL START BY STUDYING HOW OUR LIBRARY BINDS TO AND AFFECTS Y537S ERA STRUCTURE AND ANTI-CANCER ACTIVITIES (AIM 1). THIS APPROACH WILL REVEAL THE LIGAND BINDING MODES AND STRUCTURAL INTERACTIONS THAT ENABLE POTENCY. NEXT, WE WILL STUDY HOW THE MOST EFFECTIVE MOLECULES IMPACT Y537S ERA GENOMIC ACTIVITIES INCLUDING PROTEIN-PROTEIN INTERACTIONS, GENOME BINDING, AND TRANSCRIPTIONAL PROGRAMING (AIM 2). THIS APPROACH WILL SHOW WHETHER THE EFFICACIES OF SERMS AND SERDS ARISE FROM ALTERATIONS TO Y537S ERA GENOMIC ACTIVITIES. FINALLY, WE WILL REVEAL THE ANTI-TUMOR AND TISSUE-SPECIFIC ACTIVITIES OF THE MOST EFFECTIVE SERMS AND SERDS IN HORMONE-RESISTANT ER+ BREAST CANCER IN VIVO (AIM 3). THIS APPROACH WILL REVEAL WHETHER OUR IN VITRO OBSERVATIONS CORRESPOND TO IMPROVED ANTI-CANCER ACTIVITIES IN PATIENT-RELEVANT TUMOR MODELS. OVERALL, THESE STUDIES WILL PROVIDE DETAILED STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS TO IMPROVE THERAPEUTIC TARGETING OF Y537S ERA IN HORMONE-RESISTANT BREAST CANCER. | $1.4M | FY2023 | May 2023 – Apr 2028 |
| Department of Education | LMU UPWARD BOUND MATH SCIENCE | $1.4M | FY2017 | Sep 2017 – Aug 2022 |
| Department of Health and Human Services | TRAUMA CENTER BRIEF ALCOHOL TREATMENTS AND COST EFFECTIVENES | $1.4M | FY2006 | Aug 2006 – Jul 2011 |
| VA/DoDDepartment of Defense | "BURN TRAUMA AND INFECTION" | $1.4M | FY2009 | Aug 2009 – Sep 2011 |
| Department of Health and Human Services | EVALUATION OF GOAL-DIRECTED PSYCHOLOGICAL CAPITAL AND EMPLOYER COACHING IN HEALTH PROFESSION OPPORTUNITY DEVELOPMENT | $1.4M | FY2016 | Sep 2016 – Sep 2021 |
| Department of Health and Human Services | EVALUATION OF EMPOWERMENT PATHWAYS TO SELF-SUFFICIENCY IN HEALTH PROFESSIONS OPPORTUNITY WORKFORCE DEVELOPMENT FOR LOW-I | $1.3M | FY2011 | Sep 2011 – Sep 2015 |
| Department of Health and Human Services | CENTER FOR UNDERREPRESENTED RESEARCH IN ADDICTION (CURA) | $1.3M | FY2019 | Sep 2019 – Dec 2025 |
| Department of Health and Human Services | SEX DIFFERENCES IN COGNITIVE DYSFUNCTION: MITIGATION BY RNA EDITING - SUMMARY: PRENATAL STRESS (PRS) DISRUPTS BRAIN DEVELOPMENT 1-3 RESULTING IN HIGHER RISK OF DEPRESSION AND ANXIETY5, 6 IN FEMALE OFFSPRING AND A HIGHER RISK OF COGNITIVE DISORDERS SUCH AS AUTISM AND SCHIZOPHRENIA IN MALES7. DATA FROM OUR LABORATORY REVEAL SEX DIFFERENCES IN IMPORTANT MOLECULAR PATHWAYS IN THE CORTICOLIMBIC CIRCUIT IN PSYCHIATRIC DISORDERS, PARTICULARLY IN THE GLUTAMATERGIC SYSTEM12-16. GLUTAMATERGIC TRANSMISSION WITHIN THE HIPPOCAMPUS AND AMYGDALA PLAYS AN IMPORTANT ROLE IN COGNITION, AND RESILIENCE TO STRESS19-24. SIMILAR TO HUMANS, RODENTS SHOW SEX-SPECIFIC REDUCTIONS IN SPATIAL LEARNING AND INCREASED ANXIETY-LIKE BEHAVIORS AFTER EXPOSURE TO PRS 2, 32, 33. WE PROPOSE THAT THE PATHOLOGY OF PRS MAY INCLUDE AN EPITRANSCRIPTOMIC PROCESS KNOWN AS `RNA EDITING'35. PRELIMINARY DATA FROM OUR LABORATORY DEMONSTRATE DISRUPTIONS IN THE PATTERNS OF HIGHLY VARIABLE RNA EDITING IN GLUA SUBUNITS OF THE AMPA-TYPE GLUTAMATE RECEPTOR (AMPAR) IN THE HIPPOCAMPUS OF MICE EXPOSED TO PRS, WITH ASSOCIATED DEFICITS OF SOCIAL COGNITION. SIMILAR PATTERNS OF RNA EDITING OCCUR IN THE HIPPOCAMPUS OF PATIENTS WITH IMPAIRED COGNITION38-40. THE GOAL OF THE PROPOSED RESEARCH IS TO DETERMINE IF GLUA2 EDITING MEDIATES THE LONG-TERM IMPACT OF PRS. OUR CENTRAL HYPOTHESIS IS THAT PRS TRIGGERS REDUCED GLUA2 EDITING, LEADING TO LONG- TERM DETRIMENTAL FUNCTION OF THE HIPPOCAMPUS AND AMYGDALA. TO TEST A CAUSAL EFFECT OF GLUA2 EDITING WE HAVE DEVELOPED TWO NOVEL GLUA2 KNOCKIN MICE: GLUA-A MICE THAT MIMIC 0% IMMUTABLE RNA EDITING AND GLUA-G MICE THAT MIMIC 100% IMMUTABLE RNA EDITING. PRELIMINARY DATA SHOW THAT GLUA-G MUTANT MICE HAVE IMPROVED SPATIAL LEARNING. MALE BUT NOT FEMALE GLUA-G MICE HAVE RELATIVE RESILIENCE TO SOCIAL ISOLATION STRESS AND THERE ARE SEX DIFFERENCES IN RESILIENCE TO THE EFFECTS OF PRS. TO ELUCIDATE THE MECHANISMS THAT UNDERLIE THESE EVIDENTIAL CONNECTIONS BETWEEN SEX, RNA EDITING, STRESS, AND BEHAVIOR, WE PROPOSE THE FOLLOWING AIMS: 1: SEX DIFFERENCES IN THE MITIGATION OF STRESS-INDUCED COGNITIVE DEFICITS BY GLUA2 RNA EDITING, AND 2: SEX DIFFERENCES IN THE ENHANCEMENT OF RESILIENCE TO ADULT STRESS BY GLUA2 RNA EDITING. WE WILL EXPOSE GLUA-G, GLUA-A AND WT MICE TO PRS AND TEST FOR DIFFERENCES BETWEEN GENOTYPE, STRESS EXPOSURE AND SEX IN THE FOLLOWING MEASURES: (I) SYNAPTIC PLASTICITY AND MORPHOLOGY IN THE DG, CA1, CA2 AND CA3 REGIONS OF THE VENTRAL AND DORSAL HIPPOCAMPUS AND BASOLATERAL AMYGDALA. (II) AMPAR TRAFFICKING IN THESE REGIONS USING IMMUNOHISTOCHEMISTRY. (III) GENE EXPRESSION IN THESE REGIONS USING MMRNASEQ AND WESTERN BLOTTING. (IV) MEASUREMENT OF SEX AND STEROID HORMONES, (V) SOCIAL BEHAVIOR, AND COGNITIVE BEHAVIOR. THIS RESEARCH WILL INCREASE OUR UNDERSTANDING OF THE MOLECULAR AND CELLULAR MECHANISMS TRIGGERED BY STRESS THAT DIFFERENTIALLY DAMAGE THE GLUTAMATERGIC CIRCUITRY OF THE HIPPOCAMPUS AND AMYGDALA IN MALES AND FEMALES. WE WILL ALSO ASCERTAIN WHETHER RNA EDITING CAN MITIGATE STRESS-INDUCED DEFICITS. THIS RESEARCH HAS THE POTENTIAL TO IDENTIFY NOVEL TARGETS FOR PSYCHOTROPIC DRUG DEVELOPMENT AND IDENTIFY AN EXCITING NEW GENETIC MECHANISM FOR THE SAFE MANIPULATION OF SYNAPTIC PLASTICITY TO ENHANCE COGNITION AND STRESS RESILIENCE. | $1.3M | FY2025 | Jan 2025 – Oct 2029 |
| Department of Health and Human Services | MLL IN MAINTENANCE AND REGULATION OF HOX GENE EXPRESSION | $1.3M | FY2009 | Jan 2009 – Nov 2013 |
| Department of Health and Human Services | STRUCTURAL AND FUNCTIONAL BASIS OF MYOCARDIAL DYSREGULATION IN GENETIC CARDIOMYOPATHY - OVER THE PAST SEVERAL DECADES, AND ACCELERATING IN RECENT YEARS, THE SARCOMERE HAS BEEN APPRECIATED AS BOTH THE HOTSPOT FOR CARDIOMYOPATHY-CAUSING VARIANTS AND AS A PROMISING DRUG TARGET. THESE VARIANTS CAN ALTER THE STRUCTURE AND REGULATION OF THE SARCOMERE, LEADING TO ALTERED FUNCTION. THE FIELD HAS MADE SIGNIFICANT PROGRESS IN UNDERSTANDING THESE EFFECTS USING VARIOUS MODELS AND WHILE EACH OF THESE HAVE STRENGTHS, THEY ALL HAVE CAVEATS THAT LIMIT THEIR UTILITY IN UNDERSTANDING THE IN VIVO IMPACT OF CARDIOMYOPATHY-INDUCING VARIANTS. THE PORCINE HEART, THE MOST ACCURATE ANIMAL MODEL OF HUMAN HEARTS, HAS SIMILAR ISOFORM COMPOSITION, STRUCTURE, HEART RATE, AND RESPONSE TO PHYSIOLOGICAL STIMULI, ALLOWING STUDIES ON LIVE MUSCLE THAT ARE NOT FEASIBLE WITH BIOBANKED HUMAN SAMPLES. OUR RESEARCH TEAM IS UNIQUELY SUITED FOR THE SOPHISTICATED EXPERIMENTS NECESSARY TO PERFORM THESE STUDIES. TO INTERROGATE THE STRUCTURAL IMPACT OF THESE VARIANTS, WE WILL USE SYNCHROTRON X-RAY DIFFRACTION, THE ONLY TECHNIQUE CAPABLE OF OBTAINING MOLECULAR LEVEL SARCOMERE STRUCTURAL DATA FROM LIVE CARDIAC MUSCLE. SARCOMERE FUNCTION WILL BE ASSESSED BOTH AT ARGONNE AND AT NEARBY LOYOLA UNIVERSITY CHICAGO ON CUSTOM BIOPHYSICAL SETUPS. LASTLY, SARCOMERE STRUCTURE AND FUNCTION ARE REGULATED BY PROTEIN POST-TRANSLATIONAL MODIFICATIONS (PTMS) AND ISOFORM SWITCHING, WHICH WILL BE ASSESSED USING OUR TOP-OF-THE-LINE MASS SPECTROMETRY INSTRUMENTATION. WE WILL INVESTIGATE THE STRUCTURAL BASIS OF MYOFILAMENT FUNCTIONAL DYSREGULATION IN HEALTHY, HYPERTROPHIC (HCM: MYH7R403Q, MYBPC330X), DILATED (DCM: TTN16648X, RBM20R636S) CARDIOMYOPATHY TRANSGENIC PIGS ACROSS THE FOLLOWING THREE AIMS. THESE STUDIES WILL REVEAL THE UNDERLYING STRUCTURAL BASIS FOR CARDIOMYOPATHIES RESULTING FROM SARCOMERE PROTEIN VARIANTS, REVEALING TRANSLATIONAL MECHANISTIC UNDERSTANDING NECESSARY TO TREAT THESE DISEASES. IN AIM 1 WE WILL DETERMINE THE IMPACT OF HCM AND DCM MUTATIONS ON NORMAL SARCOMERE STRUCTURE. WE WILL COLLECT X-RAY DIFFRACTION PATTERNS AND FUNCTIONAL DATA FROM LIVE PORCINE CARDIAC MUSCLE TO INVESTIGATE THE STRUCTURAL BASIS OF PROTEIN VARIANTS LEADING TO HCM AND DCM. IN AIM 2 WE WILL DETERMINE THE IMPACT OF PHYSIOLOGICAL INOTROPIC INTERVENTIONS IN HCM AND DCM. A MAJOR PATHOLOGICAL MECHANISM OF THESE DISEASE-CAUSING VARIANTS IS THAT THEY MODIFY THE SARCOMERE’S ABILITY TO RESPOND APPROPRIATELY TO NORMAL PHYSIOLOGICAL CONDITIONS. HERE WE WILL ASSESS THE RESPONSE TO CONDITIONS WHICH TYPICALLY ELICIT AN IONOTROPIC RESPONSE. IN AIM 3 WE WILL DETERMINE HOW HCM AND DCM MUTATIONS AFFECT SARCOMERE FUNCTION REGULATION BY POST-TRANSLATIONAL MODIFICATIONS. | $1.3M | FY2024 | Jun 2024 – May 2028 |
| Department of Education | THE IGNACIO PROGRAM | $1.3M | FY2020 | Sep 2020 – Aug 2025 |
| Department of Health and Human Services | THE ROLE OF THE THROMBOSPONDINS IN INTIMAL HYPERPLASIA | $1.3M | FY2017 | Dec 2016 – Nov 2022 |
| Department of Health and Human Services | OPIOID WORKFORCE EXPANSION PROGRAM- PROFESSIONAL | $1.3M | FY2019 | Sep 2019 – Mar 2023 |
| Department of Health and Human Services | PREDICTING GENE REGULATION ACROSS POPULATIONS TO UNDERSTAND MECHANISMS UNDERLYING COMPLEX TRAITS | $1.3M | FY2017 | May 2017 – Jul 2026 |
| Department of Health and Human Services | NURSE FACULTY LOAN PROGRAM | $1.3M | FY2009 | Jul 2009 – Jun 2012 |
| Department of Education | PRACTICING DEMOCRACY IN COMMUNITIES: DEVELOPING A COMMUNITY-WIDE CIVIC LEARNING SYSTEM; PROVIDING INSTRUCTIONAL SUPPORTS TO SCHOOLS; GENERATING INNOVATIVE CIVIC LEARNING OPPORTUNITIES FOR STUDENTS. | $1.3M | FY2024 | Oct 2023 – Sep 2025 |
| Department of Health and Human Services | EMSC PARTNERSHIP GRANTS | $1.3M | FY2006 | Mar 2006 – Feb 2018 |
| Department of Health and Human Services | LEVERAGING CDC OPIOID OVERDOSE SURVEILLANCE FUNDING FROM THE ALBUQUERQUE AREA SOUTHWEST TRIBAL EPIDEMIOLOGY CENTER TO CREATE TRIBAL DATA AND CULTURALLY CENTER MEDICATIONS FOR OPIOID USE DISORDER - PROJECT SUMMARY/ABSTRACT FATAL OPIOID OVERDOSE RATES ARE HIGHER AMONG AMERICAN INDIAN/ALASKA NATIVE POPULATIONS THAN AMONG HISPANICS, AFRICAN AMERICANS, AND ASIAN AMERICANS, AND ARE JUST BELOW NON-HISPANIC WHITES. AI/AN OPIOID OVERDOSE RATES VARY SIGNIFICANTLY BY STATE AND COUNTY; HOWEVER, TRIBE-LEVEL DIFFERENCES ARE DIFFICULT TO ASCERTAIN DUE TO DECENTRALIZED DATA SYSTEMS THAT DIVIDE STATE HEALTH DATA AND INDIAN HEALTH SERVICE DATA. WHILE COUNTY-LEVEL HEALTH DATA IS OFTEN USED AS A PROXY FOR TRIBAL DATA, STATE DATA OFTEN MISCLASSIFY AN/AN PATIENTS, AND IN COUNTIES CONTAINING THE LANDS OF MULTIPLE TRIBES, COUNTY DATA MAY BLUR SIGNIFICANT INTER-TRIBAL VARIATION. IN ADDITION TO LIMITED TRIBE-SPECIFIC DATA, TREATMENT FOR OPIOID USE DISORDERS ALSO OFTEN FAILS TO ACCOUNT FOR THE DIVERSITY OF TRIBAL POPULATIONS. ON AVERAGE, PATIENTS WHO TAKE MEDICATION FOR OPIOID USE DISORDER (MOUD), AND SPECIFICALLY METHADONE OR BUPRENORPHINE, EXHIBIT IMPROVED TREATMENT RETENTION AND REDUCED RISK OF DRUG OVERDOSE COMPARED TO PATIENTS NOT TAKING MOUD. SOME RESEARCH ALSO SHOWS IMPROVED RETENTION FOR NALTREXONE, ANOTHER MOUD. BECAUSE MOUD INTERVENTIONS ARE RARELY TAILORED TO THE SPECIFIC CULTURAL CONTEXTS OF AI/AN PATIENTS, SOCIAL AND CULTURAL BARRIERS TO TREATMENT PERSIST IN AI/AN COMMUNITIES. TO ADDRESS THESE PROBLEMS, WE PROPOSE TO LEVERAGE CENTER FOR DISEASE CONTROL FUNDING AWARDED TO THE ALBUQUERQUE AREA SOUTHWEST TRIBAL EPIDEMIOLOGY CENTER (AASTEC) FOR IMPROVING DATA QUALITY IN OPIOID OVERDOSE SURVEILLANCE IN NEW MEXICO IN A TWO-PHASE RESEARCH PROJECT. THE PROJECT WILL DRAW UPON A COMMUNITY ADVISORY BOARD COMPOSED OF CLINICIANS AND INDIAN HEALTH FACILITY STAFF, AND USE A COLLABORATION OF EPIDEMIOLOGISTS FROM AASTEC AND THE NEW MEXICO DEPARTMENT OF HEALTH, AND ACADEMIC RESEARCHERS AT THE UNIVERSITY OF UTAH, UNIVERSITY OF NEW MEXICO, AND COLUMBIA UNIVERSITY. IN THE FIRST PHASE, WE WILL ENHANCE TRIBAL SPECIFICITY OF AI/AN OPIOID USE DISORDER AND OVERDOSE DATA BY LINKING AND GEOCODING NEW MEXICO VITAL STATISTICS AND SYNDROMIC SURVEILLANCE DATA. WE WILL THEN USE THESE DATA IN PREDICTIVE MODELS TO DETERMINE THE ROLE OF MODIFIABLE RISK AND PROTECTIVE FACTORS FOR SPECIFIC TRIBAL COMMUNITIES. WE WILL DISSEMINATE ANALYSIS REPORTS TO TRIBAL COMMUNITIES AND SEEK PARTNERSHIPS WITH TRIBES AND INDIAN HEALTH FACILITIES FOR THE SECOND PHASE OF OUR RESEARCH, WHICH ENTAILS A COMMUNITY-BASED PARTICIPATORY RESEARCH PROJECT THAT WILL DEVELOP AND TEST A CULTURALLY CENTERED IMPLEMENTATION PROGRAM FOR MOUD FOR USE IN AI/AN COMMUNITIES. WE WILL USE A STEPPED WEDGE RANDOMIZED DESIGN IN FOUR INDIAN HEALTH FACILITIES TO TEST INITIATION, RETENTION, RELAPSE, AND ACCEPTABILITY OF CULTURALLY CENTERED MOUD AMONG PATIENTS AND CLINIC STAFF OVER TIME. THE PROPOSED RESEARCH WILL STRENGTHEN PARTNERSHIPS BETWEEN TRIBAL COMMUNITIES, AASTEC, AND ACADEMIC RESEARCHERS, AND BETTER ALIGN OPIOID RESEARCH WITH TRIBAL VALUES AND PRIORITIES. WE ANTICIPATE OUR RESEARCH WILL NOT ONLY RESULT IN PUBLICATIONS IN ACADEMIC JOURNALS BUT WILL ALSO RESULT IN TOOLKITS FOR CREATING TRIBE-SPECIFIC DATA ESTIMATES FOR OTHER REGIONS, AND PROTOCOLS FOR CULTURALLY CENTERING MOUD FOR THE CONTEXTS OF OTHER AI/AN COMMUNITIES AND INDIAN HEALTH FACILITIES. | $1.3M | FY2022 | Apr 2022 – Nov 2027 |
| Department of Education | ACE: ACHIEVING COLLEGE EXCELLENCE 2020 | $1.3M | FY2020 | Sep 2020 – Aug 2025 |
| Department of Health and Human Services | NORMS RE-EDUCATION TO PROMOTE ENGAGEMENT IN PARENT-BASED INTERVENTIONS: A TYPE 1 IMPLEMENTATION-EFFECTIVENESS TRIAL - PROJECT SUMMARY UNDERAGE DRINKING ON COLLEGE CAMPUSES REMAINS A SERIOUS PUBLIC HEALTH ISSUE. RESEARCH SUGGESTS THAT PARENT- BASED INTERVENTIONS (PBIS) THAT TARGET PARENTS OF INCOMING STUDENTS CAN BE POWERFUL ADJUNCTS TO EXISTING STUDENT-LEVEL ALCOHOL PROGRAMS. ALTHOUGH TURISSI’S PARENT HANDBOOK IS THE ONLY PBI RECOMMENDED BY THE NIAAA TO REDUCE ALCOHOL RISK DURING THE TRANSITION INTO COLLEGE, THIS “GOLD STANDARD” PBI HAS DEMONSTRATED ONLY MODEST EFFECTS ON STUDENT DRINKING IN TRIALS AND HAS RELIED ON MONETARY INCENTIVES TO FACILITATE PARENT ENGAGEMENT, WHICH DO NOT TRANSLATE TO EFFECTIVE REAL-WORLD IMPLEMENTATION. AS SUCH, IT IS IMPERATIVE TO DEVELOP EFFECTIVE PBIS THAT CAN BE IMPLEMENTED EASILY AND WITHOUT INCENTIVES. ONE EFFECTIVE MOTIVATIONAL PBI COMPONENT IDENTIFIED BY OUR LAB IS PERSONALIZED NORMATIVE FEEDBACK (PNF) DESIGNED TO CORRECT PARENTS’ MISPERCEPTIONS ABOUT FIRST-YEAR STUDENT DRINKING, OTHER PARENTS’ APPROVAL FOR SUCH DRINKING, AND ALCOHOL COMMUNICATION. FURTHER, OUR PILOT TRIAL FOUND THAT COUPLING PARENT HANDBOOK-LIKE PSYCHOEDUCATIONAL CONTENT WITH SUCH PNF IN A SOCIAL MEDIA-INSPIRED APP (PARENTCANDOR OR PC PNF+) PREVENTED AND DECREASED RISKY DRINKING IN STUDENTS WHEN PARENTS WERE NOT INCENTIVIZED. QUALITATIVE DATA COLLECTED FROM PARENTS ALSO SUGGESTED SEVERAL WAYS TO IMPROVE PARENTS’ ENGAGEMENT WITH THE PC PNF+ APP WHICH ARE LIKELY TO TRANSLATE INTO EVEN STRONGER EFFECTS THAN OBSERVED IN THE INITIAL TRIAL. BUILDING ON THIS WORK, PHASE 1 OF THIS PROJECT SEEKS TO OPTIMIZE THE PC PNF+ APP BASED ON PILOT PARENT FEEDBACK. FURTHER, FNFORMED BY THEIR COMMENTS ABOUT TIME CONSTRAINTS, WE WILL ALSO DEVELOP A LESS TIME-INTENSIVE, EMAIL-BASED SOCIAL NORMS MARKETING CAMPAIGN (SNMC+) PBI THAT COMMUNICATES SIMILAR NORMATIVE INFORMATION AS IN THE PC PNF+ APP WITH BREIF HANDBOOK-LIKE TIPS FOR PARENTING AROUND ALCOHOL. PHASE 1 WILL ALSO INCLUDE A NATIONAL NORMS DOCUMENTATION SURVEY (N=2000) OF PARENTS OF INCOMING COLLEGE STUDENTS TO IDENTIFY INCLUSIVE AND GENERALIZABLE NORMS TO FEATURE IN PNF+ AND SNMC+ INTERVENTIONS. ADDITIONALLY, PARENT FOCUS GROUPS AND INTERVIEWS WITH UNIVERSITY STAKEHOLDERS AT TWO SITES WILL BE CONDUCTED TO IDENTIFY HOW THESE PBI APPROACHES CAN BE PACKAGED TO MAXIMIZE USEFULNESS FROM THE PERSPECTIVES OF PARENTS AND UNIVERSITIES. THEN, IN PHASE 2, A LARGE, MULTI-SITE IMPLEMENTATION-EFFECTIVENESS TRIAL WITH THREE COHORTS OF FIRST-YEAR STUDENTS (N=2400) WILL COMPARE THE FEASIBILITY AND EFFECTIVENESS OF PNF+ AND SNMC+ AGAINST THE “GOLD STANDARD” HANDBOOK AND A NO-PBI CONTROL. PARENTS WILL BE INVITED BY THEIR CHILD’S UNIVERSITY TO ONE OF THE PBIS JUST AS THEY WOULD BE IN THE REAL-WORLD. WE WILL OBJECTIVELY EXAMINE WHICH PBI IS MOST ENGAGING TO PARENTS, AS WELL AS WHICH IS MOST EFFECTIVE AT PREVENTING AND REDUCING STUDENT DRINKING AND CONSEQUENCES. IN ADDITION, PARENT ENGAGEMENT, ALCOHOL APPROVAL, AND COMMUNICATION WILL BE EXAMINED AS MEDIATORS OF PBI EFFECTS ON STUDENT-LEVEL OUTCOMES. FINALLY, THE MOST ENGAGING AND EFFECTIVE PBI WILL BE FURTHER DISCUSSED WITH UNIVERSITY STAKEHOLDERS TO IDENTIFY WAYS TO INCREASE THE LIKELIHOOD OF REAL-WORLD ADOPTION. | $1.3M | FY2024 | Sep 2024 – Aug 2029 |
| Department of Health and Human Services | NEW MECHANISMS OF CARDIAC RYANODINE RECEPTOR DYSFUNCTION DURING OXIDATIVE STRESS: THE ROLE OF INTERSUBUNIT CROSS-LINKING - PROJECT SUMMARY/ABSTRACT CALCIUM (CA) RELEASE THROUGH THE RYANODINE RECEPTOR (RYR) CA CHANNEL IS ESSENTIAL FOR REGULAR HEART CONTRACTION. DEFECTS IN RYR REGULATION CAUSE AN IMBALANCE IN INTRACELLULAR CA HOMEOSTASIS IN A VARIETY OF CARDIAC DISEASES. THE MOST COMMON CARDIAC PATHOLOGY, SUCH AS MYOCARDIAL INFARCTION, IS ASSOCIATED WITH OXIDATIVE STRESS. RYR CONTAINS A LARGE NUMBER OF CYSTEINE RESIDUES THAT LINK OXIDATIVE STRESS AND CA HOMEOSTASIS. HOWEVER, THE PATHOLOGICALLY RELEVANT CYSTEINES WITHIN RYR REMAIN LARGELY UNKNOWN. AS A RESULT, THE MECHANISMS OF RYR DYSFUNCTION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION ARE NOT FULLY UNDERSTOOD. THIS DELAYS OUR PROGRESS IN DESIGNING EFFECTIVE THERAPEUTIC INTERVENTIONS THAT CAN IMPROVE CA HOMEOSTASIS DURING ISCHEMIC HEART DISEASES. THE MAIN GOAL OF THIS PROPOSAL IS TO DEFINE THE MOLECULAR MECHANISMS OF RYR DYSFUNCTION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION. WE HAVE RECENTLY DISCOVERED THAT OXIDATIVE STRESS ACTIVATES RYR BY FORMING DISULFIDE BONDS BETWEEN TWO NEIGHBORING SUBUNITS: THE INTERSUBUNIT CROSS-LINKING. IT APPEARS THAT ONLY TWO CROSS-LINKING CYSTEINES PLAY A CRITICAL ROLE IN THE RYR RESPONSE TO OXIDATIVE STRESS. IN THIS PROPOSAL WE WILL TEST THE HYPOTHESIS: THE INTERSUBUNIT CROSS-LINKING IS THE PRINCIPAL REDOX MODIFICATION OF RYR RESPONSIBLE FOR CA DYSREGULATION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION. TO TEST THIS HYPOTHESIS, WE HAVE DEVELOPED A TRANSGENIC MOUSE MODEL WITH A UNIQUE RYR2 KNOCK-IN MUTATION THAT PROTECTS RYR FROM THE INTERSUBUNIT CROSS-LINKING. IN AIM 1, WE WILL DEFINE MOLECULAR MECHANISMS OF RYR DYSFUNCTION INDUCED BY THE INTERSUBUNIT CROSSLINKING. WE EXPECT TO SHOW THAT THE CROSS-LINKING ACTIVATES RYR2 BY PROMOTING LONGER CHANNEL OPENINGS. SUCH ALTERATION OF RYR FUNCTION INCREASES CA LEAK AND TRIGGERS PRO-ARRHYTHMOGENIC CA WAVES. WE EXPECT TO SHOW THAT RYR MUTATION THAT PROTECTS THE CHANNEL FROM THE CROSS-LINKING WILL NORMALIZE RYR ACTIVITY, REDUCE CA LEAK, AND PREVENT CA WAVES DURING OXIDATIVE STRESS. IN AIM 2, WE WILL DEFINE THE CRITICAL ROLE OF THE RYR INTERSUBUNIT CROSS-LINKING IN CA DYSREGULATION AND CONTRACTILE DYSFUNCTION DURING MYOCARDIAL INFARCTION. WE EXPECT TO SHOW THAT RYR MUTATION THAT PROTECTS THE CHANNEL FROM THE CROSSLINKING WILL NORMALIZE CARDIAC CA REGULATION AND IMPROVE MYOCARDIAL CONTRACTION IN THE INFARCTED HEART. WE WILL ALSO TEST WHETHER SELECTIVE PHARMACOLOGICAL INTERVENTIONS THAT STABILIZE RYR AT THE INTERSUBUNIT CROSS-LINKING REGION CAN REDUCE CA LEAK AND PREVENT CA WAVES DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION. | $1.3M | FY2025 | Feb 2025 – Nov 2028 |
| Department of Education | LOYOLA MARYMOUNT UNIVERSITY MCNAIR SCHOLARS PROGRAM | $1.3M | FY2018 | Oct 2017 – Sep 2022 |
| Department of Education | UPWARD BOUND | $1.2M | FY2012 | Sep 2012 – Aug 2017 |
| Department of Education | UPWARD BOUND PROGRAM | $1.2M | FY2010 | Sep 2010 – Aug 2012 |
| Department of Education | ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM | $1.2M | FY2010 | Jul 2010 – Dec 2012 |
| Department of Health and Human Services | MOLECULAR AND CELLULAR DETERMINANTS OF TRIM5ALPHA RESTRICTION OF HIV-1 | $1.2M | FY2011 | Feb 2011 – Aug 2020 |
| National Science Foundation | LOYOLA UNIVERSITY CHICAGO NOYCE SCHOLARS: TEACHING, LEARNING & LEADING WITH SCHOOLS AND COMMUNITIES -THIS PROJECT AIMS TO SERVE THE NATIONAL NEED OF RECRUITING, DEVELOPING, AND RETAINING A DIVERSE AND TALENTED GROUP OF HIGH SCHOOL SCIENCE AND MATHEMATICS TEACHERS WITH THE KNOWLEDGE, PRACTICES, AND DISPOSITIONS TO ENACT CULTURALLY RELEVANT STEM EDUCATION. THE PROJECT WILL IDENTIFY AND ATTRACT HIGH-ACHIEVING STEM MAJORS THROUGH SYSTEMATIC OUTREACH EFFORTS AND A TRY TEACHING STIPEND OPPORTUNITY. RECRUITMENT WILL TARGET A DIVERSE AND QUALIFIED POOL OF APPLICANTS THAT INCLUDES PEOPLE OF COLOR, FIRST GENERATION COLLEGE STUDENTS, VETERANS, AND MULTILINGUAL SPEAKERS. SCHOLARS WILL COMPLETE LOYOLA UNIVERSITY CHICAGO?S INITIAL TEACHER EDUCATION PROGRAM, ALIGNED WITH ILLINOIS? CULTURALLY RESPONSIVE TEACHING AND LEADING STANDARDS, AND DESIGNED TO SUPPORT DEVELOPMENT OF TEACHERS? DEEP UNDERSTANDING OF SUBJECT MATTER AND HOW IT CAN BE TRANSFORMATIVE TO STUDENTS? LIVES. COURSEWORK ALSO EMBEDS PREPARATION FOR EDUCATING MULTILINGUAL LEARNERS AND ENSURES ELIGIBILITY FOR THE STATE'S ENGLISH AS A SECOND LANGUAGE (ESL) ENDORSEMENT. INDUCTION SUPPORT WILL INCLUDE PARTICIPATION IN FIELD EXPERIENCES AND COACHING SHADOW DAYS IN PARTNER SCHOOLS, AS WELL AS ONGOING MENTORING AND COLLABORATIVE PROFESSIONAL LEARNING, ALL DESIGNED TO SUPPORT INSTRUCTIONAL EFFECTIVENESS AND RETENTION. IN THIS PROJECT, LOYOLA?S SCHOOL OF EDUCATION, COLLEGE OF ARTS AND SCIENCES, SCHOOL OF SUSTAINABILITY, AND CENTER FOR SCIENCE AND MATH EDUCATION WILL PARTNER WITH ILLINOIS DISTRICT 219 AND CHICAGO PUBLIC SCHOOLS. FIVE PROJECT GOALS GUIDE THE EXECUTION OF THE PROJECT. FIRST IS TO PROVIDE FINANCIAL AND OTHER SUPPORTS TO AT LEAST 19 HIGH-ACHIEVING PROSPECTIVE BIOLOGY, CHEMISTRY, PHYSICS, AND MATHEMATICS TEACHERS WHO COMMIT TO TEACHING IN HIGH-NEED SCHOOLS. SECOND IS TO INCREASE THE NUMBER AND DIVERSITY OF STEM MAJORS AND PROFESSIONALS ENTERING TEACHING. THE THIRD GOAL IS TO PREPARE CANDIDATES TO WORK WITH CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS, ENSURING THAT 100% OF SCHOLARS FULFILL REQUIREMENTS FOR THE STATE ENGLISH AS A SECOND LANGUAGE (ESL) ENDORSEMENT. FOURTH IS TO RETAIN TEACHERS IN CHICAGO HIGH-NEED SCHOOLS THROUGH RIGOROUS PREPARATION COMBINED WITH HIGH-QUALITY, MULTI-DIMENSIONAL INDUCTION SUPPORT. FINALLY, THE FIFTH GOAL IS TO STUDY PROGRAM DATA TO INFORM UNDERSTANDING OF URBAN STEM TEACHER PREPARATION, MENTORING, AND INDUCTION SUPPORT. SPECIFICALLY, PROGRAM RESEARCH WILL STUDY POTENTIAL CONNECTIONS AMONG CULTURALLY SUSTAINING INSTRUCTIONAL PRACTICES, INDUCTION SUPPORTS, AND TEACHER RETENTION. THIS TRACK 1: SCHOLARSHIPS AND STIPENDS PROJECT IS SUPPORTED THROUGH THE ROBERT NOYCE TEACHER SCHOLARSHIP PROGRAM (NOYCE). THE NOYCE PROGRAM SUPPORTS TALENTED STEM UNDERGRADUATE MAJORS AND PROFESSIONALS TO BECOME EFFECTIVE K-12 STEM TEACHERS AND EXPERIENCED, EXEMPLARY K-12 TEACHERS TO BECOME STEM MASTER TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. IT ALSO SUPPORTS RESEARCH ON THE EFFECTIVENESS AND RETENTION OF K-12 STEM TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA. | $1.2M | FY2023 | May 2023 – Apr 2028 |
| National Science Foundation | REDEFINING STEM TEACHER PREPARATION BY TEACHING, LEARNING ,AND LEADING WITH SCHOOLS AND COMMUNITIES | $1.2M | FY2017 | May 2017 – Apr 2022 |
| National Science Foundation | RECRUITING, PREPARING, AND RETAINING CULTURALLY RESPONSIVE AND EQUITY-MINDED STEM TEACHERS FOR HIGH-NEED SCHOOLS -THIS PROJECT WILL ADDRESS A CRITICAL TEACHER SHORTAGE IN MARYLAND?S URBAN, LOW-INCOME, AND RURAL SCHOOLS. TOWARDS THIS END THE PROJECT WILL RECRUIT AND PREPARE 28 SECONDARY STEM TEACHERS FOR TEACHER CERTIFICATION, LEADING TO CAREERS IN HIGH-NEED SCHOOLS. TO HELP DIVERSIFY THE TEACHER POOL, THE PROJECT LEADERS WILL PLACE PARTICULAR ATTENTION ON RECRUITING AND RETAINING TEACHERS OF COLOR AND THOSE FROM OTHER GROUPS WHO ARE SIMILARLY UNDERREPRESENTED IN THEIR PARTICIPATION IN THE STEM TEACHER PROFESSION. MAJOR PROJECT FEATURES INCLUDE: (1) INTEGRATION OF CULTURALLY RESPONSIVE TEACHING AND AMBITIOUS MATH AND SCIENCE TEACHING INTO A MASTER OF ARTS IN TEACHING (MAT) CURRICULUM; (2) OFFERING A CULTURALLY RESPONSIVE EQUITABLE STEM TEACHING (CREST) SEMINAR; AND (3) IMPLEMENTATION OF A CREST INDUCTION SERIES. BY SUPPORTING IMPROVEMENTS TO THE MAT PROGRAM, OFFERING SCHOLARSHIPS AND STIPENDS, AND IMPLEMENTING ROBUST INDUCTION SUPPORT, THIS PROJECT WILL ENHANCE STEM TEACHER PREPARATION AT LOYOLA AND INCREASE THE NUMBER OF QUALIFIED STEM TEACHERS IN MARYLAND. THE CULTURALLY RESPONSIVE EQUITABLE STEM TEACHING (CREST) PROJECT AT LOYOLA UNIVERSITY MARYLAND INCLUDES PARTNERSHIPS WITH THE LOCAL EDUCATION AGENCY (LEA), BALTIMORE COUNTY PUBLIC SCHOOLS. THREE KEY PROJECT GOALS INFORM THE EXECUTION OF THE PROJECT. FIRST IS TO RECRUIT, RETAIN, AND GRADUATE 28 HIGHLY QUALIFIED AND DIVERSE SECONDARY STEM TEACHING CANDIDATES OVER FIVE YEARS. SECOND IS TO PLACE 100% OF GRADUATES IN HIGH-NEED SCHOOLS THROUGH PARTNERSHIPS WITH LEAS, AND EMPLOYMENT AND INDUCTION SUPPORT; AND RETAIN 85% OF CREST GRADUATES IN HIGH-NEED SCHOOLS FOR THREE YEARS BY PROVIDING NEW TEACHER SUPPORT THROUGH A CREST INDUCTION SERIES. THIRD, AND FINALLY, IS TO IMPROVE THE QUALITY OF CULTURALLY RESPONSIVE STEM TEACHING PRACTICES OF PROSPECTIVE AND EARLY CAREER TEACHERS IN HIGH-NEED SCHOOLS WITH AN ENHANCED MASTER OF ART IN TEACHING CURRICULA AND AN INDUCTION SERIES. STUDENTS PARTICIPATING IN THIS PROJECT INCLUDE LOYOLA STEM BACHELOR?S DEGREE GRADUATES AND STEM PROFESSIONALS SEEKING A CAREER CHANGE. USING A COMBINATION OF CURRICULAR ACTIVITIES GROUNDED IN CULTURALLY RESPONSIVE TEACHING FOR PROSPECTIVE TEACHERS AND INDUCTION SUPPORT AS THEY ENTER THE PROFESSION, THIS PROJECT WILL IMPROVE THE QUALITY OF CULTURALLY RESPONSIVE STEM EDUCATION FOR STUDENTS IN HIGH-NEED CLASSROOMS. THE EFFECTIVENESS OF THE PROJECT ELEMENTS WILL BE ASSESSED THROUGH BOTH FORMATIVE AND SUMMATIVE DATA. THIS PROJECT WILL POTENTIALLY GENERATE NEW EVIDENCE ILLUMINATING EFFECTIVE STRATEGIES AND PRACTICES FOR RECRUITING, RETAINING, AND GRADUATING UNDERREPRESENTED POPULATIONS ENTERING STEM TEACHING CAREERS IN HIGH-NEED SCHOOLS, AND SERVE AS AN EXAMPLE FOR OTHER LIBERAL ARTS PRIVATE COLLEGES SEEKING TO DEVELOP AND EXPAND STEM TEACHER PREPARATION PROGRAMS. THIS TRACK 1: SCHOLARSHIPS AND STIPENDS PROJECT IS SUPPORTED THROUGH THE ROBERT NOYCE TEACHER SCHOLARSHIP PROGRAM (NOYCE). THE NOYCE PROGRAM SUPPORTS TALENTED STEM UNDERGRADUATE MAJORS AND PROFESSIONALS TO BECOME EFFECTIVE K-12 STEM TEACHERS AND EXPERIENCED, EXEMPLARY K-12 TEACHERS TO BECOME STEM MASTER TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. IT ALSO SUPPORTS RESEARCH ON THE PERSISTENCE, RETENTION, AND EFFECTIVENESS OF K-12 STEM TEACHERS IN HIGH-NEED SCHOOLS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA. | $1.2M | FY2023 | Jun 2023 – May 2028 |
| Department of Health and Human Services | ADVANCED NURSING EDUCATION GRANTS | $1.2M | FY2010 | Jul 2010 – Jun 2014 |
| Department of Health and Human Services | NURSE FACULTY LOAN PROGRAM | $1.2M | FY2012 | Jul 2012 – Jun 2013 |
| National Science Foundation | LIONS ROAR: LMU NOYCE SCHOLARSHIP PROGRAM | $1.2M | FY2012 | Sep 2012 – Aug 2025 |
| Department of Health and Human Services | OSTEOPONTIN REGULATES UBIQUITIN-PROTEASOME DEGRADATION OF STAT1 | $1.2M | FY2002 | Jul 2002 – Jul 2013 |
| Department of the Interior | THE U.S. FISH AND WILDLIFE SERVICE (USFWS) SHIAWASSEE NATIONAL WILDLIFE REFUGE (SNWR) PROPOSES TO CONTROL 200 ACRES OF INVASIVE PLANTS, INCREASE WATERBIRD UTILIZATION, AND REDUCE NUTRIENT RUN-OFF TO THE SAGINAW BAY AREA OF CONCERN THROUGH AN INNOVATIVE MULTI-YEAR RESTORATION AND RESEARCH PROJECT. THIS PROJECT ADDRESSES GLRI ACTION PLAN III PRIORITIES (FOCUS AREA 2) WHICH CALLS TO DEVELOP INVASIVE SPECIES CONTROL TECHNOLOGIES AND REFINE MANAGEMENT TECHNIQUES WITH INNOVATIVE EMERGING TECHNOLOGY, IMPLEMENTED AT A LARGE SCALE.WE PROPOSE TO HARVEST INVASIVE HYBRID CATTAIL (TYPHA X GLAUCA) BIOMASS FROM THE 288-ACRE MAANKIKI SOUTH UNIT WITHIN THE SNWR, CONVERT IT TO BIOCHAR ON-SITE, AND RE-APPLY THE BIOCHAR TO A PORTION OF THE UNIT. THE MAANKIKI SOUTH UNIT WAS RESTORED TO WETLAND FROM AGRICULTURAL FIELDS THROUGH A GLRI-FUNDED RESTORATION PROJECT. HOWEVER, DUE TO ITS LEGACY OF AGRICULTURE AND WATERSHED NUTRIENT ENRICHMENT, THE UNIT QUICKLY BECAME DOMINATED BY HYBRID CATTAIL, ALTERING THE WETLAND S ECOLOGICAL FUNCTIONS AND REDUCING HABITAT QUALITY FOR WATERBIRDS. MANAGING THE CATTAIL WITHIN THE UNIT IS THEREFORE A HIGH PRIORITY FOR SNWR.IN THIS PROJECT, WE WILL MANAGE INVASIVE CATTAILS TO THE BENEFIT OF WATERBIRDS ACROSS 200 ACRES OF MAANKIKI SOUTH UNIT, WHILE SIMULTANEOUSLY CONDUCTING A LARGE-SCALE EXPERIMENT TO TEST THE COMBINED EFFICACY OF INVASIVE SPECIES BIOMASS-HARVEST AND BIOCHAR RE-APPLICATION TO ACHIEVE MULTIPLE BENEFITS. WE WILL ESTABLISH A MULTI-YEAR, HIGHLY REPLICATED EXPERIMENT WITH LARGE 2.5-ACRE PLOTS, TWO LEVEL OF BIOCHAR APPLICATION, TWO-LEVELS OF REPEATED HARVEST, AND CONTROLS. WE WILL HARVEST BIOMASS ANNUALLY WITH ALLOW-GROUND-PRESSURE PLANT HARVESTER AND PROCESS IT ON-SITE WITH A MOBILE BIOCHAR PRODUCTION UNIT. THROUGHOUT THE 4-YEAR STUDY, WE WILL MONITOR PLANT RESPONSE, BIRD UTILIZATION, SOIL NUTRIENT LEVELS, PLANT AVAILABLE NUTRIENTS, SOIL CARBON CONTENT, AND NUTRIENT EXPORT FROM THE UNIT.THIS PROJECT BUILDS DIRECTLY ON GLRI SUPPORTED PROJECTS TO RESTORE MAANKIKI SOUTH UNIT AND TO DEVELOP INNOVATIVE INVASIVE PLANT MANAGEMENT TECHNIQUES. WE ANTICIPATE BROAD ECOLOGICAL BENEFITS INCLUDING THE LONG-TERM REDUCTION OF INVASIVE PLANT DOMINANCE, INCREASED WATERBIRD HABITAT, REDUCED DOWNSTREAM NUTRIENT RUNOFF, AND INCREASED CARBON STORAGE. KNOWLEDGE GAINED WILL BE USED TO DEVELOP MANAGEMENT PROTOCOLS FOR INVASIVE PLANT HARVEST, CONVERSION TO BIOCHAR AND WETLAND RE-APPLICATION. | $1.2M | FY2023 | Mar 2023 – Sep 2026 |
| Department of Health and Human Services | DYNAMICS AND CONTROL OVER HOST-ASSOCIATED BIOFILM FORMATION AND DISPERSAL | $1.2M | FY2015 | Sep 2015 – Apr 2020 |
| VA/DoDDepartment of Defense | PRESERVATION OF SKELETAL MUSCLE FOLLOWING FROSTBITE INJURY | $1.1M | FY2011 | Oct 2010 – Sep 2014 |
| Department of Health and Human Services | SPANISH-SPEAKING LATINOS' EARLY LANGUAGE ENVIRONMENTS AND DUAL LANGUAGE DEVELOPMENT | $1.1M | FY2019 | Jan 2019 – Jul 2025 |
| Department of Education | STUDENT SUPPORT SERVICES PROGRAM | $1.1M | FY2015 | Sep 2015 – Aug 2020 |
| Department of Health and Human Services | MOTS: MODELING OBESITY THROUGH SIMULATION | $1.1M | FY2009 | Aug 2009 – May 2014 |
| Agency for International Development | LOYOLA UNIVERSITY OF CHICAGO WILL INCREASE DEVELOPMENT IN CUBA THROUGH A COMPREHENSIVE PROGRAM TO RAISE THE PERFORMANCE OF CIVIL SOCIETY S BUILDING B | $1.1M | FY2008 | Mar 2008 – Mar 2010 |
| Department of Health and Human Services | INFLAMMATORY RESPONSE AFTER COMBINED INSULT OF RADIATION AND BURN INJURY | $1.1M | FY2008 | Jul 2008 – Jul 2013 |
| Department of Education | STUDENT SUCCESS SUPPORT SERVICES AT LOYOLA UNIVERSITY NEW ORLEANS | $1.1M | FY2020 | Sep 2020 – Aug 2025 |
| Department of Education | LOYOLA MARYMOUNT UNIVERSITY MCNAIR SCHOLARS PROGRAM | $1.1M | FY2023 | Oct 2022 – Sep 2026 |
| Department of Health and Human Services | ROLE OF SEROTONIN IN SMYPATHETIC FUNCTION | $1.1M | FY2002 | Sep 2002 – Nov 2013 |
| Department of Health and Human Services | INTERACTIONS BETWEEN P90 RIBOSOMAL S6 KINASE AND PROTEIN KINASE A | $1.1M | FY2007 | Aug 2007 – Jul 2011 |
| Department of Health and Human Services | MECHANISMS OF IMPAIRED ERYTHROPOIESIS IN POST BURN ANEMIA OF CRITICAL ILLNESS | $1.1M | FY2013 | Jun 2013 – Apr 2018 |
| Department of Health and Human Services | REGULATION OF THE CHEMOKINE RECEPTOR CXCR4 BY UBIQUITIN | $1.1M | FY2007 | Feb 2007 – Jan 2014 |
| Department of Health and Human Services | BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING PROGRAM | $1.1M | FY2023 | Sep 2023 – Sep 2026 |
| Department of Health and Human Services | ADVANCED NURSING EDUCATION GRANTS | $1.1M | FY2013 | Jul 2013 – Jun 2017 |
| Department of Education | STUDENT SUPPORT SERVICES PROGRAM | $1.1M | FY2010 | Sep 2010 – Aug 2015 |
| VA/DoDDepartment of Defense | NOVEL APPROACHES TO DESTROYING BIOTHREAT AGENTS | $1.1M | FY2011 | Sep 2011 – Sep 2015 |
| Department of Education | DEVELOPING FUTURE GLOBAL BUSINESS LEADERS TO INCREASE GLOBAL COMPETITIVENESS OF U.S. COMPANIES | $1M | FY2019 | Oct 2018 – Sep 2023 |
| Department of Health and Human Services | URINARY KNOWLEDGE STUDY (U-KNOW) | $1M | FY2016 | Aug 2016 – Feb 2021 |
Department of Education
$29.3M
LOYOLA_CARES_INSTITUTIONAL
Department of Education
$23.9M
LOYOLA CARES
Department of Health and Human Services
$14.8M
TCR GENE MODIFIED T CELLS FOR ADOPTIVE IMMUNOTHERAPY
Department of Education
$13.7M
LOYOLA MARYMOUNT UNIVERSITY CARES INSTITUTIONAL FUND
Department of Education
$11.2M
LMU STUDENT EMERGENCY RELIEF
Department of Education
$8.5M
INSTITUTIONAL PORTION OF HIGHER EDUCATION EMERGENCY RELIEF FUND FORMULA GRANTS
Department of Health and Human Services
$8.1M
STRUCTURAL DETERMINANTS OF CALCIUM PUMP REGULATION
Department of Health and Human Services
$7.5M
COLLABORATIVE INTEGRATION OF HCV MOLECULAR VIROLOGY AND MATHEMATICAL MODELING
Department of Education
$7.2M
LOYOLA UNIVERSITY MARYLAND CARES CERTIFICATION AGREEMENT 2
Department of Education
$6.9M
EMERGENCY FINANCIAL AID GRANTS TO STUDENTS UNDER THE CORONAVIRUS AID, RELIEF, AND ECONOMIC SECURITY (CARES) ACT
Department of Health and Human Services
$6.8M
MECHANISMS OF VIRAL PROTEASES IN CORONAVIRUS REPLICATION AND PATHOGENESIS
Department of Education
$6M
LOYOLA UNIVERSITY MARYLAND CARES CERTIFICATION AGREEMENT
Department of Health and Human Services
$5.7M
PARADOXICAL EFFECTS OF NF-KB IN ISCHEMIA; NOVEL POLYMERIC GENE SILENCING IN VIVO
Department of Health and Human Services
$4.6M
IDO1 AND IMMUNOTOLERANCE IN GLIOBLASTOMA
Department of Health and Human Services
$4.5M
GSK-3? LOCALIZES TO THE MYOFILAMENT AND MODIFIES ITS FUNCTION IN ISCHEMIC CARDIOMYOPATHY
Department of Health and Human Services
$4.4M
PLUS LOYOLA CLINICAL CENTER
Department of Health and Human Services
$3.8M
INVESTIGATING INTERFERON ANTAGONISTS IN DELAYING INNATE IMMUNE RESPONSES TO SARS-COV-2 - TITLE: INVESTIGATING INTERFERON ANTAGONISTS IN DELAYING INNATE IMMUNE RESPONSES TO SARS-COV-2 PI: SUSAN C. BAKER, PHD, LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE THE GOAL OF THIS PROPOSAL IS TO DETERMINE HOW VIRAL INTERFERON ANTAGONISTS FUNCTION IN THE REPLICATION AND PATHOGENESIS OF CORONAVIRUSES, PARTICULARLY DURING REPLICATION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2). CORONAVIRUSES (COVS) ARE A DIVERSE FAMILY OF POSITIVE-SENSE RNA VIRUSES THAT INCLUDE PATHOGENIC STRAINS INFECTING HUMAN AND ANIMAL HOSTS. COVS HAVE REPEATEDLY JUMPED FROM ANIMAL RESERVOIRS INTO HUMAN CIRCULATION, CAUSING SEVERE DISEASE AND PANDEMICS, AS WE ARE CURRENTLY EXPERIENCING WITH SARS-COV-2. DEVELOPING APPROPRIATE PROTECTIVE MEASURES AGAINST EMERGING COVS, INCLUDING SARS-COV- 2, WILL DEPEND UPON GAINING AN UNDERSTANDING OF CORONAVIRUS-HOST INTERACTIONS. WE DISCOVERED THAT THE ENDORIBONUCLEASE (ENDOU), A HIGHLY CONSERVED COMPONENT OF THE COV REPLICASE COMPLEX, REDUCES DSRNA SPECIES RECOGNIZED BY HOST PATTERN RECOGNITION RECEPTOR MDA5, DELAYING THE INDUCTION OF INTERFERON. WE REPORTED THAT VIRUSES EXPRESSING AN INACTIVE FORM OF ENDOU REPLICATE AS EFFICIENTLY AS WILD TYPE VIRUS IN IFN NON- RESPONSIVE CELLS. IMPORTANTLY, REPLICATION OF ENDOU MUTANT COVS IN INTERFERON-RESPONSIVE CELLS ACTIVATE ROBUST IMMUNE RESPONSES, WHICH EXTINGUISHES VIRUS REPLICATION AND REDUCES PATHOGENESIS IN ANIMALS. RECENTLY, WE IDENTIFIED THE TARGET OF ENDOU ACTIVITY TO BE POLY-URIDINE CONTAINING NEGATIVE SENSE RNA, WHICH WE TERM PUN RNA. THIS REMOVAL OF THE PUN RNA DELAYS THE GENERATION OF DSRNA SPECIES THAT ARE RECOGNIZED BY HOST PATTERN RECOGNITION RECEPTOR MDA5. WE HYPOTHESIZE THAT ENDOU ACTIVITY CONTRIBUTES TO THE DELAY IN THE INNATE IMMUNE RESPONSE TO SARS-COV-2 REPLICATION. HERE, WE PROPOSE TO INVESTIGATE THE MECHANISM OF HOW ENDOU ACTS IN SARS-COV-2, HOW ENDOU ASSOCIATES WITH THE REPLICASE COMPLEX, AND HOW PUN RNA CONTRIBUTES TO ACTIVATING MDA5. IN AIM 1, WE WILL EVALUATE ENDOU AND OTHER IFN ANTAGONISTS FOR THEIR ROLE AS MODULATORS OF TYPE I AND TYPE III IFN RESPONSES TO SARS-COV-2 INFECTION IN PRIMARY HUMAN AIRWAY CELLS AND IN ENTEROCYTES. WE WILL USE REVERSE GENETICS TO GENERATE VIRUSES WITH INACTIVE IFN ANTAGONISTS AND EVALUATE THE EFFECTS OF COMBINING INACTIVATION OF ENDOU WITH INACTIVATING MUTATIONS OF OTHER VIRAL PROTEIN IFN ANTAGONISTS. IN AIM 2 WE WILL DELINEATE AND DISRUPT ENDOU INTERACTIONS WITHIN THE CORONAVIRUS REPLICASE COMPLEX. THE RESULTS OF THESE STUDIES WILL GUIDE STRATEGIES FOR DISRUPTION OF ENDOU FROM THE COV REPLICASE COMPLEX, WHICH WOULD ACTIVATE PROTECTIVE IMMUNE RESPONSES TO COV INFECTIONS. IN AIM 3, WE WILL IDENTIFY REGIONS OF POLY-URIDINE NEGATIVE-SENSE RNA, TERMED PUN RNA, REQUIRED FOR RECOGNITION BY ENDOU AND MDA5. THESE STUDIES WILL PROVIDE NEW INFORMATION ON HOW PUN RNAS ARE RECOGNIZED BY ENDOU AND MDA5. OVERALL, THESE STUDIES WILL DEFINE A NEW MECHANISM FOR HOW AN ENDORIBONUCLEASE ACTS AS A VIRULENCE FACTOR. THIS NEW INFORMATION CAN BE USED TO DEVELOP ANTIVIRAL THERAPIES AND VACCINES AGAINST EXISTING AND EMERGING CORONAVIRUSES.
Department of Health and Human Services
$3.7M
GENETICS OF HYPERTENSION IN BLACKS
Department of Health and Human Services
$3.7M
LIGAND-INDEPENDENT SIGNALING OF ESTROGEN RECEPTOR BETA AND THE AGING BRAIN
Department of Health and Human Services
$3.6M
MOLECULAR MECHANISMS OF FOCAL ADHESION KINASE IN PROMOTING HEPATOCARCINOGENESIS
Department of Health and Human Services
$3.5M
METS-SLEEP: SLEEP TIMING, GUT MICROBIOTA AND CARDIOMETABOLIC RISK ACROSS THE EPIDEMIOLOGIC TRANSITION
Department of Health and Human Services
$3.5M
DATA-DRIVEN MATHEMATICAL AND COMPUTATIONAL MODELING OF HEPATITIS D INFECTION AND TREATMENT RESPONSE
Department of Health and Human Services
$3.5M
COMPUTATIONAL MODELING FOR HCV VACCINE TRIAL DESIGN AND OPTIMAL VACCINE-BASED COMBINATION INTERVENTIONS - PROJECT SUMMARY/ABSTRACT DESPITE REMARKABLE PROGRESS WITH DIRECT-ACTING ANTIVIRALS (DAAS), HEPATITIS C VIRUS (HCV) INFECTION REMAINS A SERIOUS GLOBAL PUBLIC HEALTH PROBLEM WITH OVER 1% OF THE WORLD’S POPULATION AND ABOUT 3 MILLION IN THE UNITED STATES (U.S.) INFECTED. THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES RECENTLY RENEWED THE ACTION PLAN TO PREVENT, CARE AND TREAT VIRAL HEPATITIS TO ELIMINATE VIRAL HEPATITIS INFECTION AS A PUBLIC HEALTH THREAT AND THE WHO INTRODUCED GLOBAL TARGETS FOR THE CARE AND MANAGEMENT OF HCV. WHILE THE HIGHEST UPTAKE OF HCV TREATMENT OCCURRED IN 2017 AND 1.5 MILLION PEOPLE WERE CURED, 1.6 MILLION NEW INFECTIONS OCCURRED. DUE TO MANY TREATMENT BARRIERS, ONLY AN ESTIMATED 21% OF INFECTED PATIENTS ARE DIAGNOSED AND ONLY 2% OF TOTAL INFECTED PATIENTS ARE BEING TREATED FOR THE DISEASE ANNUALLY. DAAS ALONE ARE UNLIKELY TO ACHIEVE HCV ELIMINATION; AS SUCH, THE DEVELOPMENT OF A VACCINE TO PREVENT HCV INFECTION IS AN IMPORTANT FOCUS OF ONGOING RESEARCH. VACCINE CLINICAL TRIALS FOR HCV INFECTION WILL NEED TO RECRUIT FROM HIGH-RISK POPULATIONS, SUCH AS PERSONS WHO INJECT DRUGS (PWID), WHO CONTRIBUTE AN ESTIMATED 60% OF ALL NEW HCV INFECTIONS IN THE U.S. AND HAVE AN INCREASING INCIDENCE OF HCV, ESPECIALLY AMONG YOUNG PWID. ADDITIONALLY, LIMITED ACCESS TO DAA TREATMENT, SYRINGE SERVICE PROGRAMS (SSP), AND CONTINUED INJECTION DRUG USE POSES CHALLENGES AMONG PWID EVEN AS TREATMENT WITH MEDICATION FOR OPIOID USE DISORDER (MOUD) IS EXPANDING. FACTORS CONTRIBUTING TO TRANSMISSION AND SUCCESSFUL INTERVENTION (DAAS, MOUD, SSP) AMONG PWID ARE DYNAMIC AND COMPLEX AND OCCUR AT THE INDIVIDUAL (E.G., PATHOGEN-HOST INTERPLAY, RISK BEHAVIORS), SOCIAL (E.G., INJECTION NETWORK, SOCIAL NORMS), STRUCTURAL (E.G., ACCESS TO SSP AND MOUD), AND GEOGRAPHIC (E.G., INTERACTION LOCATIONS) LEVELS. AS SUCH, PERFORMING HCV VACCINE RANDOMIZED CLINICAL TRIALS (RCT) IN THE PWID POPULATION PRESENTS MAJOR CHALLENGES. WE PROPOSE TO DEVELOP AN INTEGRATED COMPREHENSIVE COMPUTATIONAL MODELING APPROACH TO EXAMINE THESE CHALLENGES SYSTEMATICALLY AND ASSESS THE IMPACT OF SPECIFIC RCT MODIFICATIONS ON CLINICAL TRIAL SUCCESS. TO EXPLORE VACCINE TRIAL DESIGN AND OUTCOMES, OUR INTERDISCIPLINARY TEAM WILL: (1) DESIGN AND EVALUATE CLINICAL TRIALS IN LOW INCIDENCE PWID SITES, USING METROPOLITAN CHICAGO AS THE MODEL, WHICH REDUCES THE CHANCE OF SOMEONE BECOMING EXPOSED BEFORE BEING FULLY PROTECTED; (2) DESIGN AND EVALUATE CLINICAL TRIALS IN HIGH INCIDENCE PWID SITES, USING SAN FRANCISCO AS THE MODEL, WHICH INCREASES THE CHANCE OF SOMEONE BECOMING EXPOSED BEFORE BEING FULLY PROTECTED; AND (3) DISCOVER EFFECTIVE HCV VACCINE-BASED INTERVENTION STRATEGIES TO ACHIEVE WHO ELIMINATION GOALS IN THE CONTEXT OF A LICENSED VACCINE. THE LITERATURE SUPPORTS THAT NON-STERILIZING VACCINES ARE EXPECTED TO BE THE FOCUS OF FUTURE TRIALS, REMINISCENT OF RECENT COVID-19 VACCINES, THEREFORE WE WILL SIMULATE THEIR EFFECT ON TRANSMISSION TO REACH ELIMINATION. WE WILL ACCOUNT FOR SSP AND MOUD AND THEIR EFFECT ON OUTCOMES IN TWO CITIES WITH DISPARATE HCV EPIDEMIC PROFILE AMONG PWID—CHICAGO AND SAN FRANCISCO.
Department of Health and Human Services
$3.5M
ALCOHOL INTOXICATION AND POSTBURN INTESTINAL IMMUNITY
Department of Health and Human Services
$3.5M
HOST-ASSOCIATED BIOFILM FORMATION AND DISPERSAL MECHANISMS
Department of Health and Human Services
$3.4M
NOVEL PARACRINE MECHANISMS FOR CELL-BASED THERAPY OF INJURED LUNGS
Department of Health and Human Services
$3.3M
A NOVEL ANTI-SPORE NASAL VACCINE FOR PROTECTION FROM ANTHRAX
Department of Health and Human Services
$3.3M
TRAINING IN NEUROIMMUNOENDOCRINE EFFECTS OF ALCOHOL
Department of Health and Human Services
$3.3M
NEUROMOLECULAR CONSEQUENCES OF ADOLESCENT BINGE DRINKING
Department of Health and Human Services
$3.1M
THE FEMALE URINARY MICROBIOME AND URINARY INCONTINENCE
Department of Health and Human Services
$3M
MAINTAINING B CELL IMMUNITY WITH AGED B LYMPHOCYTES
Department of Health and Human Services
$3M
DETERMINANTS AND CONSEQUENCES OF LOW VITAMIN D IN POPULATIONS OF AFRICAN DESCENT
Department of Health and Human Services
$3M
GUT MICROBIOTA, SHORT CHAIN FATTY ACIDS, AND ADIPOSITY ACROSS THE EPIDEMIOLOGIC TRANSITION
Department of Health and Human Services
$3M
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULIN GENES IN GALT
Department of Education
$3M
PURPOSEFUL ENGAGEMENT IN ACADEMIC RIGOR AND LANGUAGE LEARNING (PEARLL): EFFECTS OF THE SOBRATO EARLY ACADEMY LANGUAGE (SEAL) MODEL TO PREVENT LONG TERM ENGLISH LEARNER STATUS
Department of Health and Human Services
$3M
NEW MECHANISMS OF SERCA REGULATION: DIMERIZATION AND MICROPEPTIDES
Department of Health and Human Services
$2.9M
DEFINING THE NUCLEAR IMPORT PATHWAYS OF HIV-1 - ABSTRACT HUMAN IMMUNODEFICIENCY VIRUS (HIV-1), LIKE ALL PRIMATE LENTIVIRUSES POSSESSES THE ABILITY TO INFECT NON-DIVIDING CELLS BY ENGAGING WITH COMPONENTS OF THE NUCLEAR PORE COMPLEX AND MEDIATING THE NUCLEAR TRANSLOCATION OF THE VIRAL RIBONUCLEOPROTEIN COMPLEX (RNP) FOR SUBSEQUENTLY INTEGRATION INTO THE HOST CELL GENOME. THE VIRAL CAPSID PROTEIN (CA) INTERACTS WITH NUMEROUS HOST FACTORS INVOLVING CONSTITUENTS OF THE NUCLEAR PORE COMPLEX (NPC) TO ACCOMPLISH THE PROCESS OF NUCLEAR IMPORT. UNFORTUNATELY, THE EXACT MECHANISM BY WHICH HIV-1 TRANSLOCATES THROUGH THE NUCLEAR PORE COMPLEX REMAINS ONE OF THE LEAST UNDERSTOOD STEPS OF THE VIRAL LIFE CYCLE. IN ADDITION, RECENT EVIDENCES SUPPORTING THE NOTION OF NPCS BEING MORE HETEROGENEOUS THAN PREVIOUSLY THOUGHT FURTHER CONFOUNDS THIS SITUATION. WE HAVE DEVELOPED AN INDUCIBLE NUCLEAR PORE BLOCKADE THAT ALLOWS THE RATE OF NUCLEAR IMPORT OF FUNCTIONAL, INFECTIOUS VIRAL GENOMES TO BE MONITORED IN ANY RELEVANT CELLS TYPES. USING THIS TECHNIQUE, WE OBSERVE THAT CERTAIN CA MUTANTS ARE INSENSITIVE TO A NUP62 MEDIATED NUCLEAR PORE BLOCKADE IN CELLS WHICH POTENTLY BLOCK INFECTION BY WILD TYPE CA, DEMONSTRATING THAT HIV-1 CAN UTILIZE DISTINCT NUCLEAR IMPORT PATHWAYS DURING INFECTION. IN THIS APPLICATION, WE WILL DETERMINE THE DEGREE TO WHICH NPC ARE HETEROGENEOUS AND MAP THE SPECIFIC NUCLEAR PORE CONSTITUENTS THAT MAKEUP THE NPCS UTILIZED BY HIV-1 DURING NUCLEAR ENTRY. WITH OUR NUCLEAR PORE BLOCKADE, WE NOW HAVE THE CAPABILITY TO BLOCK NPCS USING DIFFERENT NUCLEAR PORE CONSTITUENTS. AS SUCH, THIS APPLICATION AIMS TO DEFINE AND VISUALIZE THE SPECIFIC NUCLEAR PORE CONSTITUENTS THAT INTERACT AND MEDIATE THE NUCLEAR IMPORT OF HIV-1 AND HOW SPECIFIC NPC USAGE AFFECTS VIRAL INTEGRATION IN TARGET CELLS. COLLECTIVELY THIS APPLICATION WOULD CLOSE CRITICAL GAPS TO OUR UNDERSTANDING IN TO THE NUCLEAR IMPORT OF HIV-1.
National Science Foundation
$2.9M
COLLABORATIVE RESEARCH: TRI-ALLIANCE FOR POST-AWARD INNOVATION -THE TRI-ALLIANCE CONSORTIUM AIMS TO TRANSFORM POST-AWARD ACTIVITIES AT EMERGING RESEARCH INSTITUTIONS (ERIS) TO REDUCE ADMINISTRATIVE BURDEN, BETTER SUPPORT FACULTY IN THEIR RESEARCH, AND INCREASE GRANT ACTIVITY. WITHOUT ADEQUATE RESEARCH INFRASTRUCTURE, FACULTY AND STAFF AT ERIS FACE DISTINCT CHALLENGES, INCLUDING LACK OF SUPPORT SYSTEMS FOR MANAGING THE POST-AWARD RESPONSIBILITIES, ACCESS TO ACCURATE INFORMATION, AND POST-AWARD COMPLIANCE. ADDRESSING THESE ISSUES CAN HELP INCREASE THE RESEARCH CONTRIBUTIONS FROM DIVERSE INSTITUTIONS, THEREBY SUPPORTING U.S. ECONOMIC GROWTH. THE TRI-ALLIANCE CONSORTIUM, WHICH INCLUDES LOYOLA MARYMOUNT UNIVERSITY, SANTA CLARA UNIVERSITY, AND UNIVERSITY OF SAN FRANCISCO, IS DEDICATED TO ADVANCING RESEARCH EXCELLENCE THROUGH COLLABORATION AND RESOURCE SHARING. THESE CALIFORNIA-BASED INSTITUTIONS, PART OF THE ASSOCIATION OF JESUIT COLLEGES AND UNIVERSITY (AJCU), AND RECOGNIZED AS ERIS, WILL FOCUS ON THREE CORE COMPONENTS: 1) BUILDING CAPACITY FOR POST-AWARD SERVICE STRUCTURES, FUNCTIONS, AND DATA COLLECTION; 2) DEVELOPING SHARED EDUCATION AND TRAINING OPPORTUNITIES AND RESOURCE MATERIALS TO INCREASE EFFICIENCY AND REDUCE ADMINISTRATIVE BURDENS; AND 3) PILOTING INNOVATIVE CROSS-DIVISION SUPPORT ROLES THAT SPAN PRE- AND POST-AWARD ADMINISTRATION. BY SHARING RESOURCES, PILOTING INNOVATIVE POSITIONS, AND DOCUMENTING BEST PRACTICES, THE TRI-ALLIANCE WILL CREATE A TOOLKIT AVAILABLE TO ERIS, THUS FOSTERING A STRONGER, MORE EFFICIENT RESEARCH ENVIRONMENT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Department of Education
$2.9M
COMPREHENSIVE PREPARATION OF SCHOOL PSYCHOLOGISTS TO SUPPORT THE MENTAL HEALTH OF STUDENTS THAT ARE CULTURALLY AND LINGUISTICALLY DIVERSE IN THE CICERO COMMUNITY
Department of Health and Human Services
$2.9M
MOLECULAR GENETICS OF MLL-ASSOCIATED LEUKEMIA
Department of Health and Human Services
$2.8M
ADVANCED NURSING EDUCATION WORKFORCE
Department of Health and Human Services
$2.8M
WEIGHTING LONGITUDINAL DATA TO ACCESS OPIOID ANALGESIA TAPERING OUTCOMES AMONG PATIENTS WITH CO-OCCURRING CHRONIC PAIN AND SUBSTANCE USE DISORDER - PROJECT SUMMARY/ABSTRACT IN 2016, THE CENTERS FOR DISEASE CONTROL (CDC) RELEASED GUIDELINES RECOMMENDING NON-PHARMACOLOGIC TREATMENT FOR CHRONIC PAIN OVER USE OF OPIOID ANALGESIA IN RESPONSE TO RISING OVERDOSE DEATHS AND BASED ON STUDIES SHOWING NONOPIOID AND MULTIDISCIPLINARY APPROACHES TO PAIN CONTRIBUTE TO FUNCTIONAL AND PAIN SEVERITY IMPROVEMENTS. CDC GUIDELINES ALSO RECOMMENDED OPIOID TAPERING FOR CHRONIC PAIN PATIENTS WITH SUBSTANCE USE DISORDER (SUD) AND TRANSITION TO MEDICATIONS FOR OPIOID USE DISORDER (MOUD) FOR PATIENTS WITH CO-OCCURRING OPIOID USE DISORDER (OUD). WHILE OPIOID TAPERING HAS BEEN WIDELY IMPLEMENTED, FEW STUDIES ASSESS TRANSITIONS TO MOUD OR MULTIDISCIPLINARY MEDICINE USE SPECIFICALLY AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD. A PRIMARY REASON FOR THIS LIMITED KNOWLEDGE IS THE POPULATION WITH CHRONIC PAIN AND CO-OCCURRING SUD IS OFTEN RELATIVELY SMALL IN ANY GIVEN HEALTHCARE FACILITY OR SYSTEM, AND OUTCOMES OF INTEREST MAY OCCUR IN LOW TOTAL NUMBERS. THUS, A LARGE DATABASE IS REQUIRED TO CONDUCT MULTIFACTORIAL RESEARCH ON OUTCOMES ASSOCIATED WITH DIFFERENT APPROACHES TO OPIOID TAPERING, ESPECIALLY WHEN EVALUATING WHETHER TRENDS HOLD AMONG SMALLER DEMOGRAPHIC GROUPS. TO ADDRESS THIS CRITICAL GAP, OUR GOAL IS TO CREATE WEIGHTS FOR THE CERNER REAL-WORLD© DATABASE, WHICH INCLUDES ELECTRONIC HEALTH RECORDS (EHR) DATA FROM OVER 100 MILLION UNIQUE U.S. PATIENTS AT 600 PARTICIPATING HOSPITALS AND CLINICS. OUR HYPOTHESIS IS THAT WEIGHTING THE DATABASE WILL SIGNIFICANTLY ENHANCE ITS REPRESENTATIVENESS IN ORDER TO LONGITUDINALLY ASSESS THE RELATIONSHIP BETWEEN OPIOID TAPERING, MULTIDISCIPLINARY MEDICINE, MOUD, AND OUTCOMES FOR CHRONIC PAIN PATIENTS WITH CO-OCCURRING SUD. OUR AIMS ARE TO USE AMERICAN HOSPITAL ASSOCIATION AND U.S. CENSUS DATA TO CREATE WEIGHTS, STRATIFIED BY HOSPITAL CHARACTERISTICS AND ADJUSTED BY DEMOGRAPHIC VARIABLES, FOR ANALYZING THE CERNER DATABASE (AIM 1); VALIDATE THE WEIGHTING SCHEME IN AIM 1 BY COMPARING WEIGHTED ESTIMATES FROM THE CERNER DATABASE TO ESTIMATES FROM A WELL-ESTABLISHED POPULATION (THE NATIONWIDE INPATIENT SAMPLE) FOR CHRONIC PAIN, SUD, AND OVERDOSE DIAGNOSES AND RELEVANT MULTIDISCIPLINARY PAIN INTERVENTIONS FOR THE YEARS 2000-2025 (AIM 2); AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING OUD, EXAMINE HOW TAPERING OPIOID ANALGESICS AND TRANSITIONING TO MOUD AFFECTS RISK FOR OVERDOSE, SUICIDE, AND OTHER HOSPITALIZATIONS, AND ASSESS HOW SEX AND RACE/ETHNICITY OPERATE AS EFFECT MODIFIERS IN THESE RELATIONSHIPS (AIM 3); AND AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD, EXAMINE HOW TAPERING OPIOID ANALGESICS WHILE USING MULTIDISCIPLINARY PAIN TREATMENT AFFECTS RISK FOR OVERDOSE, SUICIDE, AND OTHER HOSPITALIZATIONS, AND ASSESS HOW SEX AND RACE/ETHNICITY OPERATE AS EFFECT MODIFIERS IN THESE RELATIONSHIPS (AIM 4). THIS PROJECT WILL CREATE A NATIONAL DATABASE WITH VALIDATED WEIGHTING THAT WILL ENABLE RIGOROUS EXAMINATION OF OPIOID TAPERING APPROACHES AMONG PATIENTS WITH CHRONIC PAIN AND CO-OCCURRING SUD, WHICH WILL SUBSEQUENTLY IMPROVE KNOWLEDGE OF HOW MULTIDISCIPLINARY PAIN TREATMENT AND MOUD AFFECT RISKS, WHILE CONSIDERING TAPERING-RELATED INEQUITIES AMONG DEMOGRAPHIC SUBPOPULATIONS.
Department of Education
$2.7M
ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM
Department of Health and Human Services
$2.7M
THE NKA INTERACTOME IN HEALTH AND DISEASE - PROJECT SUMMARY/ABSTRACT: THE NA/K-ATPASE (NKA), OR “SODIUM PUMP”, IS AN ENZYME THAT TRANSPORTS IONS ACROSS CELL MEMBRANES. BETWEEN 30-70% OF THE CELL’S ATP BUDGET IS SPENT BY THE NKA TO CREATE STRONG CHEMICAL GRADIENTS FOR SODIUM AND POTASSIUM. THESE GRADIENTS CONTROL CELL VOLUME, SUPPORT ELECTRICAL SIGNALING (ACTION POTENTIALS) AND ENERGIZE MANY OTHER TRANSPORT PROCESSES. DISRUPTION OF SODIUM HANDLING IS ASSOCIATED WITH DISEASES INCLUDING CARDIAC HYPERTROPHY/FAILURE, PARKINSON’S DISEASE, SCHIZOPHRENIA, AND ALZHEIMER’S DISEASE. VARIOUS CELL TYPES IN DIVERSE TISSUES OF THE BODY HAVE VERY DIFFERENT REQUIREMENTS FOR NA/K TRANSPORT, AND TRANSPORT RATES MUST RESPOND TO PHYSIOLOGICAL CHALLENGES (E.G. EXERCISE). TO ADAPT NKA TO THESE DIFFERENT CONDITIONS, THE PUMP IS REGULATED BY TISSUE-SPECIFIC TRANSMEMBRANE PEPTIDES THAT INCREASE OR DECREASE THE PUMP’S ENZYMATIC ACTIVITY. IN AIM 1 OF THE PROJECT WE WILL FOCUS ON THE NORMAL PHYSIOLOGICAL REGULATION OF NKA BY FXYDS, TESTING HOW FXYD PROTEINS BIND AND STABILIZE SPECIFIC NKA CONFORMATIONS TO ALTER NKA TRANSPORT KINETICS. WE WILL USE NOVEL SPECTROSCOPIC ASSAYS TO INVESTIGATE THE STRUCTURE AND STABILITY OF DIFFERENT NKA-FXYD REGULATORY COMPLEXES. WE WILL INVESTIGATE HOW PHYSICAL COUPLING OF TWO PUMPS INTO A SINGLE FUNCTIONAL UNIT CAN ALLOW FASTER OVERALL CYCLING. AIM 2 IS THE TRANSLATIONAL ARM OF THE RESEARCH PROJECT. THE RESEARCH TEAM WILL INVESTIGATE HOW NKA REGULATION BY FXYDS BECOMES DISORDERED IN DISEASE, USING PROTEOMIC ANALYSIS TO COMPARE THE NKA-FXYD INTERACTOME IN HEALTHY AND FAILING HUMAN HEART TISSUE. WE WILL DETERMINE WHETHER FRAGMENTS OF DIGESTED MEMBRANE PROTEINS MAY DISRUPT NKA FUNCTION IN DISEASE. WE WILL ALSO TEST THE FEASIBILITY OF USING GENE DELIVERY OF AN INHIBITORY SPECIES (FXYD1) AS A THERAPY TO IMPROVE THE CONTRACTION STRENGTH OF A FAILING HEART. FINALLY, WE WILL COMPARE FXYDS THAT ACTIVATE NKA AND FXYDS THAT INHIBIT NKA. THE PROJECT BRINGS TOGETHER 6 DIFFERENT INVESTIGATORS THAT SPECIALIZE IN DIFFERENT COMPLEMENTARY APPROACHES. THE LABORATORY OF THE PROJECT PI, PROF. SETH ROBIA, USES FLUORESCENCE SPECTROSCOPY AND CELL PHYSIOLOGY TO INVESTIGATE THE STRUCTURE, AFFINITY, AND FUNCTION OF NKA-FXYD COMPLEXES IN CARDIAC MYOCYTES AND HETEROLOGOUS CELLS. HE WORKS CLOSELY WITH TWO LOYOLA UNIVERSITY CHICAGO COLLEAGUES: JONATHAN KIRK (CO-I) AND PETE KEKENES-HUSKEY (CO-I). PROF. KIRK WILL USE PROTEOMICS APPROACHES SUCH AS MASS SPECTROMETRY TO DISCOVER POST- TRANSLATIONAL MODIFICATIONS AND NOVEL NKA REGULATORS. PROF. KEKENES-HUSKEY WILL ASSIST WITH COMPUTATIONAL MODELING OF THE PROTEIN COMPLEXES. PROF. JULIE BOSSUYT (MPI) WILL INVESTIGATE A-A COUPLING, CONDUCTING MICROSCOPY AND BIOCHEMISTRY EXPERIMENTS TO IDENTIFY THE INTERACTION INTERFACE. PROF. ARTIGAS (CO-I) AT TEXAS TECH WILL PERFORM DETAILED ELECTROPHYSIOLOGICAL ANALYSES OF FXYD PROTEINS AND MEMBRANE PROTEIN FRAGMENTS. PROF. RAZVAN CORNEA (CONSULTANT) IS AN EXPERT IN MEMBRANE PROTEIN BIOPHYSICS. HE WILL ADVISE THE TEAM ON ALL ASPECTS OF THE PROJECT. TOGETHER, THE COLLABORATORS WILL UNCOVER IMPORTANT NEW INFORMATION ABOUT NKA-FXYD STRUCTURE/FUNCTION RELATIONSHIPS, AND LEARN HOW THESE MECHANISMS BECOME DISORDERED IN DISEASE.
Department of Health and Human Services
$2.7M
LOYOLA RESEARCH COMPUTING CORE
Department of Health and Human Services
$2.7M
PATHOLOGICAL RESPONSES TO MITOCHONDRIAL ROS IN SEPSIS-INDUCED CARDIAC DYSFUNCTION
Department of Health and Human Services
$2.7M
BINGE ALCOHOL-INDUCED NEURODEGENERATION AND OMEGA-3 DHA PROTECTION
Department of Health and Human Services
$2.7M
EXPERIMENTAL IMMUNOLOGY TRAINING GRANT
Department of Health and Human Services
$2.7M
MINDFULNESS BASED STRESS REDUCTION FOR PSYCHO-IMMUNE DYSREGULATION IN CANCER
Department of Health and Human Services
$2.7M
IMMUNE DYSREGULATION BY PSYCHOSOCIAL DISTRESS
Department of Education
$2.7M
SUPPORT OF THE UPWARD BOUND PROGRAM AT LOYOLA UNIVERSITY NEW ORLEANS
Department of Health and Human Services
$2.6M
SEX-SPECIFIC REGULATION OF MICRORNAS IN ALZHEIMER DISEASE - PROJECT SUMMARY ALZHEIMER’S DISEASE IS MORE PREVALENT IN WOMEN THAN MEN, YET A BIOLOGICAL BASIS FOR THIS SEX DIFFERENCE IS NOT UNDERSTOOD. THE PRIMARY OBJECTIVE OF THIS PROPOSAL IS TO UNDERSTAND HOW 17SS-ESTRADIOL (E2) REGULATES MICRORNA (MIR) BIOGENESIS AND STABILITY ACROSS THE LIFESPAN AND IN ALZHEIMER’S DISEASE (AD). WE HYPOTHESIZE THAT DYSREGULATION OF E2-MEDIATED MIR EXPRESSION IN THE AGED BRAIN LEADS TO GREATER ALZHEIMER DISEASE RISK IN WOMEN. THE STUDIES PROPOSED ARE FOCUSED ON UNDERSTANDING HOW ESTROGENS REGULATE THESE MIRS TO GET A BETTER UNDERSTANDING OF THEIR DYSREGULATION IN AD - SPECIFICALLY IN WOMEN. THIS WILL ADDRESS A MAJOR GAP IN OUR UNDERSTANDING BECAUSE HOW E2 INFLUENCES THE COMPONENTS OF THE MIR BIOGENESIS PATHWAY TO REGULATE MATURE MIR EXPRESSION LEVELS IN A CELL- AND/OR AGE-SPECIFIC MANNER IS UNKNOWN, DESPITE SEVERAL STUDIES DEMONSTRATING TEMPORAL AND CELL-SPECIFIC EFFECTS OF E2 ON MIR EXPRESSION IN A VARIETY OF ORGAN SYSTEMS. OUR PRIOR STUDIES DEMONSTRATED THAT E2 TREATMENT ALTERED THE EXPRESSION LEVELS OF A SUBSET OF MIRS IN THE FEMALE BRAIN, AND THE ABILITY TO REGULATE THESE MIRS DEPENDED ON AGE, BRAIN REGION, AND LENGTH OF E2 DEPRIVATION (I.E., TIME POST- MENOPAUSE). COLLECTIVELY THE EXPERIMENTS IN AIM 1 WILL TEST THE HYPOTHESIS THAT E2 DIFFERENTIALLY MEDIATES MATURE MIR STABILITY DEPENDING ON AGE AND IN ALZHEIMER’S DISEASE. WE WILL USE MIR DEGRADATION ASSAYS TO DETERMINE WHETHER AGE AND/OR E2 AFFECT THE RATE OF MIR DEGRADATION AND, USING A PROTEOMICS APPROACH, IDENTIFY THE CIS- AND TRANS-ACTING FACTORS THAT REGULATE MIR STABILITY. AIM 2 WILL ADDRESSES MECHANISTICALLY HOW A SELECT SUBSET OF MIRS COULD BE SPECIFICALLY REGULATED BY E2 POST-TRANSCRIPTION. WE WILL TEST THE HYPOTHESIS THAT HNRNP H BINDING TO ERSS REDUCES ITS ASSOCIATION WITH PRI-MIR TRANSCRIPTS, ERSS INTERACTS WITH BRCA1 TO DIFFERENTIALLY FACILITATE DROSHA COMPLEX ASSEMBLY, AND THAT THESE INTERACTIONS ARE DEPENDENT ON AGE AND E2 TREATMENT. AIM 3 WILL DETERMINE THE EFFECTS OF AGE AND E2 ON MIR SUBCELLULAR LOCALIZATION AND ASSESS DISRUPTION OF E2- MEDIATED MIR SUBCELLULAR LOCALIZATION IN ALZHEIMER’S DISEASE. THIS AIM WILL TEST THE HYPOTHESIS THAT E2 FACILITATES SUBCELLULAR TRAFFICKING OF MIRS, THEREBY IMPACTING MIR FUNCTION. MOREOVER, WE WILL TEST THE HYPOTHESIS THAT MIR SUBCELLULAR LOCALIZATION CHANGES ACROSS THE LIFESPAN AND THAT NORMAL AGE-RELATED SUBCELLULAR LOCALIZATION IS DISRUPTED IN ALZHEIMER’S DISEASE. IMPACT: UNDERSTANDING THE BASIC MOLECULAR SIGNALING PATHWAYS OF E2 IN THE AGING BRAIN WILL HELP DRIVE THERAPEUTIC ADVANCES AND INFORM TREATMENT STRATEGIES FOR WOMEN WITH ALZHEIMER’S DISEASE.
Department of Health and Human Services
$2.5M
INTESTINAL BACTERIA AND EPITHELIAL BARRIER DISRUPTION AFTER ALCOHOL AND BURN INJURY
Department of Health and Human Services
$2.4M
NATIONAL INSTITUTE FOR MENTORING EARLY MINORITY FACULTY IN NEUROSCIENCE
Department of Health and Human Services
$2.4M
USING THE FITBIT FOR EARLY DETECTION OF INFECTION AND REDUCTION OF HEALTHCARE UTILIZATION AFTER DISCHARGE IN PEDIATRIC SURGICAL PATIENTS - PROJECT SUMMARY PEDIATRIC APPENDECTOMY, THE MOST PREVALENT INPATIENT PROCEDURE IN CHILDREN, IS ASSOCIATED WITH SIGNIFICANT BURDEN TO THE PATIENT, THEIR PARENTS, HEALTHCARE SYSTEMS AND THIRD PARTY PAYORS. AFTER DISCHARGE, MONITORING BY PARENTS CONSISTS ONLY OF SUCH “PROXY” SUBJECTIVE ASSESSMENTS, WHICH HAVE BEEN REPORTED AS INACCURATE, AND RESULTED IN BOTH INCREASED COMPLICATIONS (E.G., READMISSIONS), AND WASTED HEALTHCARE RESOURCES (E.G., POTENTIALLY AVOIDABLE EMERGENCY DEPARTMENT (ED) VISITS AFTER SURGERY). ADVANCES IN CONSUMER WEARABLE DEVICES (“CWDS”) THAT PASSIVELY AND NON-INVASIVELY MONITOR PHYSICAL ACTIVITY (PA), HEART RATE (HR), AND SLEEP ARE USHERING IN A NEW ERA OF SYMPTOMS SCIENCE, PARTICULARLY AFTER SURGERY. THEIR EXPANDING CAPABILITY TO GENERATE CONTINUOUS, VALID, OBJECTIVE, AND ACTIONABLE MEASURES IN NEAR-REAL TIME IN CHILDREN, PROVIDE OPPORTUNITIES TO DETECT ALTERED POST-OPERATIVE RECOVERY PATTERNS EARLY, AND THEREFORE IMPROVE THE PRECISION AND TIMELINESS OF ANY NECESSARY CLINICAL INTERVENTIONS. THE PROPOSED STUDY WILL USE A CWD, THE FITBIT INSPIRE 2, AND WILL APPLY MACHINE LEARNING METHODS TO THE FITBIT DATA (PHYSICAL ACTIVITY, HR, AND SLEEP) TO CREATE CLINICALLY MEANINGFUL ALERTS FOR EARLY DETECTION OF POSTOPERATIVE INFECTION. DURING HOSPITALIZATION AND CONTINUING AFTER DISCHARGE, A FITBIT INSPIRE 2, A WIDELY-USED, COMMERCIALLY WEARABLE DEVICE WELL-TOLERATED BY YOUNG CHILDREN (3- 18 YEARS OLD) WILL BE USED TO MEASURE STEP COUNTS, SLEEP, AND HR. THE PROPOSAL HAS 2 AIMS. AIM 1 DEVELOPS AND VALIDATES MACHINE LEARNING ALGORITHM FOR INFECTION USING THE FITBIT. AIM 2 PROSPECTIVELY FEEDS NEAR-REAL TIME FITBIT DATA ON POSTOPERATIVE APPENDECTOMY PATIENTS TO CLINICIANS, AND EXAMINES THEIR EFFECT ON CLINICAL DECISION MAKING, TIME TO FIRST CONTACT WITH THE HEALTHCARE SYSTEM, AND ON OVERALL HEALTHCARE USE PATTERNS. THE PROPOSAL IS ALIGNED WITH NINR’S RESEARCH PRIORITIES. METHODS DEVELOPED FROM THIS WORK WILL PAVE THE WAY TO DEVELOP SIMILAR ALGORITHMS FOR OTHER PATIENT POPULATIONS NEEDING A PROXY, AS WELL AS TO CHARACTERIZE OTHER SURGERIES AND, SHOULD IMPROVE OVERALL POSTOPERATIVE MANAGEMENT FOR ALL SURGICAL PATIENTS.
Department of Health and Human Services
$2.4M
MODELING THE EPIDEMIOLOGIC TRANSITION: ENERGY EXPENDITURE, OBESITY AND DIABETES
Department of Health and Human Services
$2.4M
MECHANISMS OF CONTRACTILE NETWORK ASSEMBLY
National Science Foundation
$2.3M
CYBERCORPS SCHOLARSHIP FOR SERVICE: CYBERRAMBLERS BOLSTER NATIONAL SECURITY -CYBERSECURITY IS CRITICAL TO ALL ASPECTS OF MODERN LIFE, FROM ENERGY, COMMERCE, FINANCE, EDUCATION, AND HEALTHCARE TO MANUFACTURING AND AGRICULTURE. WELL-TRAINED CYBERSECURITY PROFESSIONALS SERVING IN THE GOVERNMENT WORKFORCE ARE CRITICAL TO NATIONAL SECURITY. THIS PROJECT WILL ESTABLISH THE CYBERRAMBLERS ? LOYOLA UNIVERSITY CHICAGO CYBERCORPS? SCHOLARSHIP FOR SERVICE PROGRAM TO IMPROVE THE UNITED STATES' NATIONAL SECURITY. SCHOLARS WILL BE TRAINED IN TECHNICAL KNOWLEDGE FROM COMPUTER SCIENCE AND CYBERSECURITY, AND SOCIAL AND BEHAVIORAL KNOWLEDGE OF CYBERCRIME FROM PSYCHOLOGY, AND CRIMINAL JUSTICE AND CRIMINOLOGY. THIS LEADS TO SCHOLARS RECEIVING A WELL-ROUNDED CYBERSECURITY EDUCATION AND TRAINING. FOUR COHORTS OF UNDERGRADUATE STUDENTS MAJORING IN THE B.S. FOR CYBERSECURITY PROGRAM WILL BE RECRUITED FOR A TOTAL OF 20 STUDENTS OVER FIVE YEARS. THE STUDENT RECRUITMENT PROCESS EMPHASIZES RECRUITING AND RETAINING MEMBERS OF UNDERREPRESENTED AND UNDERSERVED GROUPS. THE OUTCOME OF THIS PROJECT WILL BE A WELL-PREPARED COHORT OF CYBERSECURITY PROFESSIONALS AND LEADERS READY TO MEET THE NATION?S CYBERSECURITY WORKFORCE NEEDS. THE PROJECT WILL BUILD ON THE EXISTING INTERDISCIPLINARY CYBERSECURITY PROGRAM TO RECRUIT STUDENTS FROM COMPUTER SCIENCE, CYBERSECURITY, PSYCHOLOGY, AND CRIMINAL JUSTICE AND CRIMINOLOGY. EACH CYBERRAMBLER SCHOLAR WILL RECEIVE TWO YEARS OF SCHOLARSHIP SUPPORT AND ADVISING AND MENTORING SUPPORT TO ENSURE ADEQUATE PROGRESS TOWARD GRADUATION AND SUCCESSFUL JOB PLACEMENT. SCHOLARS WILL BE INVOLVED IN INTERDISCIPLINARY RESEARCH AND EDUCATION AND RECEIVE TRAINING TO DEVELOP THE CRITICAL THINKING, INDEPENDENCE, TEAMWORK, AND TECHNICAL KNOWLEDGE REQUIRED IN A CYBERSECURITY CAREER. THESE SCHOLARSHIPS FOR SERVICE WILL PROVIDE THE NECESSARY HANDS-ON TRAINING AND EDUCATION FOR SCHOLARS TO START A SUCCESSFUL CYBERSECURITY CAREER AS PART OF THE GOVERNMENT WORKFORCE. TO ENSURE THE EFFECTIVENESS AND SUSTAINABILITY OF THE PROGRAM, COMPREHENSIVE FORMATIVE AND SUMMATIVE EVALUATION MECHANISMS WILL BE USED TO ASSESS THE PROGRESS AND ACHIEVEMENTS OF THE STUDENT SCHOLARS. THESE WILL SPECIFICALLY FOCUS ON SCHOLARS? SKILL DEVELOPMENT, KNOWLEDGE ACQUISITION, AND READINESS TO MEET THE NATION'S CYBERSECURITY WORKFORCE NEEDS. THIS PROJECT AIMS TO CREATE CYBERSECURITY PROFESSIONALS WHO WILL POSITIVELY IMPACT NATIONAL SECURITY AND MEET THE EVOLVING CHALLENGES OF THE CYBER LANDSCAPE THROUGH STRATEGIC RECRUITMENT, INTERDISCIPLINARY CYBERSECURITY-FOCUSED CURRICULUM, RIGOROUS EVALUATION, AND GOVERNMENT PARTNERSHIPS. THIS PROJECT IS SUPPORTED BY THE CYBERCORPS? SCHOLARSHIP FOR SERVICE (SFS) PROGRAM, WHICH FUNDS PROPOSALS ESTABLISHING OR CONTINUING SCHOLARSHIP PROGRAMS IN CYBERSECURITY AND ALIGNS WITH THE U.S. NATIONAL CYBER STRATEGY TO DEVELOP A SUPERIOR CYBERSECURITY WORKFORCE. FOLLOWING GRADUATION, SCHOLARSHIP RECIPIENTS ARE REQUIRED TO WORK IN CYBERSECURITY FOR A FEDERAL, STATE, LOCAL, OR TRIBAL GOVERNMENT ORGANIZATION FOR THE SAME DURATION AS THEIR SCHOLARSHIP SUPPORT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Department of Education
$2.3M
CENTER ON ENGLISH LEARNERS AND MULTILINGUALISM
Department of Health and Human Services
$2.3M
MICROBE-DRIVEN DEVELOPMENT OF GALT
Department of Education
$2.3M
LOYOLA UNIVERSITY NEW ORLEANS UPWARD BOUND PROJECT
Department of Education
$2.3M
LOYOLA UNIVERSITY MARYLAND SCHOOL COUNSELING SCHOLARSHIP PROGRAM: CULTURALLY RESPONSIVE AND INCLUSIVE SCHOOL-COUNSELOR PREPARATION (CRISP)
Department of Health and Human Services
$2.3M
UNCOVERING AND HARNESSING CONNECTED METABOLIC PATHWAYS ESSENTIAL TO VIRUS INFECTION.
Department of Health and Human Services
$2.3M
SELENOF IS A NOVEL TUMOR SUPPRESSOR AND A NEW TARGET TO OVERCOME RACIAL DISPARITY IN BREAST CANCER. - PROJECT SUMMARY / ABSTRACT THIS PROPOSAL ADDRESSES THE CHALLENGE OF CLOSING THE RACIAL DISPARITY GAP IN BREAST CANCER MORTALITY BY IDENTIFYING A CONTRIBUTING BIOLOGICAL FACTOR AND DEVELOPING THERAPEUTIC STRATEGIES TO OVERCOME ITS IMPACT. THE SELENOPROTEIN, SELENOF, WAS RECENTLY IDENTIFIED AS A NEW TUMOR SUPPRESSOR IN BREAST CANCER. THE BROAD HYPOTHESIS IS THAT LOWER SELENOF LEVELS IN AFRICAN AMERICAN PATIENTS CONTRIBUTE TO THE RACIAL DISPARITY IN BREAST CANCER MORTALITY BY DRIVING TUMOR PROGRESSION AND POOR PATIENT OUTCOME. THEREFORE, THERAPEUTIC STRATEGIES TO MITIGATE ITS LOSS ARE NEEDED TO HELP CLOSE THE DISPARITY GAP. THE SCIENTIFIC PREMISE FOR THE HYPOTHESIS IS BASED ON THE FOLLOWING: 1) THE GENOMES OF BREAST TUMORS FROM AFRICAN AMERICANS HAVE A 5-10 FOLD HIGHER FREQUENCY OF SELENOF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS), WHICH ACCOUNT FOR LOWER SELENOF PROTEIN LEVELS, 2) SELENOF MRNA EXPRESSION IS SIGNIFICANTLY LOWER IN BREAST TUMORS FROM AFRICAN AMERICAN PATIENTS COMPARED TO CAUCASIANS, AND LOWER SELENOF LEVELS PREDICT SHORTER SURVIVAL IN THESE PATIENTS, 3) LOSS OF SELENOF IN NORMAL BREAST EPITHELIAL CELLS RESULTED IN INCREASED PROLIFERATION AND ABROGATED CELL DEATH, FEATURES OF CELLULAR TRANSFORMATION, AND 4) OVEREXPRESSION OF SELENOF IN BREAST CANCER CELLS INDUCED CELL DEATH, BLOCKED PROLIFERATION AND SURVIVAL, ENHANCED RESPONSE TO THERAPIES, AND INHIBITED TUMOR GROWTH IN VIVO. THE EUKARYOTIC INITIATION FACTOR 4A3 (EIF4A3) WAS IDENTIFIED AS A TRANSLATIONAL REPRESSOR OF SELENOF. THE SELENOF LOCUS SNPS ARE PREDICTED TO ENHANCE EIF4A3’S BINDING AFFINITY RESULTING IN STRONGER REPRESSION OF SELENOF TRANSLATION. PRELIMINARY DATA SHOWED THAT PHARMACOLOGIC INHIBITION OF EIF4A3 RESULTS IN INCREASED SELENOF PROTEIN LEVELS AND REDUCED BREAST CANCER CELL VIABILITY IN A SELENOF-DEPENDENT MANNER. LOSS OF SELENOF ALSO RESULTED IN HYPERACTIVATION OF THE KINASE/RNASE INOSITOL-REQUIRING ENZYME 1 (IRE1), A MASTER REGULATOR OF THE UNFOLDED PROTEIN RESPONSE. THIS RENDERED CELLS HIGHLY SUSCEPTIBLE TO IRE1 INHIBITION, THUS IDENTIFYING A NEW VULNERABILITY IN THESE CELLS. FOUR AIMS ARE PROPOSED: 1) DETERMINE THE MECHANISMS UNDERLYING SELENOF-INDUCED CELL FATE IN BREAST CANCER, 2) DETERMINE WHETHER LOSS OF SELENOF DRIVES TUMORIGENESIS BY USING AFRICAN AMERICAN DERIVED XENOGRAFTS AND A MURINE MODEL OF BREAST CANCER, 3) DETERMINE THE IMPACT OF SNPS ON THE REGULATION OF SELENOF TRANSLATION BY EIF4A3, AND 4) DETERMINE WHETHER EIF4A3 OVEREXPRESSION AND THE SNPS CONTRIBUTE TO REDUCED SELENOF TUMOR LEVELS AND POOR OUTCOME IN AFRICAN AMERICAN BREAST CANCER PATIENTS. OUR WORK WILL ESTABLISH SELENOF AS A NEW TARGET TO REDUCE RACIAL DISPARITY IN BREAST CANCER, AND THUS SUPPORT THE DEVELOPMENT OF SELENOF-BASED THERAPIES. IN THE CLINIC, SELENOF’S SNPS AND LEVELS CAN ALSO SERVE AS CANDIDATE BIOMARKERS TO IDENTIFY AFRICAN AMERICAN PATIENTS AT RISK OF AGGRESSIVE DISEASE. THE DISTINCT THERAPEUTIC STRATEGIES INVESTIGATED HERE ARE LIKELY TO RESULT IN NOVEL AND MORE EFFECTIVE PERSONALIZED MEDICINE AND MAY HELP CLOSE THE DISPARITY GAP.
Department of Health and Human Services
$2.3M
A REGULATORY CASCADE THAT CONTROLS PNEUMOCOCCAL CAPSULE BIOSYNTHESIS
Department of Health and Human Services
$2.2M
MONOCYTE REGULATION OF INFANT IMMUNE RESPONSES
Department of Health and Human Services
$2.2M
NURSING WORKFORCE DIVERSITY
Department of Health and Human Services
$2.2M
SOUTHWEST ONCOLOGY GROUP
Department of Health and Human Services
$2.2M
REVOLUTIONIZING NORMATIVE RE-EDUCATION: DELIVERING ENHANCED PNF WITHIN A SOCIAL MEDIA INSPIRED GAME ABOUT COLLEGE LIFE
Department of Health and Human Services
$2.2M
ETHANOL EFFECTS ON RECOVERY AFTER INJURY
Department of Health and Human Services
$2.2M
MARKERLESS MOTION TRACKING OF LUNG TUMORS USING DUAL ENERGY IMAGING
Department of Health and Human Services
$2.2M
COLLABORATIVE INTEGRATION OF HEPATITIS B MOLECULAR VIROLOGY AND MATHEMATICAL/COMPUTATIONAL MODELING
Department of Education
$2.1M
UPWARD BOUND
Department of Health and Human Services
$2.1M
NURSE, EDUCATION, PRACTICE, QUALITY AND RETENTION - REGISTERED NURSES IN PRIMARY CARE
Department of Defense
$2.1M
A NOVEL ANTI-INFLAMMATORY PROTEIN THERAPEUTIC THAT IMPROVES RESUSCITATION AND REDUCES TRAUMA, SHOCK AND ISCHEMIA INDUCES TISSUE DAMAGE
Department of Health and Human Services
$2M
TRAINING IN TRAUMA AND BURN RESEARCH
Department of Health and Human Services
$2M
CHROMATIN ORGANIZATION AS A PREDICTOR OF STRESS INDUCED IMMUNE DYSREGULATION
Department of Education
$2M
UPWARD BOUND PROGRAM
Department of Health and Human Services
$2M
COMPUTATIONAL DISCOVERY OF EFFECTIVE HEPATITIS C INTERVENTION STRATEGIES
National Science Foundation
$2M
EMPOWERING STEM SCHOLARS FOR SUCCESS -THIS PROJECT WILL CONTRIBUTE TO THE NATIONAL NEED FOR WELL-EDUCATED SCIENTISTS, MATHEMATICIANS, ENGINEERS, AND TECHNICIANS BY SUPPORTING THE RETENTION AND GRADUATION OF HIGH-ACHIEVING, LOW-INCOME STUDENTS WITH DEMONSTRATED FINANCIAL NEED AT LOYOLA UNIVERSITY MARYLAND. A TOTAL OF 24 SCHOLARS PURSUING BACHELOR'S DEGREES IN BIOLOGY, CHEMISTRY, BIOCHEMISTRY, ENGINEERING (WITH CONCENTRATIONS IN COMPUTER, MECHANICAL, MATERIALS, OR ELECTRICAL ENGINEERING), AND FORENSIC SCIENCE WILL RECEIVE SCHOLARSHIPS AVERAGING $15,000 PER YEAR FOR UP TO FOUR YEARS. SCHOLARS WILL RECEIVE FACULTY, PEER, AND INDUSTRY MENTORING, AND THE PROJECT WILL BUILD STRONG SCHOLAR COHORTS THROUGH PRE-COLLEGE ORIENTATION; MESSINA, A COMMON FIRST-YEAR STUDENT EXPERIENCE FOR ALL LOYOLA STUDENTS THAT WILL BE SPECIALIZED FOR STEM PROJECT STUDENTS; SMALL-GROUP TUTORING; AND REGULAR COHORT EVENTS. ADDITIONAL ACTIVITIES FOR SCHOLARS WILL INCLUDE SEMINARS AND NETWORKING WITH INDUSTRY PARTNERS, ON-SITE VISITS TO REGIONAL STEM ORGANIZATIONS AND BUSINESSES, AND ASSESSMENT AND WORKSHOPS FOR THE DEVELOPMENT OF EMOTIONAL INTELLIGENCE AND PROFESSIONAL SKILLS. THE OVERALL GOAL OF THIS TRACK 2 SCHOLARSHIPS IN STEM PROJECT IS TO INCREASE STEM DEGREE COMPLETION OF ACADEMICALLY TALENTED, LOW-INCOME UNDERGRADUATE STUDENTS WITH DEMONSTRATED FINANCIAL NEED. THERE IS A SIGNIFICANT NATIONAL NEED TO GROW THE STEM WORKFORCE AND NURTURE KEY TALENT THAT WILL ENSURE ECONOMIC COMPETITIVENESS AND PROVIDE DOMESTIC LEADERSHIP ACROSS CRITICAL SECTORS. THIS PROJECT DIRECTLY SPEAKS TO THIS NEED BY SUPPORTING STEM STUDENT SUCCESS, WHICH WILL STRENGTHEN THE WORKFORCE IN ENGINEERING, BIOLOGY, CHEMISTRY AND BIOCHEMISTRY, AND FORENSIC SCIENCE FIELDS AND OTHER KEY AREAS OF NEED. THE PROJECT WILL BE ASSESSED BY AN EXPERIENCED EVALUATOR THAT WILL PROVIDE FORMATIVE AND SUMMATIVE EVALUATIONS THROUGH A WIDE-RANGE OF DATA COLLECTION METHODS (E.G., SURVEYS, FOCUS GROUPS, INSTITUTIONAL RESEARCH DATA, PROFESSIONAL DEVELOPMENT SCALES, PARTICIPATION COUNTS, ETC.) TO DETERMINE THE STEM PROJECT'S SUCCESS IN ACHIEVING ITS OBJECTIVES IN RECRUITMENT, RETENTION AND GRADUATION, CAREER AND PROFESSIONAL DEVELOPMENT, COHORT BUILDING, AND EMPLOYMENT OUTCOMES. THE DATA GENERATED WILL CONTRIBUTE TO THE KNOWLEDGE BASE REGARDING EFFECTIVE STRATEGIES TO SUPPORT TALENTED, LOW-INCOME STUDENTS IN STEM. THIS PROJECT IS FUNDED BY NSF'S SCHOLARSHIPS IN SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS PROGRAM, WHICH SEEKS TO INCREASE THE NUMBER OF ACADEMICALLY TALENTED, LOW-INCOME STUDENTS WITH DEMONSTRATED FINANCIAL NEED WHO EARN DEGREES IN STEM FIELDS. IT ALSO AIMS TO IMPROVE THE EDUCATION OF FUTURE STEM WORKERS, AND TO GENERATE KNOWLEDGE ABOUT ACADEMIC SUCCESS, RETENTION, TRANSFER, GRADUATION, AND ACADEMIC/CAREER PATHWAYS OF LOW-INCOME STUDENTS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Agency for International Development
$2M
CUBA CIVIL SOCIETY PROGRAM - CNECT
Department of Health and Human Services
$2M
LINKING NICOTINIC ACTIVATION WITH SKIN INNATE IMMUNITY AND ATOPIC DERMATITIS
Department of Health and Human Services
$2M
INCREASING ACCESS FOR EARLY CHILDHOOD MENTAL HEALTH CARE SERVICES - THE LOYOLA CENTER FOR COUNSELING & EDUCATION (LCCE) IS APPLYING FOR FUNDING TO SUPPORT THE PROPOSED PROJECT INCREASING ACCESS FOR EARLY CHILDHOOD MENTAL HEALTH CARE SERVICES. THE LCCE IS HOUSED WITHIN THE COLLEGE OF NURSING & HEALTH AT LOYOLA UNIVERSITY NEW ORLEANS. SINCE ITS INCEPTION IN 2019, LCCE HAS BEEN COMMITTED TO PROVIDING EFFECTIVE MENTAL HEALTH COUNSELING SERVICES ON A SLIDING SCALE TO UNDERSERVED FAMILIES, COUPLES, GROUPS, AND INDIVIDUALS AT EVERY STAGE OF LIFE. IN TANDEM WITH CLINICAL SERVICES, LCCE SUPERVISES EXEMPLARY TRAINING FOR GRADUATE STUDENTS IN LOYOLA UNIVERSITY’S DEPARTMENT OF COUNSELING. WITH SUPPORT FROM THE INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROGRAM, THE LCCE AIMS TO IMPROVE OUTCOMES FOR CHILDREN FROM BIRTH UP TO 12 YEARS OF AGE BY DEVELOPING, MAINTAINING, OR ENHANCING INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROMOTION, INTERVENTION, AND TREATMENT SERVICES. PROVIDING ACCESS TO THESE SERVICES TO THIS TARGET POPULATION WILL BE ADDRESSING A SIGNIFICANT NEED IN OUR COMMUNITY. THE TARGET POPULATION FOR THIS PROJECT INCLUDES CHILDREN UP TO AGE 12 IN NEED OF ACCESS TO MENTAL HEALTH CARE WHO ARE UNABLE TO ACCESS THESE SERVICES WITH A PROVIDER THAT BILLS MEDICAID OR PRIVATE INSURANCE. THERE IS A SIGNIFICANT LACK OF AVAILABLE PROVIDERS IN THE EIGHT PARISHES OF THE GREATER NEW ORLEANS AREA AND THE MAJORITY ARE EITHER NOT TAKING NEW PATIENTS OR DO NOT ACCEPT MEDICAID CLIENTS. THE TARGET POPULATION WILL BE LOW-INCOME AND MIRROR THE DEMOGRAPHICS OF THE GREATER NEW ORLEANS AREA: WHITE ALONE NOT HISPANICE: 43%; AFRICAN AMERICAN: 33%; HISPANIC: 11%; ASIAN, PACIFIC ISLANDER NOT HISPANIC: 3%; AND TWO OR MORE RACES: 4%. WITH GRANT FUNDING, THE LCCE WILL ACCOMPLISH THE FOLLOWING GOALS AND MEASURABLE OBJECTIVES: PROGRAM GOALS: 1. PROVIDE AN ADDITIONAL ACCESS POINT FOR CHILDREN OF THE GREATER NEW ORLEANS AREA IN NEED OF MENTAL HEALTH CARE SERVICES WHO ARE UNABLE TO SECURE TREATMENT FROM OTHER SOURCES MEASURABLE OBJECTIVE: SERVE 220 CHILDREN UP TO AGE 12 OVER 5 YEARS 2.PROVIDE CHILDREN WITH ACCESS TO COMPREHENSIVE SCREENING AND EVIDENCE-BASED THERAPIES MEASURABLE OBJECTIVE:100% OF CLIENTS WILL RECEIVE A RISK & NEEDS ASSESSMENT AT IN-TAKE AND ACCESS TO EVIDENCE-BASED TRAUMA-INFORMED CARE AND CHILD CENTERED PLAY THERAPY 3.CREATE A COMMUNITY OF EARLY CHILDHOOD EDUCATORS AND CARE PROVIDERS EQUIPPED TO RECOGNIZE CHILDREN IN NEED OF MENTAL HEALTHCARE SERVICES MEASURABLE OBJECTIVE:ESTABLISH 20 PARTNERSHIPS WITH EARLY CARE AND EDUCATION PROGRAMS, CHILD AND FAMILY-SERVING PROFESSIONALS OVER FIVE YEARS TO PROVIDE EDUCATIONAL AND TRAINING OUTREACH SERVICES AND PROVIDE 2 WORKSHOPS PER YEAR 4. PROVIDE SPECIALIZED TRAINING FOR MENTAL HEALTH CLINICIANS IN INFANT AND EARLY CHILDHOOD MENTAL HEALTH, INCLUDING SPECIFIC TRAINING IN PROMISING AND EVIDENCE-BASED PRACTICES AND MODELS FOR PREVENTION, EARLY INTERVENTION, AND TREATMENT MEASURABLE OBJECTIVE: 52 GRADUATE STUDENTS WILL BE TRAINED AND CERTIFIED TO USE EVIDENCE-BASED TRAUMA-INFORMED CARE AND CHILD CENTERED PLAY THERAPY OVER FIVE YEARS THE PROPOSED PROJECT WILL ALSO COLLECT ALL SAMHSA REQUIRED DATA AND PROGRAM SPECIFIC DATA, CREATE A QI PLAN, AND WORK WITH A LEAD EVALUATOR WHO WILL MONITOR THE EFFECTIVENESS AND QUALITY OF THE SERVICES PROVIDED AND THE PROGRESS TOWARDS MEETING THE PROJECT GOALS AND DELIVERABLES.
Department of Health and Human Services
$2M
THE IMPACT OF A RACE-BASED STRESS REDUCTION INTERVENTION ON WELL-BEING, INFLAMMATION, AND DNA METHYLATION IN OLDER AFRICAN AMERICAN WOMEN AT RISK FOR CARDIOMETABOLIC DISEASE - PROJECT SUMMARY THIS RANDOMIZED CONTROLLED TRIAL WILL EVALUATE THE IMPACT OF A NOVEL RACE-BASED STRESS REDUCTION PROGRAM ON WELL-BEING, INFLAMMATORY BURDEN, AND DNA METHYLATION (DNAM) IN OLDER AFRICAN AMERICAN (AA) WOMEN AT RISK FOR CARDIOMETABOLIC DISEASE (CMD). ALTHOUGH THE NUMBER OF DEATHS RELATED TO CMD CONTINUES TO DECLINE, THAT DECLINE HAS SLOWED RECENTLY WITH AAS BEARING A DISPROPORTIONATE BURDEN. FURTHERMORE, WOMEN FACE MORE SEX- SPECIFIC RISK FACTORS FOR INCREASED ADIPOSITY AND AA WOMEN HAVE THE HIGHEST PREVALENCE OF OBESITY, HYPERTENSION, AND PREDIABETES COMPARED TO ALL OTHER RACIAL AND ETHNIC GROUPS. CHRONIC STRESS IS ASSOCIATED WITH LOW-GRADE INFLAMMATION AND INCREASED CMD RISK. GROWING EVIDENCE DEMONSTRATES THAT STRESSORS SUCH AS RACISM AND DISCRIMINATION ARE SIGNIFICANT CONTRIBUTING FACTORS TO PSYCHOLOGICAL DISTRESS, LOW-GRADE CHRONIC INFLAMMATION, AND CMD HEALTH DISPARITIES AMONG MINORITIES, PARTICULARLY AMONG OLDER AA WOMEN WHO ENDURE THE INTERSECTION OF BOTH RACISM AND SEXISM ACROSS THEIR LIFESPAN. RESILIENCE, STRESS, AND ETHNICITY (RISE) IS A GROUP-BASED, 8-WEEK INTERVENTION THAT INTEGRATES COGNITIVE-BEHAVIORAL STRATEGIES FOCUSED ON THE BIOPSYCHOSOCIAL IMPACT OF RACISM, RACIAL IDENTITY DEVELOPMENT, AND EMPOWERMENT. BASED ON OUR PRELIMINARY WORK, WE ANTICIPATE THAT PARTICIPATION IN RISE WILL REDUCE PSYCHOLOGICAL DISTRESS AND INFLAMMATION. FURTHER, OUR PREVIOUS WORK DEMONSTRATED THAT WOMEN WITH HIGH LEVELS OF PERCEIVED DISCRIMINATION HAVE A GREATER PROINFLAMMATORY CYTOKINE RESPONSE TO ACUTE STRESS AND DECREASED DNAM OF GENES RELATED TO INFLAMMATION AND HYPERTENSION. DNAM IS ONE TYPE OF EPIGENETIC PROCESS THAT MODULATES GENE EXPRESSION BY ADDING OR REMOVING METHYL GROUPS TO DNA IN RESPONSE TO THE ENVIRONMENT. STUDIES DEMONSTRATE THAT HYPER OR HYPO METHYLATION OF GENES DUE CHRONIC STRESSORS, INCLUDING RACISM AND DISCRIMINATION ARE SIGNIFICANTLY ASSOCIATED WITH CMD RISK. EMERGING EVIDENCE DEMONSTRATES THAT PSYCHOBEHAVIORAL INTERVENTIONS MAY MODIFY METHYLATION OF STRESS RESPONSE-RELATED GENES POTENTIALLY BUFFERING THE IMPACT OF PSYCHOLOGICAL STRESS AT THE MOLECULAR LEVEL. HOWEVER, FEW STUDIES HAVE EXAMINED THE IMPACT OF A PSYCHOBEHAVIORAL INTERVENTION ON CHANGES IN DNAM AND NONE HAVE ADDRESSED CHRONIC STRESS IN OLDER AA WOMEN.THEREFORE, THE SPECIFIC AIMS ARE: (1) DETERMINE THE EXTENT TO WHICH PARTICIPATION IN RISE DECREASES STRESS-RELATED SYMPTOMS AND INFLAMMATORY BURDEN IN OLDER AA WOMEN AT RISK FOR CMD; (2) EVALUATE THE EXTENT TO WHICH RISE INCREASES THE USE OF ADAPTIVE COPING VERSUS MALADAPTIVE COPING STRATEGIES IN OLDER AA WOMEN AT RISK FOR CMD; AND (3) DETERMINE THE EXTENT TO WHICH PARTICIPATION IN RISE MODIFIES DNAM OF STRESS RESPONSE- RELATED CANDIDATE GENES IN OLDER AA WOMEN AT RISK FOR CMD FROM BASELINE TO POST RISE INTERVENTION. AA WOMEN 50 TO 70 YEARS OF AGE WHO ARE AT RISK FOR CMD WILL BE RANDOMIZED INTO EITHER AN 8-WEEK RISE PROGRAM OR A HEALTH EDUCATION PROGRAM. RISE IS AN INNOVATIVE INTERVENTION THAT ADDRESSES PERCEIVED RACISM AND DISCRIMINATION AT THE INDIVIDUAL LEVEL. FURTHER, RISE HAS THE POTENTIAL TO IMPROVE THE HEALTH OF MINORITY WOMEN IMPACTED BY RACISM AND DISCRIMINATION.
Department of Defense
$2M
ANALYZING THE SPREAD OF ANTHRAX IN FARMS IN PAKISTAN AND JORDAN
Department of Health and Human Services
$2M
FRANK-STARLING'S LAW OF THE HEART: CELLULAR MECHANISMS
Department of Health and Human Services
$2M
PS09-007, EVALUATING LOCALLY DEVELOPED HOMEGROWN HIV PREVENTION INTERVENTIONS
Department of Education
$2M
ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM
Department of Education
$2M
ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM
Department of Health and Human Services
$1.9M
SCHOLARSHIPS FOR DISADVANTAGED STUDENTS
Department of Health and Human Services
$1.9M
BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING PROGRAM
Department of Health and Human Services
$1.9M
COMMENSAL EXOPOLYSACCHARIDE PROTECTION FROM INFLAMMATION
Department of Health and Human Services
$1.9M
INFLAMMASOME-MEDIATED CORNEAL EPITHELIAL CELL DEFENSES INHIBITED BY PATHOGENIC BACTERIA - PROJECT SUMMARY/ABSTRACT THE HEALTHY CORNEAL EPITHELIUM IS AN EFFECTIVE BARRIER TO PATHOGENIC AND ENVIRONMENTAL BACTERIA. BECAUSE OF THIS, CORNEAL INFECTION OR KERATITIS MODELS OFTEN RELY ON BYPASSING THE EPITHELIUM ALTOGETHER BY INTRODUCING MICROBES DIRECTLY INTO THE CORNEAL STROMA, WHERE THEY INITIATE IMMUNE CELL RESPONSES THAT CAN DAMAGE TISSUE AND CAUSE VISION-THREATENING SCARRING. A LIMITATION OF THIS EXPERIMENTAL APPROACH IS THAT EPITHELIAL DEFENSE MECHANISMS ARE UNABLE TO BE IDENTIFIED OR INVESTIGATED. THE BACTERIAL PATHOGEN PSEUDOMONAS AERUGINOSA IS THE MOST COMMON INFECTION ASSOCIATED WITH SOFT CONTACT LENS WEAR, SUGGESTING IT IS UNIQUELY CAPABLE OF CAUSING INFECTION IN THE STROMA EVEN WHEN THE EPITHELIUM REMAINS INTACT. ONE WAY IN WHICH P. AERUGINOSA COLONIZES THE EPITHELIUM IS BY INVADING AND REPLICATING INSIDE EPITHELIAL CELLS, WHICH HAS BEEN INVESTIGATED IN CULTURED CELLS, AND OBSERVED IN MOUSE CORNEAL INFECTION MODELS. PRELIMINARY DATA SHOW THAT THE TOXIN EXOS PRODUCED BY P. AERUGINOSA SUPPRESSES CASPASE-4 MEDIATED PYROPTOSIS OF INVADED CORNEAL EPITHELIAL CELLS, BUYING TIME FOR BACTERIA TO REPLICATE IN A PROTECTED NICHE. ADDITIONAL DATA INDICATE THAT A DIFFERENT INFLAMMASOME PATHWAY IS ALSO ACTIVE IN CORNEAL EPITHELIAL CELLS, AND LEADS TO PRODUCTION OF THE CYTOKINE IL-1SS, WHICH EXOS ALSO SUPPRESSES. THEREFORE, A NOVEL ROLE FOR EXOS IN CORNEAL INFECTION COULD BE TO PROLONG A NICHE FOR BACTERIA TO REPLICATE WITHIN CORNEAL EPITHELIAL CELLS, WHILE LIMITING SECRETION OF CYTOKINES THAT RECRUIT IMMUNE CELLS. USING IMAGING METHODS TO SELECTIVELY MONITOR INVADED CELLS, AND CRISPR-CAS9 TO MANIPULATE CORNEAL EPITHELIAL CELLS GENETICALLY, WE WILL ANSWER THREE OUTSTANDING QUESTIONS REGARDING BOTH CORNEAL EPITHELIAL DEFENSE, AND BACTERIAL SUBVERSION OF IT: 1. HOW DOES EXOS BLOCK CASPASE-4-MEDIATED PYROPTOSIS? 2. HOW DO CORNEAL EPITHELIAL CELLS DETECT AND RESPOND TO P. AERUGINOSA? 3. WHAT IS THE SIGNIFICANCE OF EPITHELIAL CELL INFLAMMASOME ACTIVATION AND PYROPTOSIS IN PROTECTING THE EYE FROM DEVELOPING KERATITIS IN THE STROMA? SUCCESSFUL COMPLETION OF THESE AIMS WILL IDENTIFY A NEW MECHANISM OF HOST DEFENSE AT THE OCULAR SURFACE, FURTHER OUR UNDERSTANDING OF INFLAMMASOMES IN EPITHELIAL CELLS, AND ELUCIDATE HOW A UNIQUELY DEVASTATING CORNEAL PATHOGEN IS ABLE TO OVERCOME HOST DEFENSES.
Department of Health and Human Services
$1.9M
KCNQ CHANNELS AND VASOCONSTRICTOR SIGNAL TRANSDUCTION
Department of Health and Human Services
$1.9M
MECHANISMS UNDERLYING SEXUALLY DIFFERENTIATED BRAIN REMODELING DURING ADOLESCENCE
Department of Health and Human Services
$1.9M
ACETYL PHOSPHATE AS A GLOBAL STRESS SIGNAL
Department of Health and Human Services
$1.9M
PHOSPHODIESTERASE 1 (PDE1) REGULATION OF MYOCARDIAL CALCIUM AND FUNCTION - PROJECT SUMMARY THE CYCLIC NUCLEOTIDE CAMP SERVES AS A SECOND MESSENGER CRITICAL IN MULTIPLE CELLULAR PROCESSES. TWO PROTEINS HELP TO REGULATE THE LEVEL OF CAMP. G-PROTEIN COUPLED RECEPTORS (GPCRS) ARE TRANSMEMBRANE PROTEINS INVOLVED IN CAMP PRODUCTION. G PROTEINS ARE HETEROTRIMERIC, AND A SUBSET OF GPCRS CONSISTS OF A STIMULATORY, CATALYTIC G⍺ SUBUNIT (G⍺S) THAT UPON RECEPTOR LIGAND BINDING, INCREASE ADENYLYL CYCLASE (AC) PRODUCTION OF CAMP. PHOSPHODIESTERASES (PDES), ON THE OTHER HAND, HYDROLYZE CAMP INTO AMP. IN HEART FAILURE ANIMAL MODELS AND HUMAN PATIENTS, PDE1 INHIBITION HELPS TO IMPROVE CARDIAC FUNCTION BY INCREASING MYOCARDIAL CONTRACTILITY, IMPROVING RELAXATION, AND VASODILATING TO LOWER HEMODYNAMIC STRESS ON THE HEART. THESE EFFECTS ARE SIMILAR TO THOSE UPON PDE3 INHIBITION, BUT WHEREAS THE LATTER IS ASSOCIATED WITH FATAL ARRHYTHMIAS, NO ARRHYTHMIC EVENTS HAVE BEEN ASSOCIATED WITH PDE1 INHIBITOR USE. COMPARTMENTALIZED CAMP SIGNALING THAT IS UNIQUE TO PDE1 VS PDE3 MAY HELP TO EXPLAIN THIS IMPORTANT DIFFERENCE. IT IS KNOWN THAT SPECIFIC PDE-GPCR PAIRINGS WORK TOGETHER TO REGULATE DISTINCT POOLS OF CAMP. THE HEART EXPRESSES MORE THAN 200 GPCRS AND 3 CAMP-HYDROLYZING PDES (1, 3, AND 4). UNIQUE PAIRINGS HELP TO ESTABLISH COMPARTMENTALIZED GRADIENTS OF CAMP SIGNALING THAT ENABLE THE MODULATION OF SPECIFIC CELLULAR PROCESSES IN RESPONSE TO DIFFERENT STIMULI. WHILE MULTIPLE GPCR PAIRINGS WITH PDE3 OR PDE4 HAVE BEEN KNOWN, WHICH GPCR(S) PAIR WITH PDE1 REMAINS UNKNOWN. IN THIS DIVERSITY SUPPLEMENTAL PROJECT, WE WILL IDENTIFY THE GPCR(S) THAT FUNCTIONALLY ENHANCE(S) THE POSITIVE INOTROPIC EFFECTS OF PDE1 INHIBITION. WE WILL DO SO BY EMPLOYING CARDIOMYOCYTE CONTRACTILITY AND CALCIUM, AND FORSTER RESONANCE ENERGY TRANSFER (FRET) IMAGING EXPERIMENTS, AND CARDIAC SLICE PHYSIOLOGIC STUDIES. GUINEA PIG HEARTS, WHICH ARE MUCH MORE LIKE THE HUMAN HEART IN PDE BIOLOGY VERSUS THE COMMONLY USED RAT AND MOUSE MODELS WILL BE USED. OUR HYPOTHESIS IS THAT PDE1 WILL ESTABLISH A G⍺S- ASSOCIATED CAMP GRADIENT THAT IS DISTINCT FROM THAT REGULATED BY PDE3. THIS IS AN IMPORTANT QUESTION BECAUSE OF CLINICAL POTENTIALS OF PDE1 INHIBITION IN PATIENTS WITH PARKINSON’S DISEASE OR HEART FAILURE. THE COMPLETION OF OUR AIM WILL THUS CONTRIBUTE ORIGINAL FINDINGS WITH DIRECT CLINICAL RELEVANCE THAT CAN POTENTIALLY HELP IMPROVE THE HEALTH AND LIFE QUALITY OF PATIENTS.
Department of Health and Human Services
$1.8M
CONTRIBUTION OF CDIA TO PSEUDOMONAS AERUGINOSA PATHOBIOLOGY - PROJECT SUMMARY/ABSTRACT PSEUDOMONAS AERUGINOSA IS A LEADING CAUSE OF HEALTHCARE-ACQUIRED INFECTIONS WORLDWIDE. MANY GLOBALLY- DISTRIBUTED HIGH-RISK STRAINS ARE EMERGING DUE TO AN INCREASE IN ANTIBIOTIC RESISTANCE AND ACQUISITION OF NOVEL VIRULENCE TRAITS. WITH DIMINISHING TREATMENT OPTIONS FOR MANY OF THESE SEVERE P. AERUGINOSA INFECTIONS, STUDIES AIMED AT UNCOVERING THE VIRULENCE STRATEGIES USED BY THESE AGGRESSIVE CLINICAL STRAINS SHOULD HELP TO IDENTIFY NEW TARGETS FOR THERAPEUTIC INTERVENTION. OUR RESEARCH PROGRAM AIMS TO ELUCIDATE VIRULENCE STRATEGIES THAT ENHANCE THE PATHOGENICITY OF P. AERUGINOSA. WE RECENTLY EMPLOYED A COMPARATIVE GENOMICS APPROACH TO INTERROGATE THE ACCESSORY GENOMES OF 100 CLINICAL ISOLATES FOR POTENTIAL FACTORS THAT AUGMENT THE VIRULENCE OF P. AERUGINOSA. BY COMPARING VIRULENCE IN A MOUSE INFECTION MODEL WITH THE PRESENCE OR ABSENCE OF GENES IN THE ACCESSORY GENOME, WE IDENTIFIED SEVERAL VIRULENCE DETERMINANTS ENRICHED AMONG HIGHLY VIRULENT P. AERUGINOSA STRAINS THAT WERE ABSENT FROM LESS VIRULENT STRAINS. FROM THIS WORK WE IDENTIFIED AN ACCESSORY VIRULENCE FACTOR THAT SPANNED A PORTION OF TWO GENES ENCODING PRODUCTS INVOLVED IN CONTACT-DEPENDENT GROWTH INHIBITION (CDI). CDI IS ONE TYPE OF COMPETITIVE MECHANISM MICROORGANISMS USE TO ANTAGONIZE THEIR IMMEDIATE NEIGHBORS BY DELIVERING PROTEIN TOXINS DIRECTLY INTO TARGETED CELLS. THIS ANTAGONISM IS EXECUTED BY CDIA, A LARGE MULTIDOMAIN EXOPROTEIN THAT SITS AT THE SURFACE OF AN ATTACKING CELL AND DELIVERS A SELF-CONTAINED TOXIN DOMAIN INTO THE TARGETED CELL. THE IMPORTANCE OF THIS PROPOSAL STEMS FROM OUR DISCOVERY THAT: (I) CDIA CONTAINS A TOXIN DOMAIN THAT HAS TRNASE ACTIVITY AGAINST PROKARYOTIC AND EUKARYOTIC SUBSTRATES, (II) MUTATIONS THAT ABROGATE THE IN VITRO TRNASE ACTIVITY ATTENUATE BOTH CDI AND VIRULENCE IN MICE, (III) THE CDIA-TOXIN DOMAIN HAS CYTOPATHIC EFFECTS ON EUKARYOTIC CELLS DEPENDENT UPON ITS TRNASE ACTIVITY. TO OUR KNOWLEDGE THIS DULE ROLE FOR CDIA IN BOTH INTERBACTERIAL COMPLETION AND VIRULENCE WITHIN A MAMMALIAN HOST HAS NOT YET BEEN INVESTIGATED FOR P. AERUGINOSA. FROM THIS PRELIMINARY WORK WE HYPOTHESIZE THAT P. AERUGINOSA CAN UTILIZE CDIA TO INTOXICATE HOST CELLS FOR OVERCOMING BARRIERS TO INFECTION. OUR PROPOSAL SEEKS TO ANSWER A NUMBER OF OUTSTANDING QUESTIONS AT THE MOLECULAR (AIM 1), CELLULAR (AIM 2), AND ORGANISMAL (AIM 3) LEVEL. SUCCESSFUL COMPLETION OF THESE AIMS WILL PROVIDE DETAILED INSIGHT INTO HOW CDIA CONTRIBUTES TO P. AERUGINOSA PATHOBIOLOGY.
Department of Health and Human Services
$1.8M
THE ROLE OF PTEN PHOSPHORYLATION REMODELING IN HEMATOPOIETIC STEM CELL REGULATION
Department of Health and Human Services
$1.8M
PROBING CELLULAR INTRACELLULAR CALCIUM SIGNALING AND SENSING THROUGH COMPUTATION
Department of Health and Human Services
$1.8M
NUCLEAR LIPID-SENSOR IN TYPE II DIABETIC NEUROPATHY
Department of Health and Human Services
$1.8M
REQUIREMENTS FOR BACTERIAL COLONIZATION OF ANIMAL TISSUE
Department of Health and Human Services
$1.8M
DEVELOPMENT OF B CELL MEMORY IN ALLERGIC ASTHMA - PROJECT SUMMARY/ABSTRACT ALLERGIC ASTHMA IS A CHRONIC INFLAMMATORY DISEASE OF THE LUNGS WITHOUT CURE. REPETITIVE ALLERGEN EXPOSURE IN THE AIRWAY LEADS TO THE GENERATION OF PATHOGENIC IMMUNE MEMORY AND THE EXCESSIVE PRODUCTION OF ALLERGEN SPECIFIC IGE ANTIBODIES THAT MEDIATE INFLAMMATION, AIRWAY CONSTRICTION AND RESPIRATORY DISTRESS IN PATIENTS WITH ALLERGIC ASTHMA. MEMORY B CELLS ARE A KEY COMPONENT OF IMMUNE MEMORY. THE PHENOTYPIC AND FUNCTIONAL HETEROGENEITY OF MBCS AFFORDS THEIR DIFFERENTIAL ANTIBODY RESPONSES AS WELL AS IMPACT THEIR TRAFFICKING, TISSUE RETENTION AND ABILITY TO DISSEMINATE SYSTEMICALLY. IN A MOUSE MODEL OF ALLERGIC LUNG INFLAMMATION, WE HAVE OBSERVED STABLE LUNG- LOCALIZED MBCS AND EVIDENCE FOR THE GENERATION OF PATHOGENIC ANTIBODY RESPONSES IN SENSITIZED LUNGS. WE HYPOTHESIZE THAT AFTER LOCAL ANTIGEN SENSITIZATION, THE LUNG ACQUIRES IMMUNE FUNCTIONS REMINISCENT OF THOSE IN SECONDARY LYMPHOID TISSUES, CAPABLE OF MAINTAINING LONG-LIVED MEMORY B CELLS AS WELL AS GENERATING NEW MBCS THAT CAN RECIRCULATE AND DISSEMINATE IN OTHER TISSUES TO MEDIATE SYSTEMIC ALLERGIC INFLAMMATION. IN THIS STUDY, WE WILL 1) PROBE THE DEVELOPMENT OF MEMORY B CELLS (MBCS) IN ALLERGIC LUNGS INCLUDING IN-DEPTH CHARACTERIZATION OF THE CRITICAL MBC SUBSET THAT CONTRIBUTES TO ALLERGEN SPECIFIC IGE RESPONSE, AND 2) HOW THESE MBCS DISSEMINATE SYSTEMICALLY. WE WILL ALSO 3) EXPLORE STRATEGIES TO INTERCEPT THE SYSTEMIC DISSEMINATION OF PATHOGENIC MBCS TO HALT THE PROGRESSION OF ALLERGIC INFLAMMATION. THESE STUDIES WILL ADVANCE OUR FUNDAMENTAL UNDERSTANDING OF MEMORY B CELLS AS WELL AS HELP DEVISE NEW THERAPEUTIC STRATEGIES FOR ALLERGIC ASTHMA.
Department of Health and Human Services
$1.8M
THE CELL BIOLOGY OF TRIM5ALPHA
Department of Health and Human Services
$1.8M
SELF-MANAGEMENT IN ADOLESCENTS AND YOUNG ADULTS WITH SPINA BIFIDA
Department of Defense
$1.8M
EFFECTS OF INFECTION ON HOST RESPONSE TO TRAUMA
Department of Defense
$1.8M
TAS::57 3600::TAS "CONGRESSIONAL ADD FOR THE NANOTECHNOLOGY AND RAPID PROTOTYPING PROJECT AT LOYOLA MARYMOUNT UNIVERSITY"
Department of Health and Human Services
$1.7M
A PRECISION MEDICINE APPROACH TO RETT SYNDROME
Department of Health and Human Services
$1.7M
DEVELOP AN ORAL HIV VACCINE USING PAPILLOMA VIRUS-LIKE PARTICLES AS A VECTOR
Department of Health and Human Services
$1.7M
NEW MECHANISMS OF SERCA2A REGULATION: ROLE OF LUMINAL CALCIUM - PROJECT SUMMARY/ABSTRACT SERCA2A CA PUMP PLAYS A CENTRAL ROLE IN HEART FUNCTION. THE SPEED AT WHICH SERCA2A REMOVES CA FROM THE CYTOSOL IS THE MAIN DETERMINANT OF THE RATE OF CARDIAC MUSCLE RELAXATION. SERCA2A ALSO SETS THE TOTAL AMOUNT OF CA IN THE SARCOPLASMIC RETICULUM (SR), WHICH DETERMINES THE STRENGTH OF CARDIAC CONTRACTION. IT IS NOT SURPRISING, THAT IMPAIRED SERCA2A FUNCTION HAS BEEN REPORTED IN A NUMBER OF PATHOLOGICAL CONDITIONS, INCLUDING HEART FAILURE (HF). THUS, UNDERSTANDING MECHANISMS OF SERCA REGULATION IS OF GREAT CLINICAL IMPORTANCE. BESIDES ACTIVATION OF MUSCLE CONTRACTION, SR LUMINAL CA ([CA]SR) PLAYS AN IMPORTANT ROLE IN REGULATION OF SR PROTEIN FUNCTION. WHILE SERCA2A ACTIVITY CONTROLS [CA]SR, LESS IS KNOWN ABOUT HOW CHANGES IN [CA]SR AFFECT SERCA2A CA TRANSPORT. OUR PRELIMINARY RESULTS SUGGEST THAT SR LUMINAL CA PLAYS AN IMPORTANT ROLE IN REGULATION OF SERCA2A. IN THIS PROJECT WE WILL USE ADVANCED STRUCTURAL ANALYSES, INNOVATIVE MOLECULAR BIOLOGICAL TECHNIQUES, NEW ORGANELLE-SPECIFIC SENSORS, STATE-OF-THE-ART OPTICAL METHODS AND IN VIVO GENE DELIVERY TO EXPLORE THIS NEW MECHANISM OF SERCA2A REGULATION. IN AIM 1, WE WILL TEST THE HYPOTHESIS THAT LUMINAL CA REGULATES SERCA2A BY INCREASING THE PUMP’S CATALYTIC EFFICACY AND BY RELIEVING THE PHOSPHOLAMBAN (PLB) INHIBITORY EFFECT. MOLECULAR DYNAMIC SIMULATIONS WILL BE USED TO SELECT SPECIFIC DOMAINS ON THE SERCA2A LUMINAL SIDE THAT ARE INVOLVED IN CA REGULATION. SITE-DIRECTED MUTAGENESIS WILL BE USED TO IDENTIFY THE SPECIFIC AMINO ACIDS THAT FORM THE LUMINAL CA-BINDING SITES AND TO DEVELOP THE LUMINAL CA-INSENSITIVE SERCA2A MUTANT. WE WILL ASSESS EFFECTS OF THE LUMINAL CA REGULATION ON CA TRANSPORT, THE ATPASE ACTIVITY AND THE PLB INTERACTION. THEN, MYOCYTES EXPRESSING THE LUMINAL CA-INSENSITIVE SERCA2A MUTANT WILL BE STUDIED TO DEFINE THE ROLE OF THIS NOVEL MECHANISM IN CARDIAC CA CYCLING. WE EXPECT THAT THE OUTCOME OF THIS WORK WILL GREATLY ADVANCE OUR UNDERSTANDING OF SERCA2A FUNCTION. WE EXPECT THAT THE OUTCOME OF THESE STUDIES WILL PROVIDE A DETAILED VIEW OF THIS NEW MECHANISM OF SERCA2A REGULATION, ADVANCING OUR UNDERSTANDING OF THE CA PUMP’S FUNCTION. IN AIM 2, WE WILL TEST THE HYPOTHESIS THAT LUMINAL REDOX POTENTIAL REGULATES SERCA2A BY STABILIZING ITS LUMINAL CA BINDING SITES, THUS, IMPROVING THE PUMP’S REGULATION BY [CA]SR. MOLECULAR DYNAMIC SIMULATIONS WILL BE USED TO FORECAST THE ROLE OF THE SERCA2A LUMINAL DISULFIDE BOND IN THE PUMP CATALYTIC CYCLE. WE WILL ASSESS WHETHER MUTATION OF LUMINAL CYSTEINES LEADS TO A LOSS-OF-FUNCTION PHENOTYPE BY ABOLISHING SERCA2A REGULATION BY LUMINAL CA. NEWLY DEVELOPED APPROACHES TO MEASURE LUMINAL REDOX POTENTIAL AND [CA]SR WILL BE USED TO DEFINE THE CROSS-TALK BETWEEN LUMINAL REDOX POTENTIAL AND SERCA2A ACTIVITY. WE WILL INVESTIGATE THE CONTRIBUTION OF THIS NEW MECHANISM TO SERCA2A DYSFUNCTION AND CA MISHANDLING IN HF. THE LIKELY OUTCOME OF THESE STUDIES IS A NEW CONCEPT THAT CAN EXPLAIN HOW ALTERATIONS IN SERCA2A STRUCTURE/FUNCTION CAUSE DEFECTS IN CA REGULATION IN HF.
Department of Health and Human Services
$1.7M
CAN THE SUNSHINE VITAMIN IMPROVE MOOD AND SELF-MANAGEMENT IN WOMEN WITH DIABETES
Department of Defense
$1.7M
USE OF NOVEL ANGIOPOIETIN-1 MIMETIC PEPTIDE FOR THE TREATMENT OF BURN SHOCK-ASSOCIATED ENDOTHELIAL DYSFUNCTION IN SEVERE BURN INJURY
Department of Health and Human Services
$1.7M
RIP1/RIP3-CALPAIN-STAT3 AND NF-KAPPA B PATHWAYS IN AML PATHOGENESIS AND TREATMENT
Department of Health and Human Services
$1.7M
BRAVE MINORITY YOUTH VIOLENCE PREVENTION PROGRAM
Department of Health and Human Services
$1.6M
MECHANISMS OF ENTEROPATHOGENIC E. COLI EFFECTS ON POLARITY AND TIGHT JUNCTIONS
Department of Health and Human Services
$1.6M
TARGETING HSP70 IN AUTOIMMUNE VITILIGO
Department of Health and Human Services
$1.6M
FEASIBILITY AND EFFECTIVENESS OF GAMIFIED DIGITAL INTERVENTION TO PREVENT ALCOHOL AND MENTAL HEALTH RISKS - PROJECT ABSTRACT SEXUAL MINORITY WOMEN CONSUME ALCOHOL, EXPERIENCE ALCOHOL-RELATED PROBLEMS, AND SUFFER FROM MENTAL HEALTH PROBLEMS AT HIGHER RATES THAN DO THEIR HETEROSEXUAL PEERS. ALTHOUGH SEVERAL CLINICAL PROGRAMS ARE BEING DEVELOPED FOR SEXUAL MINORITY WOMEN (SMW) SEEKING TREATMENT FOR THESE PROBLEMS, ONLY A SMALL PROPORTION OF SMW NEEDING IT EVER SEEK TREATMENT. MEANWHILE, PREVENTIVE INTERVENTIONS ABLE TO AVOID THESE PROBLEMS BY REDUCING DRINKING AND IMPROVING PSYCHOLOGICAL WELL-BEING AMONG NON-TREATMENT SEEKING SMW HAVE BEEN SLOW TO EMERGE. THE PROPOSED RESEARCH BUILDS ON R21AA025767, WHICH ESTABLISHED THE PRELIMINARY FEASIBILITY AND EFFECTIVENESS OF DELIVERING PERSONALIZED NORMATIVE FEEDBACK ON DRINKING AND COPING BEHAVIORS TO SMW WITHIN A BROADER APP-BASED SOCIAL COMPETITION DESIGNED TO CHALLENGE HARMFUL STEREOTYPES ABOUT THIS POPULATION AND FOSTER A SUPPORTIVE VIRTUAL COMMUNITY. IN OUR PILOT TRIAL, SEXUAL MINORITY WOMEN ENTHUSIASTICALLY ENGAGED WITH THE APP IN THE ABSENCE OF PARTICIPATION INCENTIVES FOR DOING SO. FURTHER, RELATIVE TO A SUB-SAMPLE THAT RECEIVED PNF ON CONTROL TOPICS WITHIN THE COMPETITION, THOSE WHO RECEIVED PNF ON DRINKING AND COPING SUBSTANTIALLY REDUCED THEIR CONSUMPTION AND NEGATIVE CONSEQUENCES OVER A 4-MONTH PERIOD. MOREOVER, QUALITATIVE FEEDBACK SUGGESTED THAT NEGATIVE STEREOTYPE DISCONFIRMING PNF AND SOCIAL MEDIA INSPIRED COMMUNITY FEATURES (PRESENT ACROSS CONDITIONS) MAY HAVE ALSO PROVIDED PSYCHOLOGICAL BENEFITS BEYOND THE ALCOHOL AND COPING PNF EVALUATED. TO BUILD ON THESE PROMISING FINDINGS AND REMEDY LIMITATIONS, THIS RESEARCH PROPOSES TO FIRST OPTIMIZE THE APP BASED ON FEEDBACK FROM PARTICIPANTS IN THE PILOT TRIAL (AIM1) AND THEN CONDUCT A LARGE, SOPHISTICATED, TYPE I IMPLEMENTATION-EFFECTIVENESS TRIAL TO SIMULTANEOUSLY EXAMINE THE EFFECTS OF THE FULLY FEATURED APP ON DRINKING, ALCOHOL-RELATED PROBLEMS, AND PSYCHOLOGICAL WELL-BEING RELATIVE TO A LIMITED FEATURE PSYCHOEDUCATIONAL CONTROL VERSION OF THE APP (AIM2), IDENTIFY EXPLANATORY PSYCHOLOGICAL MECHANISMS ASSOCIATED WITH THE FULLY FEATURED APP’S EFFECTIVENESS (AIM3), ELUCIDATE DEMOGRAPHIC AND SEXUAL MINORITY STIGMA-RELATED MODERATORS (AIM4), AND EXAMINE ENGAGEMENT, ACCEPTABILITY, AND SUSTAINABILITY OF USE UNDER REAL WORLD CONDITIONS AMONG A SUB-SAMPLE OF UNINCENTIVIZED, FULLY FEATURED APP USERS (AIM 5).
Department of Defense
$1.6M
A NEW PHARMACOLOGICAL TARGET TO REDUCE THE INCIDENCE OF ACUTE RESPIRATORY DISTRESS SYNDROME AFTER ACUTE LUNG INJURY IN TRAUMA PATIENTS
Department of Health and Human Services
$1.6M
MODULATING TOLERANCE IN A SPONTANEOUS MOUSE MODEL OF AUTOIMMUNE VITILIGO
Department of Health and Human Services
$1.6M
THE ROLE OF SPARTIN IN AUTOPHAGY OF LIPID DROPLETS: IMPLICATIONS FOR SPG20 DISEAS
Department of Health and Human Services
$1.6M
LOYOLA-UKRAINIAN CATHOLIC UNIVERSITY INTERNATIONAL BIOETHICS RESEARCH TRAINING PROGRAM
Department of Health and Human Services
$1.6M
TCR AFFINITY AND THERAPEUTIC EFFICACY OF T CELLS
Department of Health and Human Services
$1.6M
DEFINING THE MICROTUBULE MOTORS WHICH DRIVE THE UNCOATING AND TRAFFICKING OF HIV
Department of Health and Human Services
$1.6M
RESCUING ANTI-TUMOR RESPONSES OF TCR-TD T CELLS BY NKG2D-STIMULATION
Department of State
$1.6M
STRENGTHENING THE CAPACITY OF THE AFRICAN UNION TO PROMOTE GOVERNANCE AND THE RULE OF LAW IN ITS STATES
Department of Health and Human Services
$1.5M
PROBING MACROPHAGE CELL NUCLEOTIDE SENSING AND CALCIUM SIGNALING THROUGH COMPUTATION - WHILE INAMMATION IS A NATURAL IMMUNE SYSTEM RESPONSE THAT BEGINS THE HEALING PROCESS, CHRONIC INAM- MATION IS TIED TO MANY HUMAN DISEASES INCLUDING CANCER, CARDIAC DYSFUNCTION, AND SEPSIS. A KEY ELEMENT OF INAMMATORY RESPONSES ARE MACROPHAGES, A WHITE BLOOD CELL THAT ELIMINATES PATHOGENS OR DYING TISSUES. AN ENDOGENOUS 'DANGER SIGNAL', ADENOSINE TRIPHOSPHATE (ATP), STIMULATES CA-DEPENDENT INAMMATORY PATHWAYS IN MACROPHAGES. WHILE PREVIOUS RESEARCH HAS MADE GREAT STRIDES IN UNDERSTANDING INAMMATION, MY LAB SEEKS TO UNCOVER ROLES OF ATP IN DRIVING MACROPHAGE INAMMATORY RESPONSES THROUGH MULTI-SCALE COMPUTATIONAL MODELS WE DEVELOP. WITH NEW MODELS OF INAMMATORY RESPONSES IN MACROPHAGES, OUR LAB CAN PREDICT PROTEIN AND CELL BEHAVIOR IN INTEGRATED, PHYSIOLOGICAL SYSTEMS TO BETTER UNDERSTAND THE IMMUNE SYSTEM. THE CURRENT PARADIGM FOR ATP-TRIGGERED INAMMATION IN MACROPHAGES IS THAT UPREGULATION OF NUCLEOTIDE- SENSING P2X CHANNELS SENSITIZES INAMMATORY RESPONSES, INCLUDING CYTOKINE AND REACTIVE OXYGEN SPECIES (ROS) RELEASE. HOWEVER, THIS PARADIGM DOES NOT ACCOUNT FOR SEVERAL OBSERVATIONS. ONE, WHILE P2X EXPRESSION IS INCREASED IN INAMMATORY MACROPHAGES, THESE RECEPTORS ALSO SUPPORT PHAGOCYTOSIS AND MIGRATION IN RESTING MACROPHAGES. HOW THESE PROCESSES ARE SELECTIVELY CONTROLLED BY P2X SUBTYPES LIKE P2X4 AND P2X7 IS UNRESOLVED. TWO, INAMMATORY MACROPHAGES HARBOR POST-TRANSLATIONAL MODICATIONS (PTMS) OF MANY PROTEINS THAT SENSE CA, YET LITTLE IS KNOWN ABOUT HOW PTMS IMPACT IMMUNE PATHWAYS THEY CONTROL. THREE, RELEASE AND DEGRADATION OF ATP BY PANNEXINS AND ECTONUCLEOTIDASES CONTROL ATP THAT ACTIVATES P2X, YET FEW STUDIES HAVE EVALUATED THEIR COUPLING. OUR LAB IS UNIQUELY POSITIONED TO EXTEND THIS PARADIGM BY PROBING MECHANISMS UNDERLYING THESE OBSERVATIONS AND THE LARGELY UNSTUDIED COUPLING OF P2X-, ATP-, AND CA-DRIVEN INAMMATION. OUR LAB AND ASSEMBLED COLLAB- ORATORS WILL INVESTIGATE THE OVERALL HYPOTHESIS VIA COMPUTATIONAL MODELING AND EXPERIMENTAL APPROACHES: P2X CHANNELS IN MACROPHAGES HELP NUCLEATE CHRONIC INAMMATION VIA ATP-INDUCED ATP RELEASE (AUTOCRINIC) MECHANISMS THAT SELECTIVELY PRIME CA-DEPENDENT, PRO-INAMMATORY SIGNALING PATHWAYS. THIS HYPOTHESIS STEMS FROM QUESTIONS THAT EMERGED FROM OUR INVESTIGATIONS DURING THE INITIAL ESI MIRA AWARD: 1. DOES INCREASED P2X4 AND P2X7 EXPRESSION AND THE RESULTING CA SIGNALS THEY INDUCE IN MACROPHAGES PROLONG PRO-INAMMATORY RELEASE OF CYTOKINES AND ROS? 2. DO PTMS LIKE ROS OXIDATION IN THE CA-SENSOR CALMODULIN (CAM) ATTENUATE ITS ACTIVATION OF PRO-INAMMATORY SIGNALING PATHWAYS? 3. DO (AUTOCRINIC) ATP-INDUCED, ATP RELEASE IN MACROPHAGES PROLONG PRO-INAMMATORY INCREASES IN INTRACELLULAR CA? OUR LONG-TERM GOAL TO UNDERSTAND MACROPHAGE PHYSIOLOGY THROUGH COMPUTATION WILL BE ACCELERATED BY THE PROPOSED INVESTIGATIONS. KEY EXPECTED OUTCOMES FROM THIS GRANT PERIOD INCLUDE NEW MECHANISMS AND SIMULATION TOOLS FOR AUTOCRINIC, ATP-DRIVEN INAMMATORY RESPONSES MEDIATED BY P2X RECEPTORS. SINCE ALL EUKARYOTIC CELLS USE CA, INSIGHTS FROM MODELING MACROPHAGES WILL HAVE BROAD IMPACTS BEYOND IMMUNE FUNCTION.
Department of Health and Human Services
$1.5M
ADVANCED NURSING EDUCATION WORKFORCE
Department of Health and Human Services
$1.5M
NURSE EDUCATION, PRACTICE, QUALITY, AND RETENTION - INTERPROFESSIONAL COLLBORATIVE PRACTICE
Department of Education
$1.5M
OER FOR SOCIAL JUSTICE AT FOUR CALIFORNIA CATHOLIC COLLEGES & UNIVERSITIES
Department of Health and Human Services
$1.5M
EXTRATUMORAL BIOLOGICAL DETERMINANTS THAT DECREASE SURVIVAL IN OLDER ADULTS WITH GLIOBLASTOMA - PROJECT SUMMARY WILD-TYPE ISOCITRATE DEHYDROGENASE 1/2 GLIOBLASTOMA (GBM) IS THE MOST COMMON AND AGGRESSIVE FORM OF MALIGNANT PRIMARY BRAIN TUMOR IN ADULTS WITH A MEDIAN AGE OF ONSET AT 68-70 YEARS OLD. IDHWT GBM PATIENTS REPRESENT >70% OF ALL GBM PATIENT DIAGNOSES, AND AMONG THOSE INDIVIDUALS, OLDER ADULTS =65 YEARS OF AGE HAVE A SIGNIFICANTLY DECREASED MEDIAN OVERALL SURVIVAL (MOS) AS COMPARED TO YOUNGER IDHWT GBM PATIENTS AFTER TREATMENT WITH STANDARD OF CARE RADIATION (RT) AND TEMOZOLOMIDE. WE HAVE ALSO STUDIED OUR ONGOING CLINICAL TRIAL NCT04047706 AND DETERMINED THAT NEWLY-DIAGNOSED OLDER ADULT IDHWT MGMT PROMOTER UNMETHYLATED GBM PATIENTS WHO ARE TREATED WITH RT, NIVOLUMAB (PD-1 MAB), AND BMS-986205 [IDO ENZYME INHIBITOR (IDOI)] HAVE A DECREASED MOS AS COMPARED TO SIMILARLY-TREATED YOUNGER GBM PATIENTS (P<0.0007). STRIKINGLY, >33% OF THE YOUNGEST PATIENTS IN THIS TRIAL ARE STILL ALIVE AT 36 MONTHS POST-TREATMENT INITIATION. THE POOR PROGNOSIS OF OLDER ADULT GBM PATIENTS STARKLY CONTRASTS WITH INDIVIDUALS WHO UNDERGO TREATMENT FOR OTHER FORMS OF AGGRESSIVE CANCER THAT ARISES OUTSIDE OF THE BRAIN. FOR EXAMPLE, FORMER PRESIDENT JIMMY CARTER WAS DIAGNOSED WITH METASTATIC MELANOMA AT 91 YEARS OF AGE AND SUBSEQUENTLY TREATED WITH IMMUNOTHERAPY. STRIKINGLY, PRESIDENT CARTER IS STILL ALIVE TODAY AT 98 YEARS OLD. WE HYPOTHESIZE THAT MAJOR CONTRIBUTING FACTORS TO THE WORSE SURVIVAL OUTCOMES OF OLDER ADULT GBM PATIENTS DEPEND ON: (I) HOW INTRATUMORAL GENE EXPRESSION LEVELS DO NOT CHANGE WITH DIFFERENCES IN GBM PATIENT AGE [SHAH ET AL., 2021, CELL REPORTS. 37(10):110100], BUT RATHER, (II) HOW EXTRATUMORAL LEVELS OF IMMUNOSUPPRESSION INCREASE IN THE OLDER ADULT BRAIN AND POTENTLY SUPPRESS THERAPEUTIC EFFICACY IN OLDER ADULTS WITH GBM [LADOMERSKY…WAINWRIGHT, 2020, CLINICAL CANCER RESEARCH. 26(19):5232-5245], AND (III) HOW EXTRATUMORAL LEVELS OF SENESCENCE INCREASE IN THE OLDER ADULT BRAIN [KIM…WAINWRIGHT, 2021, NEURO-ONCOLOGY ADVANCES. 3(1):VDAB125]. TO UNDERSTAND THE EFFECTS OF ADVANCED AGE-MEDIATED CHANGES IN THE EXTRATUMORAL OLDER ADULT BRAIN, THAT IN-TURN, PROMOTES THE MALADAPTIVE RESPONSE TO GBM AND/OR GBM TREATMENTS, WE WILL: (I) STUDY EXTRATUMORAL IDO-MEDIATED IMMUNOSUPPRESSION OF THERAPEUTIC EFFICACY IN OLDER ADULT MICE WITH GBM; (II) CHARACTERIZE EXTRATUMORAL SENESCENCE LEVELS AND THEIR EFFECTS ON SURVIVAL OUTCOMES OF OLDER ADULT MICE WITH GBM; (III) QUANTIFY AGING PARAMETERS IN THE EXTRATUMORAL HUMAN BRAIN FROM INDIVIDUALS ACROSS THE LIFESPAN THAT DID OR DID NOT HAVE GBM. THIS RESEARCH IS HIGHLY INNOVATIVE AND SIGNIFICANT FOR ITS GOAL TO UNDERSTAND AGING- DEPENDENT MECHANISMS THAT CONTRIBUTE TO WORSE SURVIVAL OUTCOMES IN OLDER ADULTS WITH IDHWT GBM.
Department of Health and Human Services
$1.5M
RATIONAL DESIGN OF A UNIQUE VACCINE FOR EMERGING PANDEMIC CORONAVIRUSES - ABSTRACT SARS-COV-2 HAS CAUSED THE GLOBAL COVID-19 PANDEMIC. VACCINES AGAINST SARS-COV-2, MOSTLY USING SPIKE (S) PROTEIN AS A TARGET ANTIGEN TO INDUCE NEUTRALIZING ANTIBODIES, HAVE BEEN DEVELOPED AT UNPRECEDENTED SPEED AND SEVERAL HAVE BEEN APPROVED FOR USE IN HUMAN. THE CURRENTLY DEVELOPED VACCINES INDUCE NEUTRALIZING ANTIBODIES AND PROVIDE PROTECTION AGAINST SARS-COV-2 ORIGINAL STRAIN OR EARLIER VARIANTS, BUT THEY HAVE REDUCED NEUTRALIZING ACTIVITY OR PROTECTION AGAINST RECENT VARIANTS. BASED ON THE FACT THAT THREE PANDEMIC CORONAVIRUSES (COVS) HAVE EMERGED WITHIN 20 YEARS, SOME UNKNOWN COVS WITH PANDEMIC POTENTIAL ARE EXPECTED TO EMERGE IN THE FORESEEABLE FUTURE. THEREFORE, A VACCINE IS URGENTLY NEEDED TO PREVENT A FUTURE EMERGING COV. THREE COV OUTBREAKS CAUSED BY THE THREE HIGHLY PATHOGENIC COVS (SARS-COV, SARS-COV-2 AND MERS-COV) ARE ALL FROM BETA-COVS, IN PARTICULAR, FROM SARBECOVIRUS AND MERBECOVIRUS LINEAGES, WE THUS REASON THAT FUTURE EMERGING COVS CAUSING PANDEMICS MAY MOST LIKELY COME FROM THESE TWO LINEAGES AND THAT BOTH LINEAGES SHOULD BE TARGETED TO DEVELOP A VACCINE TO PREVENT AGAINST THE FUTURE EMERGING VIRUS. HOWEVER, WE CANNOT PREDICT THE SEQUENCES OF S PROTEIN OF FUTURE EMERGING COV TO MAKE A VACCINE TARGETING S TO INDUCE NEUTRALIZING ANTIBODIES. OUR PRIOR DATA SHOWED THAT A S PROTEIN-BASED VACCINE BY USING UBIQUITINATION AND GENE REARRANGEMENT STRATEGY TO ENHANCE ITS DEGRADATION IN PROTEASOME INDUCED STRONG T CELL RESPONSES, IN PARTICULAR CTLS. THIS VACCINE SIGNIFICANTLY PROTECTED MICE AGAINST SARS-COV-2-INDUCED SURVIVAL AND WEIGHT LOSS, AND THE PROTECTION REQUIRED CD4+ AND CD8+ T CELLS. THUS, WE WILL DESIGN COV VACCINES THAT TARGET THE PROTEINS WITH GREAT HOMOLOGY (I.E., S2, M, AND N) FROM SARBECOVIRUSES AND MERBECOVIRUSES TO INDUCE PROTECTIVE T CELLS. FURTHERMORE, UPPER RESPIRATORY TRACT TISSUE-RESIDENT MEMORY T CELLS (TRM) PLAY ESSENTIAL ROLES IN PROVIDING IMMEDIATE PROTECTION, AND MUCOSAL IMMUNIZATION IS THE ONLY WAY TO INDUCE UPPER RESPIRATORY TRACT TRM. BECAUSE PAPILLOMAVIRUS-LIKE PARTICLES (PV- VLPS) INDUCE MUCOSAL IMMUNE RESPONSES, WHICH SERVE AS A MUCOSAL DELIVERY VECTOR AND ADJUVANT, WE HYPOTHESIZE THAT PV-VLPS CAN DELIVER COV HOMOLOGOUS ANTIGENS TO NASAL-ASSOCIATED LYMPHOID TISSUE, AND INDUCE RESPIRATORY TRACT TRM FOR EFFECTIVE PROTECTION AGAINST SARBECOVIRUS AND MERBECOVIRUS-CAUSED RESPIRATORY SYNDROME AND PNEUMONIA. USING SARBECOVIRUSES AND MERBECOVIRUSES AS MODEL VIRUSES, THIS PROPOSAL WILL 1) DEVELOP A PV-VLP-BASED, T CELL-INDUCING MUCOSAL COV VACCINE TARGETING CONSERVED COV ANTIGENS (S2, M AND N) AND USING GENE REARRANGEMENT AND UBIQUITINATION STRATEGIES, 2) DETERMINE IF THE VACCINE INDUCES MUCOSAL AND SYSTEMIC IMMUNE RESPONSES TO SARBECOVIRUSES AND MERBECOVIRUSES, IN PARTICULAR, LONG-TERM UPPER RESPIRATORY TRACT TRM, AND 3) EVALUATE VACCINE'S CROSS-PROTECTIVE EFFICACY AGAINST INFECTIONS OF SARBECOVIRUSES AND MERBECOVIRUSES IN MOUSE MODELS. WE HAVE SOLID PRELIMINARY DATA, WELL-ESTABLISHED ANIMAL MODELS AND VACCINE PLATFORMS, AND A STRONG RESEARCH TEAM WITH DECADES OF EXTENSIVE EXPERIENCE IN DEVELOPING SAFE AND EFFECTIVE COV VACCINES, PROVIDING FEASIBILITY AND BASIS FOR THE PROPOSED STUDIES.
Department of Education
$1.5M
ACCELERATING TRANSFER AND LOW-INCOME ACCESS AND SUCCESS (ATLAS) PROGRAM
Department of Health and Human Services
$1.5M
CALCIUM RELEASE CHANNEL DYSFUNCTION: MOLECULAR MECHANISMS
Department of Health and Human Services
$1.5M
REGULATION OF NOTCH SIGNALING BY ERBB-2: NOVEL THERAPEUTIC STRATEGY
Department of Health and Human Services
$1.5M
NURSE EDUCATION, PRACTICE, QUALITY, AND RETENTION - INTERPROFESSIONAL COLLBORATIVE PRACTICE
Department of Health and Human Services
$1.5M
NOTCH-1 AND IGF-1 CROSSTALK: NEW THERAPEUTIC STRATEGIES FOR NSCLC
Agency for International Development
$1.5M
AWARDING LOYOLA UNIVERSITY CHICAGO A TWO YEAR COOPERATIVE AGREEMENT FOR $1,500,000 IN SUPPORT OF THEIR PROGRAM ENTITLED, "YES WE CAN!: PARTNERING WIT
Department of Health and Human Services
$1.5M
SYSTEMATIC IDENTIFICATION OF HEMATOPOIETIC STEM CELL EXPANSION FACTORS
Department of Health and Human Services
$1.5M
JNK SUPPRESSION OF CONNEXIN43 ENHANCES ATRIAL FIBRILLATION IN AGED ATRIA
Department of Health and Human Services
$1.5M
STRUCTURE CHANGES OF ION-MOTIVE ATPASES
Department of Health and Human Services
$1.5M
THE MODERATION EFFECT OF SOCIAL SUPPORT NETWORKS ON THE RELATIONSHIP BETWEEN OPIOID USE AND SUICIDE ATTEMPTS AMONG NATIVE AMERICAN YOUTH IN NEW MEXICO
Department of Education
$1.5M
LMU UPWARD BOUND CLASSIC
Department of Health and Human Services
$1.5M
CHEMOKINE-MEDIATED MODULATON OF OPIOID-INDUCED PAIN
Department of Health and Human Services
$1.5M
MECHANISMS OF FORK RESTART IN RESPONSE TO GENOTOXIC STRESS
Department of Defense
$1.4M
EFFECTS OF INFECTION ON BURN-INDUCES HYPERMETABOLISM AND ORGAN DYSFUNCTION
Department of Health and Human Services
$1.4M
NURSE EDUCATION PRACTICE AND RETENTION
Department of Health and Human Services
$1.4M
BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING FOR PROFESSIONALS AND PARAPROFESSIONALS
Department of Health and Human Services
$1.4M
STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS THAT IMPROVE Y537S ESTROGEN RECEPTOR ANTAGONISM - SUMMARY THIS PROPOSAL STUDIES HOW DRUG-INDUCED STRUCTURAL CHANGES TO Y537S ESTROGEN RECEPTOR ALPHA (ERA) IMPACT ANTI- TUMORAL ACTIVITIES IN HORMONE-RESISTANT BREAST CANCER CELLS. BREAST CANCER IS THE SECOND LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES. ACQUIRED RESISTANCE TO HORMONE THERAPIES IS A LEADING CONTRIBUTOR TO MORTALITY. IN APPROXIMATELY 40% OF PROGRESSIVE ER+ PATIENTS, PROLONGED SELECTIVE PRESSURE BY ANTIESTROGENIC THERAPIES GIVES RAISE TO TUMORS BEARING ACTIVATING SOMATIC ESR1 (THE GENE FOR ERA) MUTATIONS. THESE MUTATIONS RESIST INHIBITION BY CLINICALLY APPROVED HORMONE THERAPIES AND ENGAGE NEW TRANSCRIPTIONAL PROGRAMS THAT BOOST METASTATIC POTENTIAL. Y537S MISSENSE MUTATION IS AMONG THE MOST COMMON AND ENABLES THE GREATEST HORMONE-FREE TRANSCRIPTIONAL ACTIVITIES AND RESISTANCE TO ANTIESTROGEN. NEXT GENERATION SELECTIVE ESTROGEN RECEPTOR DEGRADERS (SERDS) HAVE BEEN CLINICALLY DEPLOYED TO ADDRESS THIS MECHANISM OF DRUG RESISTANCE. HOWEVER, THEY SHOW VARIABLE ACTIVITIES IN Y537S ESR1 BREAST CANCERS AND POSSESS COMMON SIDE-EFFECTS THAT WILL LIMIT THEIR LONG-TERM USE. WE RECENTLY STUDIED HOW A PANEL OF 17 SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS) AND SERDS BIND TO AND AFFECT Y537S ERA ACTIVITIES IN BREAST CANCER CELLS. WE IDENTIFIED STRUCTURALLY DISTINCT SERMS AND SERDS WITH IMPROVED ACTIVITIES IN THIS SETTING. WHILE STRUCTURALLY DISTINCT, OUR X-RAY CO-CRYSTAL STRUCTURES SHOWED THAT THE MOST EFFECTIVE MOLECULES ENGAGED THE SAME S537-E380 HYDROGEN BOND TO REINFORCE THE THERAPEUTIC ANTAGONIST CONFORMATION. THEREFORE, WE HYPOTHESIZE THAT NOVEL LIGAND-DEPENDENT STRUCTURAL INTERACTIONS WILL IMPROVE THERAPEUTIC ANTAGONISTIC ACTIVITIES IN THE Y537S ESR1 SETTING. IN THIS STUDY, WE WILL LEVERAGE OUR LIBRARY OF OVER 100 DIVERSE SERMS AND SERDS TO REVEAL THE STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS THAT UNDERLIE IMPROVED ANTI- CANCER ACTIVITIES Y537S ESR1 BREAST CANCER CELLS. WE WILL START BY STUDYING HOW OUR LIBRARY BINDS TO AND AFFECTS Y537S ERA STRUCTURE AND ANTI-CANCER ACTIVITIES (AIM 1). THIS APPROACH WILL REVEAL THE LIGAND BINDING MODES AND STRUCTURAL INTERACTIONS THAT ENABLE POTENCY. NEXT, WE WILL STUDY HOW THE MOST EFFECTIVE MOLECULES IMPACT Y537S ERA GENOMIC ACTIVITIES INCLUDING PROTEIN-PROTEIN INTERACTIONS, GENOME BINDING, AND TRANSCRIPTIONAL PROGRAMING (AIM 2). THIS APPROACH WILL SHOW WHETHER THE EFFICACIES OF SERMS AND SERDS ARISE FROM ALTERATIONS TO Y537S ERA GENOMIC ACTIVITIES. FINALLY, WE WILL REVEAL THE ANTI-TUMOR AND TISSUE-SPECIFIC ACTIVITIES OF THE MOST EFFECTIVE SERMS AND SERDS IN HORMONE-RESISTANT ER+ BREAST CANCER IN VIVO (AIM 3). THIS APPROACH WILL REVEAL WHETHER OUR IN VITRO OBSERVATIONS CORRESPOND TO IMPROVED ANTI-CANCER ACTIVITIES IN PATIENT-RELEVANT TUMOR MODELS. OVERALL, THESE STUDIES WILL PROVIDE DETAILED STRUCTURAL-TRANSCRIPTIONAL RELATIONSHIPS TO IMPROVE THERAPEUTIC TARGETING OF Y537S ERA IN HORMONE-RESISTANT BREAST CANCER.
Department of Education
$1.4M
LMU UPWARD BOUND MATH SCIENCE
Department of Health and Human Services
$1.4M
TRAUMA CENTER BRIEF ALCOHOL TREATMENTS AND COST EFFECTIVENES
Department of Defense
$1.4M
"BURN TRAUMA AND INFECTION"
Department of Health and Human Services
$1.4M
EVALUATION OF GOAL-DIRECTED PSYCHOLOGICAL CAPITAL AND EMPLOYER COACHING IN HEALTH PROFESSION OPPORTUNITY DEVELOPMENT
Department of Health and Human Services
$1.3M
EVALUATION OF EMPOWERMENT PATHWAYS TO SELF-SUFFICIENCY IN HEALTH PROFESSIONS OPPORTUNITY WORKFORCE DEVELOPMENT FOR LOW-I
Department of Health and Human Services
$1.3M
CENTER FOR UNDERREPRESENTED RESEARCH IN ADDICTION (CURA)
Department of Health and Human Services
$1.3M
SEX DIFFERENCES IN COGNITIVE DYSFUNCTION: MITIGATION BY RNA EDITING - SUMMARY: PRENATAL STRESS (PRS) DISRUPTS BRAIN DEVELOPMENT 1-3 RESULTING IN HIGHER RISK OF DEPRESSION AND ANXIETY5, 6 IN FEMALE OFFSPRING AND A HIGHER RISK OF COGNITIVE DISORDERS SUCH AS AUTISM AND SCHIZOPHRENIA IN MALES7. DATA FROM OUR LABORATORY REVEAL SEX DIFFERENCES IN IMPORTANT MOLECULAR PATHWAYS IN THE CORTICOLIMBIC CIRCUIT IN PSYCHIATRIC DISORDERS, PARTICULARLY IN THE GLUTAMATERGIC SYSTEM12-16. GLUTAMATERGIC TRANSMISSION WITHIN THE HIPPOCAMPUS AND AMYGDALA PLAYS AN IMPORTANT ROLE IN COGNITION, AND RESILIENCE TO STRESS19-24. SIMILAR TO HUMANS, RODENTS SHOW SEX-SPECIFIC REDUCTIONS IN SPATIAL LEARNING AND INCREASED ANXIETY-LIKE BEHAVIORS AFTER EXPOSURE TO PRS 2, 32, 33. WE PROPOSE THAT THE PATHOLOGY OF PRS MAY INCLUDE AN EPITRANSCRIPTOMIC PROCESS KNOWN AS `RNA EDITING'35. PRELIMINARY DATA FROM OUR LABORATORY DEMONSTRATE DISRUPTIONS IN THE PATTERNS OF HIGHLY VARIABLE RNA EDITING IN GLUA SUBUNITS OF THE AMPA-TYPE GLUTAMATE RECEPTOR (AMPAR) IN THE HIPPOCAMPUS OF MICE EXPOSED TO PRS, WITH ASSOCIATED DEFICITS OF SOCIAL COGNITION. SIMILAR PATTERNS OF RNA EDITING OCCUR IN THE HIPPOCAMPUS OF PATIENTS WITH IMPAIRED COGNITION38-40. THE GOAL OF THE PROPOSED RESEARCH IS TO DETERMINE IF GLUA2 EDITING MEDIATES THE LONG-TERM IMPACT OF PRS. OUR CENTRAL HYPOTHESIS IS THAT PRS TRIGGERS REDUCED GLUA2 EDITING, LEADING TO LONG- TERM DETRIMENTAL FUNCTION OF THE HIPPOCAMPUS AND AMYGDALA. TO TEST A CAUSAL EFFECT OF GLUA2 EDITING WE HAVE DEVELOPED TWO NOVEL GLUA2 KNOCKIN MICE: GLUA-A MICE THAT MIMIC 0% IMMUTABLE RNA EDITING AND GLUA-G MICE THAT MIMIC 100% IMMUTABLE RNA EDITING. PRELIMINARY DATA SHOW THAT GLUA-G MUTANT MICE HAVE IMPROVED SPATIAL LEARNING. MALE BUT NOT FEMALE GLUA-G MICE HAVE RELATIVE RESILIENCE TO SOCIAL ISOLATION STRESS AND THERE ARE SEX DIFFERENCES IN RESILIENCE TO THE EFFECTS OF PRS. TO ELUCIDATE THE MECHANISMS THAT UNDERLIE THESE EVIDENTIAL CONNECTIONS BETWEEN SEX, RNA EDITING, STRESS, AND BEHAVIOR, WE PROPOSE THE FOLLOWING AIMS: 1: SEX DIFFERENCES IN THE MITIGATION OF STRESS-INDUCED COGNITIVE DEFICITS BY GLUA2 RNA EDITING, AND 2: SEX DIFFERENCES IN THE ENHANCEMENT OF RESILIENCE TO ADULT STRESS BY GLUA2 RNA EDITING. WE WILL EXPOSE GLUA-G, GLUA-A AND WT MICE TO PRS AND TEST FOR DIFFERENCES BETWEEN GENOTYPE, STRESS EXPOSURE AND SEX IN THE FOLLOWING MEASURES: (I) SYNAPTIC PLASTICITY AND MORPHOLOGY IN THE DG, CA1, CA2 AND CA3 REGIONS OF THE VENTRAL AND DORSAL HIPPOCAMPUS AND BASOLATERAL AMYGDALA. (II) AMPAR TRAFFICKING IN THESE REGIONS USING IMMUNOHISTOCHEMISTRY. (III) GENE EXPRESSION IN THESE REGIONS USING MMRNASEQ AND WESTERN BLOTTING. (IV) MEASUREMENT OF SEX AND STEROID HORMONES, (V) SOCIAL BEHAVIOR, AND COGNITIVE BEHAVIOR. THIS RESEARCH WILL INCREASE OUR UNDERSTANDING OF THE MOLECULAR AND CELLULAR MECHANISMS TRIGGERED BY STRESS THAT DIFFERENTIALLY DAMAGE THE GLUTAMATERGIC CIRCUITRY OF THE HIPPOCAMPUS AND AMYGDALA IN MALES AND FEMALES. WE WILL ALSO ASCERTAIN WHETHER RNA EDITING CAN MITIGATE STRESS-INDUCED DEFICITS. THIS RESEARCH HAS THE POTENTIAL TO IDENTIFY NOVEL TARGETS FOR PSYCHOTROPIC DRUG DEVELOPMENT AND IDENTIFY AN EXCITING NEW GENETIC MECHANISM FOR THE SAFE MANIPULATION OF SYNAPTIC PLASTICITY TO ENHANCE COGNITION AND STRESS RESILIENCE.
Department of Health and Human Services
$1.3M
MLL IN MAINTENANCE AND REGULATION OF HOX GENE EXPRESSION
Department of Health and Human Services
$1.3M
STRUCTURAL AND FUNCTIONAL BASIS OF MYOCARDIAL DYSREGULATION IN GENETIC CARDIOMYOPATHY - OVER THE PAST SEVERAL DECADES, AND ACCELERATING IN RECENT YEARS, THE SARCOMERE HAS BEEN APPRECIATED AS BOTH THE HOTSPOT FOR CARDIOMYOPATHY-CAUSING VARIANTS AND AS A PROMISING DRUG TARGET. THESE VARIANTS CAN ALTER THE STRUCTURE AND REGULATION OF THE SARCOMERE, LEADING TO ALTERED FUNCTION. THE FIELD HAS MADE SIGNIFICANT PROGRESS IN UNDERSTANDING THESE EFFECTS USING VARIOUS MODELS AND WHILE EACH OF THESE HAVE STRENGTHS, THEY ALL HAVE CAVEATS THAT LIMIT THEIR UTILITY IN UNDERSTANDING THE IN VIVO IMPACT OF CARDIOMYOPATHY-INDUCING VARIANTS. THE PORCINE HEART, THE MOST ACCURATE ANIMAL MODEL OF HUMAN HEARTS, HAS SIMILAR ISOFORM COMPOSITION, STRUCTURE, HEART RATE, AND RESPONSE TO PHYSIOLOGICAL STIMULI, ALLOWING STUDIES ON LIVE MUSCLE THAT ARE NOT FEASIBLE WITH BIOBANKED HUMAN SAMPLES. OUR RESEARCH TEAM IS UNIQUELY SUITED FOR THE SOPHISTICATED EXPERIMENTS NECESSARY TO PERFORM THESE STUDIES. TO INTERROGATE THE STRUCTURAL IMPACT OF THESE VARIANTS, WE WILL USE SYNCHROTRON X-RAY DIFFRACTION, THE ONLY TECHNIQUE CAPABLE OF OBTAINING MOLECULAR LEVEL SARCOMERE STRUCTURAL DATA FROM LIVE CARDIAC MUSCLE. SARCOMERE FUNCTION WILL BE ASSESSED BOTH AT ARGONNE AND AT NEARBY LOYOLA UNIVERSITY CHICAGO ON CUSTOM BIOPHYSICAL SETUPS. LASTLY, SARCOMERE STRUCTURE AND FUNCTION ARE REGULATED BY PROTEIN POST-TRANSLATIONAL MODIFICATIONS (PTMS) AND ISOFORM SWITCHING, WHICH WILL BE ASSESSED USING OUR TOP-OF-THE-LINE MASS SPECTROMETRY INSTRUMENTATION. WE WILL INVESTIGATE THE STRUCTURAL BASIS OF MYOFILAMENT FUNCTIONAL DYSREGULATION IN HEALTHY, HYPERTROPHIC (HCM: MYH7R403Q, MYBPC330X), DILATED (DCM: TTN16648X, RBM20R636S) CARDIOMYOPATHY TRANSGENIC PIGS ACROSS THE FOLLOWING THREE AIMS. THESE STUDIES WILL REVEAL THE UNDERLYING STRUCTURAL BASIS FOR CARDIOMYOPATHIES RESULTING FROM SARCOMERE PROTEIN VARIANTS, REVEALING TRANSLATIONAL MECHANISTIC UNDERSTANDING NECESSARY TO TREAT THESE DISEASES. IN AIM 1 WE WILL DETERMINE THE IMPACT OF HCM AND DCM MUTATIONS ON NORMAL SARCOMERE STRUCTURE. WE WILL COLLECT X-RAY DIFFRACTION PATTERNS AND FUNCTIONAL DATA FROM LIVE PORCINE CARDIAC MUSCLE TO INVESTIGATE THE STRUCTURAL BASIS OF PROTEIN VARIANTS LEADING TO HCM AND DCM. IN AIM 2 WE WILL DETERMINE THE IMPACT OF PHYSIOLOGICAL INOTROPIC INTERVENTIONS IN HCM AND DCM. A MAJOR PATHOLOGICAL MECHANISM OF THESE DISEASE-CAUSING VARIANTS IS THAT THEY MODIFY THE SARCOMERE’S ABILITY TO RESPOND APPROPRIATELY TO NORMAL PHYSIOLOGICAL CONDITIONS. HERE WE WILL ASSESS THE RESPONSE TO CONDITIONS WHICH TYPICALLY ELICIT AN IONOTROPIC RESPONSE. IN AIM 3 WE WILL DETERMINE HOW HCM AND DCM MUTATIONS AFFECT SARCOMERE FUNCTION REGULATION BY POST-TRANSLATIONAL MODIFICATIONS.
Department of Education
$1.3M
THE IGNACIO PROGRAM
Department of Health and Human Services
$1.3M
THE ROLE OF THE THROMBOSPONDINS IN INTIMAL HYPERPLASIA
Department of Health and Human Services
$1.3M
OPIOID WORKFORCE EXPANSION PROGRAM- PROFESSIONAL
Department of Health and Human Services
$1.3M
PREDICTING GENE REGULATION ACROSS POPULATIONS TO UNDERSTAND MECHANISMS UNDERLYING COMPLEX TRAITS
Department of Health and Human Services
$1.3M
NURSE FACULTY LOAN PROGRAM
Department of Education
$1.3M
PRACTICING DEMOCRACY IN COMMUNITIES: DEVELOPING A COMMUNITY-WIDE CIVIC LEARNING SYSTEM; PROVIDING INSTRUCTIONAL SUPPORTS TO SCHOOLS; GENERATING INNOVATIVE CIVIC LEARNING OPPORTUNITIES FOR STUDENTS.
Department of Health and Human Services
$1.3M
EMSC PARTNERSHIP GRANTS
Department of Health and Human Services
$1.3M
LEVERAGING CDC OPIOID OVERDOSE SURVEILLANCE FUNDING FROM THE ALBUQUERQUE AREA SOUTHWEST TRIBAL EPIDEMIOLOGY CENTER TO CREATE TRIBAL DATA AND CULTURALLY CENTER MEDICATIONS FOR OPIOID USE DISORDER - PROJECT SUMMARY/ABSTRACT FATAL OPIOID OVERDOSE RATES ARE HIGHER AMONG AMERICAN INDIAN/ALASKA NATIVE POPULATIONS THAN AMONG HISPANICS, AFRICAN AMERICANS, AND ASIAN AMERICANS, AND ARE JUST BELOW NON-HISPANIC WHITES. AI/AN OPIOID OVERDOSE RATES VARY SIGNIFICANTLY BY STATE AND COUNTY; HOWEVER, TRIBE-LEVEL DIFFERENCES ARE DIFFICULT TO ASCERTAIN DUE TO DECENTRALIZED DATA SYSTEMS THAT DIVIDE STATE HEALTH DATA AND INDIAN HEALTH SERVICE DATA. WHILE COUNTY-LEVEL HEALTH DATA IS OFTEN USED AS A PROXY FOR TRIBAL DATA, STATE DATA OFTEN MISCLASSIFY AN/AN PATIENTS, AND IN COUNTIES CONTAINING THE LANDS OF MULTIPLE TRIBES, COUNTY DATA MAY BLUR SIGNIFICANT INTER-TRIBAL VARIATION. IN ADDITION TO LIMITED TRIBE-SPECIFIC DATA, TREATMENT FOR OPIOID USE DISORDERS ALSO OFTEN FAILS TO ACCOUNT FOR THE DIVERSITY OF TRIBAL POPULATIONS. ON AVERAGE, PATIENTS WHO TAKE MEDICATION FOR OPIOID USE DISORDER (MOUD), AND SPECIFICALLY METHADONE OR BUPRENORPHINE, EXHIBIT IMPROVED TREATMENT RETENTION AND REDUCED RISK OF DRUG OVERDOSE COMPARED TO PATIENTS NOT TAKING MOUD. SOME RESEARCH ALSO SHOWS IMPROVED RETENTION FOR NALTREXONE, ANOTHER MOUD. BECAUSE MOUD INTERVENTIONS ARE RARELY TAILORED TO THE SPECIFIC CULTURAL CONTEXTS OF AI/AN PATIENTS, SOCIAL AND CULTURAL BARRIERS TO TREATMENT PERSIST IN AI/AN COMMUNITIES. TO ADDRESS THESE PROBLEMS, WE PROPOSE TO LEVERAGE CENTER FOR DISEASE CONTROL FUNDING AWARDED TO THE ALBUQUERQUE AREA SOUTHWEST TRIBAL EPIDEMIOLOGY CENTER (AASTEC) FOR IMPROVING DATA QUALITY IN OPIOID OVERDOSE SURVEILLANCE IN NEW MEXICO IN A TWO-PHASE RESEARCH PROJECT. THE PROJECT WILL DRAW UPON A COMMUNITY ADVISORY BOARD COMPOSED OF CLINICIANS AND INDIAN HEALTH FACILITY STAFF, AND USE A COLLABORATION OF EPIDEMIOLOGISTS FROM AASTEC AND THE NEW MEXICO DEPARTMENT OF HEALTH, AND ACADEMIC RESEARCHERS AT THE UNIVERSITY OF UTAH, UNIVERSITY OF NEW MEXICO, AND COLUMBIA UNIVERSITY. IN THE FIRST PHASE, WE WILL ENHANCE TRIBAL SPECIFICITY OF AI/AN OPIOID USE DISORDER AND OVERDOSE DATA BY LINKING AND GEOCODING NEW MEXICO VITAL STATISTICS AND SYNDROMIC SURVEILLANCE DATA. WE WILL THEN USE THESE DATA IN PREDICTIVE MODELS TO DETERMINE THE ROLE OF MODIFIABLE RISK AND PROTECTIVE FACTORS FOR SPECIFIC TRIBAL COMMUNITIES. WE WILL DISSEMINATE ANALYSIS REPORTS TO TRIBAL COMMUNITIES AND SEEK PARTNERSHIPS WITH TRIBES AND INDIAN HEALTH FACILITIES FOR THE SECOND PHASE OF OUR RESEARCH, WHICH ENTAILS A COMMUNITY-BASED PARTICIPATORY RESEARCH PROJECT THAT WILL DEVELOP AND TEST A CULTURALLY CENTERED IMPLEMENTATION PROGRAM FOR MOUD FOR USE IN AI/AN COMMUNITIES. WE WILL USE A STEPPED WEDGE RANDOMIZED DESIGN IN FOUR INDIAN HEALTH FACILITIES TO TEST INITIATION, RETENTION, RELAPSE, AND ACCEPTABILITY OF CULTURALLY CENTERED MOUD AMONG PATIENTS AND CLINIC STAFF OVER TIME. THE PROPOSED RESEARCH WILL STRENGTHEN PARTNERSHIPS BETWEEN TRIBAL COMMUNITIES, AASTEC, AND ACADEMIC RESEARCHERS, AND BETTER ALIGN OPIOID RESEARCH WITH TRIBAL VALUES AND PRIORITIES. WE ANTICIPATE OUR RESEARCH WILL NOT ONLY RESULT IN PUBLICATIONS IN ACADEMIC JOURNALS BUT WILL ALSO RESULT IN TOOLKITS FOR CREATING TRIBE-SPECIFIC DATA ESTIMATES FOR OTHER REGIONS, AND PROTOCOLS FOR CULTURALLY CENTERING MOUD FOR THE CONTEXTS OF OTHER AI/AN COMMUNITIES AND INDIAN HEALTH FACILITIES.
Department of Education
$1.3M
ACE: ACHIEVING COLLEGE EXCELLENCE 2020
Department of Health and Human Services
$1.3M
NORMS RE-EDUCATION TO PROMOTE ENGAGEMENT IN PARENT-BASED INTERVENTIONS: A TYPE 1 IMPLEMENTATION-EFFECTIVENESS TRIAL - PROJECT SUMMARY UNDERAGE DRINKING ON COLLEGE CAMPUSES REMAINS A SERIOUS PUBLIC HEALTH ISSUE. RESEARCH SUGGESTS THAT PARENT- BASED INTERVENTIONS (PBIS) THAT TARGET PARENTS OF INCOMING STUDENTS CAN BE POWERFUL ADJUNCTS TO EXISTING STUDENT-LEVEL ALCOHOL PROGRAMS. ALTHOUGH TURISSI’S PARENT HANDBOOK IS THE ONLY PBI RECOMMENDED BY THE NIAAA TO REDUCE ALCOHOL RISK DURING THE TRANSITION INTO COLLEGE, THIS “GOLD STANDARD” PBI HAS DEMONSTRATED ONLY MODEST EFFECTS ON STUDENT DRINKING IN TRIALS AND HAS RELIED ON MONETARY INCENTIVES TO FACILITATE PARENT ENGAGEMENT, WHICH DO NOT TRANSLATE TO EFFECTIVE REAL-WORLD IMPLEMENTATION. AS SUCH, IT IS IMPERATIVE TO DEVELOP EFFECTIVE PBIS THAT CAN BE IMPLEMENTED EASILY AND WITHOUT INCENTIVES. ONE EFFECTIVE MOTIVATIONAL PBI COMPONENT IDENTIFIED BY OUR LAB IS PERSONALIZED NORMATIVE FEEDBACK (PNF) DESIGNED TO CORRECT PARENTS’ MISPERCEPTIONS ABOUT FIRST-YEAR STUDENT DRINKING, OTHER PARENTS’ APPROVAL FOR SUCH DRINKING, AND ALCOHOL COMMUNICATION. FURTHER, OUR PILOT TRIAL FOUND THAT COUPLING PARENT HANDBOOK-LIKE PSYCHOEDUCATIONAL CONTENT WITH SUCH PNF IN A SOCIAL MEDIA-INSPIRED APP (PARENTCANDOR OR PC PNF+) PREVENTED AND DECREASED RISKY DRINKING IN STUDENTS WHEN PARENTS WERE NOT INCENTIVIZED. QUALITATIVE DATA COLLECTED FROM PARENTS ALSO SUGGESTED SEVERAL WAYS TO IMPROVE PARENTS’ ENGAGEMENT WITH THE PC PNF+ APP WHICH ARE LIKELY TO TRANSLATE INTO EVEN STRONGER EFFECTS THAN OBSERVED IN THE INITIAL TRIAL. BUILDING ON THIS WORK, PHASE 1 OF THIS PROJECT SEEKS TO OPTIMIZE THE PC PNF+ APP BASED ON PILOT PARENT FEEDBACK. FURTHER, FNFORMED BY THEIR COMMENTS ABOUT TIME CONSTRAINTS, WE WILL ALSO DEVELOP A LESS TIME-INTENSIVE, EMAIL-BASED SOCIAL NORMS MARKETING CAMPAIGN (SNMC+) PBI THAT COMMUNICATES SIMILAR NORMATIVE INFORMATION AS IN THE PC PNF+ APP WITH BREIF HANDBOOK-LIKE TIPS FOR PARENTING AROUND ALCOHOL. PHASE 1 WILL ALSO INCLUDE A NATIONAL NORMS DOCUMENTATION SURVEY (N=2000) OF PARENTS OF INCOMING COLLEGE STUDENTS TO IDENTIFY INCLUSIVE AND GENERALIZABLE NORMS TO FEATURE IN PNF+ AND SNMC+ INTERVENTIONS. ADDITIONALLY, PARENT FOCUS GROUPS AND INTERVIEWS WITH UNIVERSITY STAKEHOLDERS AT TWO SITES WILL BE CONDUCTED TO IDENTIFY HOW THESE PBI APPROACHES CAN BE PACKAGED TO MAXIMIZE USEFULNESS FROM THE PERSPECTIVES OF PARENTS AND UNIVERSITIES. THEN, IN PHASE 2, A LARGE, MULTI-SITE IMPLEMENTATION-EFFECTIVENESS TRIAL WITH THREE COHORTS OF FIRST-YEAR STUDENTS (N=2400) WILL COMPARE THE FEASIBILITY AND EFFECTIVENESS OF PNF+ AND SNMC+ AGAINST THE “GOLD STANDARD” HANDBOOK AND A NO-PBI CONTROL. PARENTS WILL BE INVITED BY THEIR CHILD’S UNIVERSITY TO ONE OF THE PBIS JUST AS THEY WOULD BE IN THE REAL-WORLD. WE WILL OBJECTIVELY EXAMINE WHICH PBI IS MOST ENGAGING TO PARENTS, AS WELL AS WHICH IS MOST EFFECTIVE AT PREVENTING AND REDUCING STUDENT DRINKING AND CONSEQUENCES. IN ADDITION, PARENT ENGAGEMENT, ALCOHOL APPROVAL, AND COMMUNICATION WILL BE EXAMINED AS MEDIATORS OF PBI EFFECTS ON STUDENT-LEVEL OUTCOMES. FINALLY, THE MOST ENGAGING AND EFFECTIVE PBI WILL BE FURTHER DISCUSSED WITH UNIVERSITY STAKEHOLDERS TO IDENTIFY WAYS TO INCREASE THE LIKELIHOOD OF REAL-WORLD ADOPTION.
Department of Health and Human Services
$1.3M
NEW MECHANISMS OF CARDIAC RYANODINE RECEPTOR DYSFUNCTION DURING OXIDATIVE STRESS: THE ROLE OF INTERSUBUNIT CROSS-LINKING - PROJECT SUMMARY/ABSTRACT CALCIUM (CA) RELEASE THROUGH THE RYANODINE RECEPTOR (RYR) CA CHANNEL IS ESSENTIAL FOR REGULAR HEART CONTRACTION. DEFECTS IN RYR REGULATION CAUSE AN IMBALANCE IN INTRACELLULAR CA HOMEOSTASIS IN A VARIETY OF CARDIAC DISEASES. THE MOST COMMON CARDIAC PATHOLOGY, SUCH AS MYOCARDIAL INFARCTION, IS ASSOCIATED WITH OXIDATIVE STRESS. RYR CONTAINS A LARGE NUMBER OF CYSTEINE RESIDUES THAT LINK OXIDATIVE STRESS AND CA HOMEOSTASIS. HOWEVER, THE PATHOLOGICALLY RELEVANT CYSTEINES WITHIN RYR REMAIN LARGELY UNKNOWN. AS A RESULT, THE MECHANISMS OF RYR DYSFUNCTION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION ARE NOT FULLY UNDERSTOOD. THIS DELAYS OUR PROGRESS IN DESIGNING EFFECTIVE THERAPEUTIC INTERVENTIONS THAT CAN IMPROVE CA HOMEOSTASIS DURING ISCHEMIC HEART DISEASES. THE MAIN GOAL OF THIS PROPOSAL IS TO DEFINE THE MOLECULAR MECHANISMS OF RYR DYSFUNCTION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION. WE HAVE RECENTLY DISCOVERED THAT OXIDATIVE STRESS ACTIVATES RYR BY FORMING DISULFIDE BONDS BETWEEN TWO NEIGHBORING SUBUNITS: THE INTERSUBUNIT CROSS-LINKING. IT APPEARS THAT ONLY TWO CROSS-LINKING CYSTEINES PLAY A CRITICAL ROLE IN THE RYR RESPONSE TO OXIDATIVE STRESS. IN THIS PROPOSAL WE WILL TEST THE HYPOTHESIS: THE INTERSUBUNIT CROSS-LINKING IS THE PRINCIPAL REDOX MODIFICATION OF RYR RESPONSIBLE FOR CA DYSREGULATION DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION. TO TEST THIS HYPOTHESIS, WE HAVE DEVELOPED A TRANSGENIC MOUSE MODEL WITH A UNIQUE RYR2 KNOCK-IN MUTATION THAT PROTECTS RYR FROM THE INTERSUBUNIT CROSS-LINKING. IN AIM 1, WE WILL DEFINE MOLECULAR MECHANISMS OF RYR DYSFUNCTION INDUCED BY THE INTERSUBUNIT CROSSLINKING. WE EXPECT TO SHOW THAT THE CROSS-LINKING ACTIVATES RYR2 BY PROMOTING LONGER CHANNEL OPENINGS. SUCH ALTERATION OF RYR FUNCTION INCREASES CA LEAK AND TRIGGERS PRO-ARRHYTHMOGENIC CA WAVES. WE EXPECT TO SHOW THAT RYR MUTATION THAT PROTECTS THE CHANNEL FROM THE CROSS-LINKING WILL NORMALIZE RYR ACTIVITY, REDUCE CA LEAK, AND PREVENT CA WAVES DURING OXIDATIVE STRESS. IN AIM 2, WE WILL DEFINE THE CRITICAL ROLE OF THE RYR INTERSUBUNIT CROSS-LINKING IN CA DYSREGULATION AND CONTRACTILE DYSFUNCTION DURING MYOCARDIAL INFARCTION. WE EXPECT TO SHOW THAT RYR MUTATION THAT PROTECTS THE CHANNEL FROM THE CROSSLINKING WILL NORMALIZE CARDIAC CA REGULATION AND IMPROVE MYOCARDIAL CONTRACTION IN THE INFARCTED HEART. WE WILL ALSO TEST WHETHER SELECTIVE PHARMACOLOGICAL INTERVENTIONS THAT STABILIZE RYR AT THE INTERSUBUNIT CROSS-LINKING REGION CAN REDUCE CA LEAK AND PREVENT CA WAVES DURING OXIDATIVE STRESS AND MYOCARDIAL INFARCTION.
Department of Education
$1.3M
LOYOLA MARYMOUNT UNIVERSITY MCNAIR SCHOLARS PROGRAM
Department of Education
$1.2M
UPWARD BOUND
Department of Education
$1.2M
UPWARD BOUND PROGRAM
Department of Education
$1.2M
ENGLISH LANGUAGE ACQUISITION: NATIONAL PROFESSIONAL DEVELOPMENT PROGRAM
Department of Health and Human Services
$1.2M
MOLECULAR AND CELLULAR DETERMINANTS OF TRIM5ALPHA RESTRICTION OF HIV-1
National Science Foundation
$1.2M
LOYOLA UNIVERSITY CHICAGO NOYCE SCHOLARS: TEACHING, LEARNING & LEADING WITH SCHOOLS AND COMMUNITIES -THIS PROJECT AIMS TO SERVE THE NATIONAL NEED OF RECRUITING, DEVELOPING, AND RETAINING A DIVERSE AND TALENTED GROUP OF HIGH SCHOOL SCIENCE AND MATHEMATICS TEACHERS WITH THE KNOWLEDGE, PRACTICES, AND DISPOSITIONS TO ENACT CULTURALLY RELEVANT STEM EDUCATION. THE PROJECT WILL IDENTIFY AND ATTRACT HIGH-ACHIEVING STEM MAJORS THROUGH SYSTEMATIC OUTREACH EFFORTS AND A TRY TEACHING STIPEND OPPORTUNITY. RECRUITMENT WILL TARGET A DIVERSE AND QUALIFIED POOL OF APPLICANTS THAT INCLUDES PEOPLE OF COLOR, FIRST GENERATION COLLEGE STUDENTS, VETERANS, AND MULTILINGUAL SPEAKERS. SCHOLARS WILL COMPLETE LOYOLA UNIVERSITY CHICAGO?S INITIAL TEACHER EDUCATION PROGRAM, ALIGNED WITH ILLINOIS? CULTURALLY RESPONSIVE TEACHING AND LEADING STANDARDS, AND DESIGNED TO SUPPORT DEVELOPMENT OF TEACHERS? DEEP UNDERSTANDING OF SUBJECT MATTER AND HOW IT CAN BE TRANSFORMATIVE TO STUDENTS? LIVES. COURSEWORK ALSO EMBEDS PREPARATION FOR EDUCATING MULTILINGUAL LEARNERS AND ENSURES ELIGIBILITY FOR THE STATE'S ENGLISH AS A SECOND LANGUAGE (ESL) ENDORSEMENT. INDUCTION SUPPORT WILL INCLUDE PARTICIPATION IN FIELD EXPERIENCES AND COACHING SHADOW DAYS IN PARTNER SCHOOLS, AS WELL AS ONGOING MENTORING AND COLLABORATIVE PROFESSIONAL LEARNING, ALL DESIGNED TO SUPPORT INSTRUCTIONAL EFFECTIVENESS AND RETENTION. IN THIS PROJECT, LOYOLA?S SCHOOL OF EDUCATION, COLLEGE OF ARTS AND SCIENCES, SCHOOL OF SUSTAINABILITY, AND CENTER FOR SCIENCE AND MATH EDUCATION WILL PARTNER WITH ILLINOIS DISTRICT 219 AND CHICAGO PUBLIC SCHOOLS. FIVE PROJECT GOALS GUIDE THE EXECUTION OF THE PROJECT. FIRST IS TO PROVIDE FINANCIAL AND OTHER SUPPORTS TO AT LEAST 19 HIGH-ACHIEVING PROSPECTIVE BIOLOGY, CHEMISTRY, PHYSICS, AND MATHEMATICS TEACHERS WHO COMMIT TO TEACHING IN HIGH-NEED SCHOOLS. SECOND IS TO INCREASE THE NUMBER AND DIVERSITY OF STEM MAJORS AND PROFESSIONALS ENTERING TEACHING. THE THIRD GOAL IS TO PREPARE CANDIDATES TO WORK WITH CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS, ENSURING THAT 100% OF SCHOLARS FULFILL REQUIREMENTS FOR THE STATE ENGLISH AS A SECOND LANGUAGE (ESL) ENDORSEMENT. FOURTH IS TO RETAIN TEACHERS IN CHICAGO HIGH-NEED SCHOOLS THROUGH RIGOROUS PREPARATION COMBINED WITH HIGH-QUALITY, MULTI-DIMENSIONAL INDUCTION SUPPORT. FINALLY, THE FIFTH GOAL IS TO STUDY PROGRAM DATA TO INFORM UNDERSTANDING OF URBAN STEM TEACHER PREPARATION, MENTORING, AND INDUCTION SUPPORT. SPECIFICALLY, PROGRAM RESEARCH WILL STUDY POTENTIAL CONNECTIONS AMONG CULTURALLY SUSTAINING INSTRUCTIONAL PRACTICES, INDUCTION SUPPORTS, AND TEACHER RETENTION. THIS TRACK 1: SCHOLARSHIPS AND STIPENDS PROJECT IS SUPPORTED THROUGH THE ROBERT NOYCE TEACHER SCHOLARSHIP PROGRAM (NOYCE). THE NOYCE PROGRAM SUPPORTS TALENTED STEM UNDERGRADUATE MAJORS AND PROFESSIONALS TO BECOME EFFECTIVE K-12 STEM TEACHERS AND EXPERIENCED, EXEMPLARY K-12 TEACHERS TO BECOME STEM MASTER TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. IT ALSO SUPPORTS RESEARCH ON THE EFFECTIVENESS AND RETENTION OF K-12 STEM TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
National Science Foundation
$1.2M
REDEFINING STEM TEACHER PREPARATION BY TEACHING, LEARNING ,AND LEADING WITH SCHOOLS AND COMMUNITIES
National Science Foundation
$1.2M
RECRUITING, PREPARING, AND RETAINING CULTURALLY RESPONSIVE AND EQUITY-MINDED STEM TEACHERS FOR HIGH-NEED SCHOOLS -THIS PROJECT WILL ADDRESS A CRITICAL TEACHER SHORTAGE IN MARYLAND?S URBAN, LOW-INCOME, AND RURAL SCHOOLS. TOWARDS THIS END THE PROJECT WILL RECRUIT AND PREPARE 28 SECONDARY STEM TEACHERS FOR TEACHER CERTIFICATION, LEADING TO CAREERS IN HIGH-NEED SCHOOLS. TO HELP DIVERSIFY THE TEACHER POOL, THE PROJECT LEADERS WILL PLACE PARTICULAR ATTENTION ON RECRUITING AND RETAINING TEACHERS OF COLOR AND THOSE FROM OTHER GROUPS WHO ARE SIMILARLY UNDERREPRESENTED IN THEIR PARTICIPATION IN THE STEM TEACHER PROFESSION. MAJOR PROJECT FEATURES INCLUDE: (1) INTEGRATION OF CULTURALLY RESPONSIVE TEACHING AND AMBITIOUS MATH AND SCIENCE TEACHING INTO A MASTER OF ARTS IN TEACHING (MAT) CURRICULUM; (2) OFFERING A CULTURALLY RESPONSIVE EQUITABLE STEM TEACHING (CREST) SEMINAR; AND (3) IMPLEMENTATION OF A CREST INDUCTION SERIES. BY SUPPORTING IMPROVEMENTS TO THE MAT PROGRAM, OFFERING SCHOLARSHIPS AND STIPENDS, AND IMPLEMENTING ROBUST INDUCTION SUPPORT, THIS PROJECT WILL ENHANCE STEM TEACHER PREPARATION AT LOYOLA AND INCREASE THE NUMBER OF QUALIFIED STEM TEACHERS IN MARYLAND. THE CULTURALLY RESPONSIVE EQUITABLE STEM TEACHING (CREST) PROJECT AT LOYOLA UNIVERSITY MARYLAND INCLUDES PARTNERSHIPS WITH THE LOCAL EDUCATION AGENCY (LEA), BALTIMORE COUNTY PUBLIC SCHOOLS. THREE KEY PROJECT GOALS INFORM THE EXECUTION OF THE PROJECT. FIRST IS TO RECRUIT, RETAIN, AND GRADUATE 28 HIGHLY QUALIFIED AND DIVERSE SECONDARY STEM TEACHING CANDIDATES OVER FIVE YEARS. SECOND IS TO PLACE 100% OF GRADUATES IN HIGH-NEED SCHOOLS THROUGH PARTNERSHIPS WITH LEAS, AND EMPLOYMENT AND INDUCTION SUPPORT; AND RETAIN 85% OF CREST GRADUATES IN HIGH-NEED SCHOOLS FOR THREE YEARS BY PROVIDING NEW TEACHER SUPPORT THROUGH A CREST INDUCTION SERIES. THIRD, AND FINALLY, IS TO IMPROVE THE QUALITY OF CULTURALLY RESPONSIVE STEM TEACHING PRACTICES OF PROSPECTIVE AND EARLY CAREER TEACHERS IN HIGH-NEED SCHOOLS WITH AN ENHANCED MASTER OF ART IN TEACHING CURRICULA AND AN INDUCTION SERIES. STUDENTS PARTICIPATING IN THIS PROJECT INCLUDE LOYOLA STEM BACHELOR?S DEGREE GRADUATES AND STEM PROFESSIONALS SEEKING A CAREER CHANGE. USING A COMBINATION OF CURRICULAR ACTIVITIES GROUNDED IN CULTURALLY RESPONSIVE TEACHING FOR PROSPECTIVE TEACHERS AND INDUCTION SUPPORT AS THEY ENTER THE PROFESSION, THIS PROJECT WILL IMPROVE THE QUALITY OF CULTURALLY RESPONSIVE STEM EDUCATION FOR STUDENTS IN HIGH-NEED CLASSROOMS. THE EFFECTIVENESS OF THE PROJECT ELEMENTS WILL BE ASSESSED THROUGH BOTH FORMATIVE AND SUMMATIVE DATA. THIS PROJECT WILL POTENTIALLY GENERATE NEW EVIDENCE ILLUMINATING EFFECTIVE STRATEGIES AND PRACTICES FOR RECRUITING, RETAINING, AND GRADUATING UNDERREPRESENTED POPULATIONS ENTERING STEM TEACHING CAREERS IN HIGH-NEED SCHOOLS, AND SERVE AS AN EXAMPLE FOR OTHER LIBERAL ARTS PRIVATE COLLEGES SEEKING TO DEVELOP AND EXPAND STEM TEACHER PREPARATION PROGRAMS. THIS TRACK 1: SCHOLARSHIPS AND STIPENDS PROJECT IS SUPPORTED THROUGH THE ROBERT NOYCE TEACHER SCHOLARSHIP PROGRAM (NOYCE). THE NOYCE PROGRAM SUPPORTS TALENTED STEM UNDERGRADUATE MAJORS AND PROFESSIONALS TO BECOME EFFECTIVE K-12 STEM TEACHERS AND EXPERIENCED, EXEMPLARY K-12 TEACHERS TO BECOME STEM MASTER TEACHERS IN HIGH-NEED SCHOOL DISTRICTS. IT ALSO SUPPORTS RESEARCH ON THE PERSISTENCE, RETENTION, AND EFFECTIVENESS OF K-12 STEM TEACHERS IN HIGH-NEED SCHOOLS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Department of Health and Human Services
$1.2M
ADVANCED NURSING EDUCATION GRANTS
Department of Health and Human Services
$1.2M
NURSE FACULTY LOAN PROGRAM
National Science Foundation
$1.2M
LIONS ROAR: LMU NOYCE SCHOLARSHIP PROGRAM
Department of Health and Human Services
$1.2M
OSTEOPONTIN REGULATES UBIQUITIN-PROTEASOME DEGRADATION OF STAT1
Department of the Interior
$1.2M
THE U.S. FISH AND WILDLIFE SERVICE (USFWS) SHIAWASSEE NATIONAL WILDLIFE REFUGE (SNWR) PROPOSES TO CONTROL 200 ACRES OF INVASIVE PLANTS, INCREASE WATERBIRD UTILIZATION, AND REDUCE NUTRIENT RUN-OFF TO THE SAGINAW BAY AREA OF CONCERN THROUGH AN INNOVATIVE MULTI-YEAR RESTORATION AND RESEARCH PROJECT. THIS PROJECT ADDRESSES GLRI ACTION PLAN III PRIORITIES (FOCUS AREA 2) WHICH CALLS TO DEVELOP INVASIVE SPECIES CONTROL TECHNOLOGIES AND REFINE MANAGEMENT TECHNIQUES WITH INNOVATIVE EMERGING TECHNOLOGY, IMPLEMENTED AT A LARGE SCALE.WE PROPOSE TO HARVEST INVASIVE HYBRID CATTAIL (TYPHA X GLAUCA) BIOMASS FROM THE 288-ACRE MAANKIKI SOUTH UNIT WITHIN THE SNWR, CONVERT IT TO BIOCHAR ON-SITE, AND RE-APPLY THE BIOCHAR TO A PORTION OF THE UNIT. THE MAANKIKI SOUTH UNIT WAS RESTORED TO WETLAND FROM AGRICULTURAL FIELDS THROUGH A GLRI-FUNDED RESTORATION PROJECT. HOWEVER, DUE TO ITS LEGACY OF AGRICULTURE AND WATERSHED NUTRIENT ENRICHMENT, THE UNIT QUICKLY BECAME DOMINATED BY HYBRID CATTAIL, ALTERING THE WETLAND S ECOLOGICAL FUNCTIONS AND REDUCING HABITAT QUALITY FOR WATERBIRDS. MANAGING THE CATTAIL WITHIN THE UNIT IS THEREFORE A HIGH PRIORITY FOR SNWR.IN THIS PROJECT, WE WILL MANAGE INVASIVE CATTAILS TO THE BENEFIT OF WATERBIRDS ACROSS 200 ACRES OF MAANKIKI SOUTH UNIT, WHILE SIMULTANEOUSLY CONDUCTING A LARGE-SCALE EXPERIMENT TO TEST THE COMBINED EFFICACY OF INVASIVE SPECIES BIOMASS-HARVEST AND BIOCHAR RE-APPLICATION TO ACHIEVE MULTIPLE BENEFITS. WE WILL ESTABLISH A MULTI-YEAR, HIGHLY REPLICATED EXPERIMENT WITH LARGE 2.5-ACRE PLOTS, TWO LEVEL OF BIOCHAR APPLICATION, TWO-LEVELS OF REPEATED HARVEST, AND CONTROLS. WE WILL HARVEST BIOMASS ANNUALLY WITH ALLOW-GROUND-PRESSURE PLANT HARVESTER AND PROCESS IT ON-SITE WITH A MOBILE BIOCHAR PRODUCTION UNIT. THROUGHOUT THE 4-YEAR STUDY, WE WILL MONITOR PLANT RESPONSE, BIRD UTILIZATION, SOIL NUTRIENT LEVELS, PLANT AVAILABLE NUTRIENTS, SOIL CARBON CONTENT, AND NUTRIENT EXPORT FROM THE UNIT.THIS PROJECT BUILDS DIRECTLY ON GLRI SUPPORTED PROJECTS TO RESTORE MAANKIKI SOUTH UNIT AND TO DEVELOP INNOVATIVE INVASIVE PLANT MANAGEMENT TECHNIQUES. WE ANTICIPATE BROAD ECOLOGICAL BENEFITS INCLUDING THE LONG-TERM REDUCTION OF INVASIVE PLANT DOMINANCE, INCREASED WATERBIRD HABITAT, REDUCED DOWNSTREAM NUTRIENT RUNOFF, AND INCREASED CARBON STORAGE. KNOWLEDGE GAINED WILL BE USED TO DEVELOP MANAGEMENT PROTOCOLS FOR INVASIVE PLANT HARVEST, CONVERSION TO BIOCHAR AND WETLAND RE-APPLICATION.
Department of Health and Human Services
$1.2M
DYNAMICS AND CONTROL OVER HOST-ASSOCIATED BIOFILM FORMATION AND DISPERSAL
Department of Defense
$1.1M
PRESERVATION OF SKELETAL MUSCLE FOLLOWING FROSTBITE INJURY
Department of Health and Human Services
$1.1M
SPANISH-SPEAKING LATINOS' EARLY LANGUAGE ENVIRONMENTS AND DUAL LANGUAGE DEVELOPMENT
Department of Education
$1.1M
STUDENT SUPPORT SERVICES PROGRAM
Department of Health and Human Services
$1.1M
MOTS: MODELING OBESITY THROUGH SIMULATION
Agency for International Development
$1.1M
LOYOLA UNIVERSITY OF CHICAGO WILL INCREASE DEVELOPMENT IN CUBA THROUGH A COMPREHENSIVE PROGRAM TO RAISE THE PERFORMANCE OF CIVIL SOCIETY S BUILDING B
Department of Health and Human Services
$1.1M
INFLAMMATORY RESPONSE AFTER COMBINED INSULT OF RADIATION AND BURN INJURY
Department of Education
$1.1M
STUDENT SUCCESS SUPPORT SERVICES AT LOYOLA UNIVERSITY NEW ORLEANS
Department of Education
$1.1M
LOYOLA MARYMOUNT UNIVERSITY MCNAIR SCHOLARS PROGRAM
Department of Health and Human Services
$1.1M
ROLE OF SEROTONIN IN SMYPATHETIC FUNCTION
Department of Health and Human Services
$1.1M
INTERACTIONS BETWEEN P90 RIBOSOMAL S6 KINASE AND PROTEIN KINASE A
Department of Health and Human Services
$1.1M
MECHANISMS OF IMPAIRED ERYTHROPOIESIS IN POST BURN ANEMIA OF CRITICAL ILLNESS
Department of Health and Human Services
$1.1M
REGULATION OF THE CHEMOKINE RECEPTOR CXCR4 BY UBIQUITIN
Department of Health and Human Services
$1.1M
BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING PROGRAM
Department of Health and Human Services
$1.1M
ADVANCED NURSING EDUCATION GRANTS
Department of Education
$1.1M
STUDENT SUPPORT SERVICES PROGRAM
Department of Defense
$1.1M
NOVEL APPROACHES TO DESTROYING BIOTHREAT AGENTS
Department of Education
$1M
DEVELOPING FUTURE GLOBAL BUSINESS LEADERS TO INCREASE GLOBAL COMPETITIVENESS OF U.S. COMPANIES
Department of Health and Human Services
$1M
URINARY KNOWLEDGE STUDY (U-KNOW)
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2024 · Source: IRS e-Filed Form 990
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023 | $241K | $48.6K | $262.9K | $282.9K | $282.3K |
| 2022 | $267.3K | $82.1K | $258.7K | $305.5K | $299.5K |
| 2021 | $247.9K | $64.9K | $249.3K | $344.3K | $311.9K |
| 2020 | $231.4K | $40.9K | $246.3K | $321.9K |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | PDF not yet published by IRSView Filing → |
| 2022 | 990 | Data |
Financial data: IRS Form 990 via ProPublica Nonprofit Explorer (Tax Year 2023)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Kathleen Andrus | President | 10 | $0 | $0 | $0 | $0 |
| Karin Wille | Secretary | 10 | $0 | $0 | $0 | $0 |
| Bill O'Brien | Treasurer | 10 | $0 | $0 | $0 | $0 |
Kathleen Andrus
President
$0
Hrs/Wk
10
Compensation
$0
Related Orgs
$0
Other
$0
Karin Wille
Secretary
$0
Hrs/Wk
10
Compensation
$0
Related Orgs
$0
Other
$0
Bill O'Brien
Treasurer
$0
Hrs/Wk
10
Compensation
$0
Related Orgs
$0
Other
$0
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Caren Dewar | Board Member | 10 | $0 | $0 | $0 | $0 |
| Mike O'Donnell | Board Member | 10 | $0 | $0 | $0 | $0 |
Caren Dewar
Board Member
$0
Hrs/Wk
10
Compensation
$0
Related Orgs
$0
Other
$0
Mike O'Donnell
Board Member
$0
Hrs/Wk
10
Compensation
$0
Related Orgs
$0
Other
$0
| $287.9K |
| 2019 | $228.4K | $43.5K | $226.7K | $312.6K | $308.8K |
| 2018 | $226.7K | $43.7K | $209K | $301.7K | $297.1K |
| 2017 | $232.4K | $57.6K | $198K | $285.4K | $277.5K |
| 2016 | $276.3K | $67.7K | $249.4K | $243.4K | $236.6K |
| 2015 | $272.7K | $77.8K | $261.1K | $185.8K | $182.4K |
| 2014 | $309.5K | $50K | $402.6K | $172.7K | $168.5K |
| 2013 | $305.3K | $38.1K | $370.3K | $251.3K | $247K |
| 2011 | $252.1K | $59.3K | $342.1K | $319.3K | $286.2K |
| 2021 | 990 | Data | PDF not yet published by IRS |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data | PDF not yet published by IRS |
| 2012 | 990 | — |
| 2011 | 990 | Data |
| 2010 | 990-EZ | — |
| 2009 | 990-EZ | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |